<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://lv.abol.hr/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/" />
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/" />
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/" />
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/" />
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/supplement/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/supplement/" />
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/supplement/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/supplement/" />
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/o-nama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/o-nama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/o-nama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/o-nama/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/o-nama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/o-nama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/o-nama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/o-nama/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/impressum/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/impressum/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/impressum/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/impressum/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/impressum/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/impressum/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/impressum/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/impressum/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/vlasnistvo-i-upravljanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/vlasnistvo-i-upravljanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/vlasnistvo-i-upravljanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/vlasnistvo-i-upravljanje/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/vlasnistvo-i-upravljanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/vlasnistvo-i-upravljanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/vlasnistvo-i-upravljanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/vlasnistvo-i-upravljanje/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/urednicki-odbor/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/urednicki-odbor/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/urednicki-odbor/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/urednicki-odbor/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/urednicki-odbor/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/urednicki-odbor/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/urednicki-odbor/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/urednicki-odbor/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/publicisticka-etika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/publicisticka-etika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/publicisticka-etika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/publicisticka-etika/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/publicisticka-etika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/publicisticka-etika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/publicisticka-etika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/publicisticka-etika/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/upute-autorima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/upute-autorima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/upute-autorima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/upute-autorima/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/upute-autorima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/upute-autorima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/upute-autorima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/upute-autorima/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/izjave/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/izjave/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/izjave/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/izjave/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/izjave/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/izjave/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/izjave/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/izjave/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/podsjetnik/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/podsjetnik/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/podsjetnik/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/podsjetnik/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/podsjetnik/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/podsjetnik/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/podsjetnik/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/podsjetnik/" />
    <lastmod>2026-07-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/naknade-za-autore/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/naknade-za-autore/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/naknade-za-autore/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/naknade-za-autore/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/naknade-za-autore/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/naknade-za-autore/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/naknade-za-autore/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/naknade-za-autore/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/prenosenje-autorskih-prava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/prenosenje-autorskih-prava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/prenosenje-autorskih-prava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/prenosenje-autorskih-prava/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/prenosenje-autorskih-prava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/prenosenje-autorskih-prava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/prenosenje-autorskih-prava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/prenosenje-autorskih-prava/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/arhiva-od-2003/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/arhiva-od-2003/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/arhiva-od-2003/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/arhiva-od-2003/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/arhiva-od-2003/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/arhiva-od-2003/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/arhiva-od-2003/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/arhiva-od-2003/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/arhiva-od-1877/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/arhiva-od-1877/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/arhiva-od-1877/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/arhiva-od-1877/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/arhiva-od-1877/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/arhiva-od-1877/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/arhiva-od-1877/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/arhiva-od-1877/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/info/supplement/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/supplement/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/info/supplement/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/info/supplement/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/info/supplement/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2026&amp;issue=4307</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4307" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2026&amp;issue=4307" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4307" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2026&amp;issue=4307</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4307" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2026&amp;issue=4307" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4307" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2026/1-2_LV_2026.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2026&amp;issue=4338</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4338" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2026&amp;issue=4338" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4338" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2026&amp;issue=4338</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4338" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2026&amp;issue=4338" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2026&amp;issue=4338" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2026/3-4_LV_2026.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2025&amp;issue=4284</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4284" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4284" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4284" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2025&amp;issue=4284</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4284" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4284" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4284" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2025/1-2_LV_2025.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2025&amp;issue=4303</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4303" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4303" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4303" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2025&amp;issue=4303</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4303" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4303" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4303" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2025/11-12_LV_2025.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2025&amp;issue=4286</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4286" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4286" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4286" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2025&amp;issue=4286</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4286" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4286" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4286" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2025/3-4_LV_2025.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2025&amp;issue=4290</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4290" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4290" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4290" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2025&amp;issue=4290</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4290" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4290" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4290" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2025/5-6_LV_2025.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2025&amp;issue=4299</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4299" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4299" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4299" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2025&amp;issue=4299</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4299" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4299" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4299" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2025/7-8_LV_2025.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2025&amp;issue=4301</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4301" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4301" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4301" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2025&amp;issue=4301</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4301" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2025&amp;issue=4301" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2025&amp;issue=4301" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2025/9-10_LV_2025.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2024&amp;issue=4317</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4317" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4317" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4317" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2024&amp;issue=4317</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4317" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4317" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4317" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2024/1-2_LV_2024.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2024&amp;issue=4281</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4281" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4281" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4281" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2024&amp;issue=4281</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4281" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4281" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4281" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2024/11-12_LV_2024.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2024&amp;issue=4273</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4273" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4273" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4273" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2024&amp;issue=4273</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4273" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4273" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4273" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2024/3-4_LV_2024.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2024&amp;issue=4275</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4275" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4275" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4275" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2024&amp;issue=4275</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4275" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4275" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4275" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2024/5-6_LV_2024.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2024&amp;issue=4277</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4277" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4277" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4277" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2024&amp;issue=4277</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4277" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4277" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4277" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2024/7-8_LV_2024.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2024&amp;issue=4278</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4278" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4278" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4278" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2024&amp;issue=4278</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4278" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2024&amp;issue=4278" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2024&amp;issue=4278" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2024/9-10_LV_2024.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2023&amp;issue=4255</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4255" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4255" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4255" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2023&amp;issue=4255</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4255" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4255" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4255" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2023/1-2_LV_2023.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2023&amp;issue=4270</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4270" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4270" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4270" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2023&amp;issue=4270</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4270" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4270" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4270" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2023/11-12_LV_2023.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2023&amp;issue=4257</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4257" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4257" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4257" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2023&amp;issue=4257</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4257" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4257" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4257" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2023/3-4_LV_2023.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2023&amp;issue=4262</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4262" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4262" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4262" />
    <lastmod>2023-07-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2023&amp;issue=4262</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4262" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4262" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4262" />
    <lastmod>2023-07-27</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2023/5-6_LV_2023.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2023&amp;issue=4265</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4265" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4265" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4265" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2023&amp;issue=4265</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4265" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4265" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4265" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2023/7-8_LV_2023.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2023&amp;issue=4267</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4267" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4267" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4267" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2023&amp;issue=4267</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4267" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2023&amp;issue=4267" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2023&amp;issue=4267" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2023/9-10_LV_2023.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2022&amp;issue=4237</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4237" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4237" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4237" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2022&amp;issue=4237</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4237" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4237" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4237" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2022/1-2_LV_2022.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2022&amp;issue=4234</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4234" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4234" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4234" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2022&amp;issue=4234</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4234" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4234" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4234" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2022/11-12_LV_2022.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2022&amp;issue=4250</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4250" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4250" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4250" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2022&amp;issue=4250</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4250" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4250" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4250" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2022/3-4_LV_2022.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2022&amp;issue=4251</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4251" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4251" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4251" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2022&amp;issue=4251</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4251" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4251" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4251" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2022/5-6_LV_2022.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2022&amp;issue=4252</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4252" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4252" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4252" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2022&amp;issue=4252</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4252" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4252" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4252" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2022/7-8_LV_2022.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2022&amp;issue=4253</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4253" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4253" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4253" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2022&amp;issue=4253</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4253" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2022&amp;issue=4253" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2022&amp;issue=4253" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2022/9-10_LV_2022.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2021&amp;issue=4235</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4235" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4235" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4235" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2021&amp;issue=4235</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4235" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4235" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4235" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2021/1-2_LV_2021.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2021&amp;issue=4246</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4246" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4246" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4246" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2021&amp;issue=4246</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4246" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4246" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4246" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2021/11-12_LV_2021.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2021&amp;issue=4236</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4236" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4236" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4236" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2021&amp;issue=4236</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4236" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4236" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4236" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2021/3-4_LV_2021.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2021&amp;issue=4238</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4238" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4238" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4238" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2021&amp;issue=4238</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4238" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4238" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4238" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2021/5-6_LV_2021.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2021&amp;issue=4240</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4240" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4240" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4240" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2021&amp;issue=4240</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4240" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4240" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4240" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2021/7-8_LV_2021.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2021&amp;issue=4239</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4239" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4239" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4239" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2021&amp;issue=4239</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4239" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2021&amp;issue=4239" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2021&amp;issue=4239" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2021/9-10_LV_2021.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2020&amp;issue=4222</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4222" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4222" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4222" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2020&amp;issue=4222</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4222" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4222" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4222" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2020/1-2_LV_2020.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2020&amp;issue=4232</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4232" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4232" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4232" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2020&amp;issue=4232</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4232" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4232" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4232" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2020/11-12_LV_2020.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2020&amp;issue=4225</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4225" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4225" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4225" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2020&amp;issue=4225</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4225" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4225" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4225" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2020/3-4_LV_2020.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2020&amp;issue=4212</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4212" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4212" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4212" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2020&amp;issue=4212</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4212" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4212" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4212" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2020/5-6_LV_2020.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2020&amp;issue=4228</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4228" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4228" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4228" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2020&amp;issue=4228</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4228" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4228" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4228" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2020/7-8_LV_2020.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2020&amp;issue=4230</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4230" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4230" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4230" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2020&amp;issue=4230</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4230" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2020&amp;issue=4230" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2020&amp;issue=4230" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2020/9-10_LV_2020.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2019&amp;issue=4209</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4209" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4209" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4209" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2019&amp;issue=4209</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4209" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4209" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4209" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2019&amp;issue=4221</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4221" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4221" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4221" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2019&amp;issue=4221</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4221" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4221" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4221" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2019/11-12_LV_2019.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2019&amp;issue=4210</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4210" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4210" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4210" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2019&amp;issue=4210</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4210" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4210" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4210" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2019&amp;issue=4213</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4213" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4213" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4213" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2019&amp;issue=4213</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4213" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4213" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4213" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2019/5-6_LV_2019.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2019&amp;issue=4217</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4217" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4217" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4217" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2019&amp;issue=4217</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4217" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4217" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4217" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2019/7-8_LV_2019.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2019&amp;issue=4218</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4218" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4218" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4218" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2019&amp;issue=4218</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4218" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2019&amp;issue=4218" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2019&amp;issue=4218" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2019/9-10_LV_2019.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2018&amp;issue=4198</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4198" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4198" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4198" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2018&amp;issue=4198</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4198" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4198" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4198" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2018/1-2_LV_2018.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2018&amp;issue=4207</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4207" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4207" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4207" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2018&amp;issue=4207</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4207" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4207" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4207" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2018/11-12_LV_2018.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2018&amp;issue=4199</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4199" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4199" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4199" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2018&amp;issue=4199</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4199" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4199" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4199" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2018/3-4_LV_2018.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2018&amp;issue=4201</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4201" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4201" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4201" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2018&amp;issue=4201</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4201" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4201" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4201" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2018/5-6_LV_2018.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2018&amp;issue=4203</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4203" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4203" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4203" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2018&amp;issue=4203</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4203" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4203" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4203" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2018/7-8_LV_2018.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2018&amp;issue=4206</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4206" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4206" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4206" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2018&amp;issue=4206</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4206" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2018&amp;issue=4206" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2018&amp;issue=4206" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2018/9-10_LV_2018.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2017&amp;issue=4183</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4183" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4183" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4183" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2017&amp;issue=4183</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4183" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4183" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4183" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2017/1-2_LV_2017.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2017&amp;issue=4197</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4197" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4197" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4197" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2017&amp;issue=4197</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4197" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4197" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4197" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2017&amp;issue=4185</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4185" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4185" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4185" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2017&amp;issue=4185</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4185" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4185" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4185" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2017/3-4_LV_2017.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2017&amp;issue=4314</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4314" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4314" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4314" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2017&amp;issue=4314</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4314" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4314" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4314" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2017/5-6_LV_2017.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2017&amp;issue=4315</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4315" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4315" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4315" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2017&amp;issue=4315</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4315" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4315" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4315" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2017&amp;issue=4316</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4316" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4316" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4316" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2017&amp;issue=4316</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4316" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2017&amp;issue=4316" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2017&amp;issue=4316" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2017/9-10_LV_2017.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2016&amp;issue=4249</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4249" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4249" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4249" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2016&amp;issue=4249</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4249" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4249" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4249" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2016&amp;issue=4182</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4182" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4182" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4182" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2016&amp;issue=4182</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4182" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4182" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4182" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2016/11-12_LV_2016.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2016&amp;issue=4184</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4184" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4184" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4184" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2016&amp;issue=4184</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4184" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4184" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4184" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2016/3-4_LV_2016.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2016&amp;issue=4174</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4174" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4174" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4174" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2016&amp;issue=4174</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4174" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4174" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4174" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2016/5-6_LV_2016.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2016&amp;issue=4179</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4179" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4179" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4179" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2016&amp;issue=4179</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4179" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4179" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4179" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2016/7-8_LV_2016.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2016&amp;issue=4181</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4181" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4181" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4181" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2016&amp;issue=4181</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4181" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2016&amp;issue=4181" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2016&amp;issue=4181" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2016/9-10_LV_2016.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2015&amp;issue=4152</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4152" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4152" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4152" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2015&amp;issue=4152</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4152" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4152" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4152" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2015&amp;issue=4162</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4162" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4162" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4162" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2015&amp;issue=4162</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4162" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4162" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4162" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2015&amp;issue=4155</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4155" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4155" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4155" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2015&amp;issue=4155</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4155" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4155" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4155" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2015&amp;issue=4156</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4156" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4156" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4156" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2015&amp;issue=4156</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4156" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4156" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4156" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2015&amp;issue=4159</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4159" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4159" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4159" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2015&amp;issue=4159</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4159" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4159" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4159" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2015&amp;issue=4160</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4160" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4160" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4160" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2015&amp;issue=4160</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4160" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2015&amp;issue=4160" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2015&amp;issue=4160" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2014&amp;issue=4133</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4133" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4133" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4133" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2014&amp;issue=4133</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4133" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4133" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4133" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2014&amp;issue=4149</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4149" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4149" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4149" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2014&amp;issue=4149</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4149" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4149" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4149" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2014&amp;issue=4136</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4136" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4136" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4136" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2014&amp;issue=4136</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4136" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4136" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4136" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2014&amp;issue=4138</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4138" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4138" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4138" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2014&amp;issue=4138</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4138" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4138" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4138" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2014&amp;issue=4142</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4142" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4142" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4142" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2014&amp;issue=4142</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4142" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4142" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4142" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2014&amp;issue=4147</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4147" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4147" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4147" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2014&amp;issue=4147</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4147" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2014&amp;issue=4147" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2014&amp;issue=4147" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2013&amp;issue=4115</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4115" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4115" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4115" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2013&amp;issue=4115</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4115" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4115" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4115" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2013&amp;issue=4131</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4131" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4131" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4131" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2013&amp;issue=4131</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4131" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4131" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4131" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2013&amp;issue=4118</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4118" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4118" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4118" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2013&amp;issue=4118</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4118" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4118" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4118" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2013&amp;issue=4121</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4121" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4121" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4121" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2013&amp;issue=4121</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4121" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4121" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4121" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2013&amp;issue=4125</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4125" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4125" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4125" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2013&amp;issue=4125</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4125" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4125" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4125" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2013&amp;issue=4128</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4128" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4128" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4128" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2013&amp;issue=4128</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4128" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2013&amp;issue=4128" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2013&amp;issue=4128" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2012&amp;issue=4086</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4086" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4086" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4086" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2012&amp;issue=4086</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4086" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4086" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4086" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2012&amp;issue=4111</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4111" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4111" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4111" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2012&amp;issue=4111</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4111" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4111" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4111" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2012&amp;issue=4088</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4088" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4088" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4088" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2012&amp;issue=4088</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4088" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4088" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4088" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2012&amp;issue=4091</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4091" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4091" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4091" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2012&amp;issue=4091</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4091" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4091" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4091" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2012&amp;issue=4124</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4124" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4124" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4124" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2012&amp;issue=4124</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4124" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4124" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4124" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2012&amp;issue=4100</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4100" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4100" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4100" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2012&amp;issue=4100</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4100" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2012&amp;issue=4100" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2012&amp;issue=4100" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2011&amp;issue=4063</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4063" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4063" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4063" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2011&amp;issue=4063</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4063" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4063" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4063" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2011&amp;issue=4082</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4082" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4082" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4082" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2011&amp;issue=4082</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4082" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4082" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4082" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2011&amp;issue=4067</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4067" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4067" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4067" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2011&amp;issue=4067</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4067" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4067" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4067" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2011&amp;issue=4072</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4072" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4072" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4072" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2011&amp;issue=4072</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4072" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4072" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4072" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2011&amp;issue=4074</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4074" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4074" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4074" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2011&amp;issue=4074</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4074" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4074" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4074" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2011/7-8_LV_2011.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2011&amp;issue=4080</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4080" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4080" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4080" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2011&amp;issue=4080</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4080" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2011&amp;issue=4080" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2011&amp;issue=4080" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2010&amp;issue=4066</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4066" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4066" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4066" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2010&amp;issue=4066</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4066" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4066" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4066" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2010/1-2_LV_2010.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2010&amp;issue=4059</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4059" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4059" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4059" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2010&amp;issue=4059</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4059" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4059" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4059" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2010&amp;issue=4312</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4312" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4312" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4312" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2010&amp;issue=4312</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4312" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4312" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4312" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2010/3-4_LV_2010.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2010&amp;issue=4051</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4051" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4051" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4051" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2010&amp;issue=4051</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4051" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4051" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4051" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2010/5-6_LV_2010.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2010&amp;issue=4126</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4126" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4126" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4126" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2010&amp;issue=4126</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4126" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4126" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4126" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2010/7-8_LV_2010.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2010&amp;issue=4057</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4057" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4057" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4057" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2010&amp;issue=4057</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4057" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2010&amp;issue=4057" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2010&amp;issue=4057" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2009&amp;issue=4017</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4017" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4017" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4017" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2009&amp;issue=4017</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4017" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4017" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4017" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2009/1-2_LV_2009.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2009&amp;issue=4112</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4112" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4112" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4112" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2009&amp;issue=4112</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4112" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4112" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4112" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2009/11-12_LV_2009.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2009&amp;issue=4022</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4022" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4022" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4022" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2009&amp;issue=4022</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4022" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4022" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4022" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2009/3-4_LV_2009.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2009&amp;issue=4311</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4311" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4311" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4311" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2009&amp;issue=4311</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4311" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4311" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4311" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2009/5-6_LV_2009.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2009&amp;issue=4029</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4029" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4029" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4029" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2009&amp;issue=4029</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4029" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4029" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4029" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2009/7-8_LV_2009.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2009&amp;issue=4037</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4037" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4037" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4037" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2009&amp;issue=4037</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4037" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2009&amp;issue=4037" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2009&amp;issue=4037" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2009/9-10_LV_2009.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2008&amp;issue=3925</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=3925" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=3925" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=3925" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2008&amp;issue=3925</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=3925" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=3925" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=3925" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2008/1-2_LV_2008.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2008&amp;issue=4336</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4336" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4336" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4336" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2008&amp;issue=4336</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4336" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4336" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4336" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2008/11-12_LV_2008.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2008&amp;issue=4332</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4332" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4332" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4332" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2008&amp;issue=4332</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4332" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4332" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4332" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2008/3-4_LV_2008.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2008&amp;issue=4333</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4333" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4333" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4333" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2008&amp;issue=4333</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4333" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4333" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4333" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2008/5-6_LV_2008.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2008&amp;issue=4334</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4334" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4334" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4334" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2008&amp;issue=4334</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4334" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4334" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4334" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2008/7-8_LV_2008.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2008&amp;issue=4335</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4335" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4335" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4335" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2008&amp;issue=4335</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4335" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2008&amp;issue=4335" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2008&amp;issue=4335" />
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2008/9-10_LV_2008.pdf</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=4326</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4326" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4326" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4326" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=4326</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4326" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4326" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4326" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2007/1-2_LV_2007.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=4330</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4330" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4330" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4330" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=4330</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4330" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4330" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4330" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/10-11-2007/10-11_LV_2007.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=4331</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4331" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4331" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4331" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=4331</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4331" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4331" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4331" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/12-2007/12_LV_2007.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=4327</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4327" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4327" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4327" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=4327</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4327" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4327" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4327" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2007/3-4_LV_2007.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=4328</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4328" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4328" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4328" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=4328</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4328" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4328" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4328" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-2007/5_LV_2007.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=4329</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4329" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4329" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4329" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=4329</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4329" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=4329" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=4329" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/6-7-2007/6-7_LV_2007.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2007&amp;issue=3999</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=3999" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=3999" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=3999" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2007&amp;issue=3999</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=3999" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2007&amp;issue=3999" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2007&amp;issue=3999" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/8-9-2007/8-9_LV_2007.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2006&amp;issue=4322</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4322" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4322" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4322" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2006&amp;issue=4322</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4322" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4322" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4322" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2006/1-2_LV_2006.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2006&amp;issue=4325</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4325" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4325" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4325" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2006&amp;issue=4325</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4325" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4325" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4325" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2006/11-12_LV_2006.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2006&amp;issue=4323</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4323" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4323" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4323" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2006&amp;issue=4323</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4323" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4323" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4323" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2006/3-4_LV_2006.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2006&amp;issue=3924</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3924" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=3924" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3924" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2006&amp;issue=3924</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3924" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=3924" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3924" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2006/5-6_LV_2006.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2006&amp;issue=4324</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4324" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4324" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4324" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2006&amp;issue=4324</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4324" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=4324" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=4324" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2006/7-8_LV_2006.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2006&amp;issue=3984</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3984" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=3984" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3984" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2006&amp;issue=3984</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3984" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2006&amp;issue=3984" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2006&amp;issue=3984" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2006/9-10_LV_2006.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2005&amp;issue=3961</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=3961" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=3961" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=3961" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2005&amp;issue=3961</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=3961" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=3961" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=3961" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2005/1-2_LV_2005.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2005&amp;issue=4321</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4321" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4321" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4321" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2005&amp;issue=4321</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4321" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4321" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4321" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2005/11-12_LV_2005.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2005&amp;issue=4318</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4318" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4318" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4318" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2005&amp;issue=4318</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4318" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4318" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4318" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2005/3-4_LV_2005.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2005&amp;issue=4310</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4310" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4310" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4310" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2005&amp;issue=4310</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4310" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4310" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4310" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2005&amp;issue=4319</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4319" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4319" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4319" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2005&amp;issue=4319</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4319" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4319" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4319" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2005/7-8_LV_2005.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2005&amp;issue=4320</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4320" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4320" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4320" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2005&amp;issue=4320</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4320" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2005&amp;issue=4320" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2005&amp;issue=4320" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2005/9-10_LV_2005.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2004&amp;issue=3948</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3948" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3948" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3948" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2004&amp;issue=3948</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3948" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3948" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3948" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2004/1-2_LV_2004.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2004&amp;issue=3960</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3960" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3960" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3960" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2004&amp;issue=3960</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3960" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3960" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3960" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2004/11-12_LV_2004.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2004&amp;issue=3951</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3951" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3951" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3951" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2004&amp;issue=3951</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3951" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3951" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3951" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2004/3-4_LV_2004.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2004&amp;issue=3952</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3952" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3952" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3952" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2004&amp;issue=3952</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3952" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3952" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3952" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2004/5-6_LV_2004.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2004&amp;issue=3955</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3955" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3955" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3955" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2004&amp;issue=3955</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3955" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3955" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3955" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2004/7-8_LV_2004.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2004&amp;issue=3958</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3958" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3958" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3958" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2004&amp;issue=3958</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3958" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2004&amp;issue=3958" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2004&amp;issue=3958" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2004/9-10_LV_2004.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2003&amp;issue=3927</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3927" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3927" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3927" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2003&amp;issue=3927</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3927" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3927" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3927" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/1-2-2003/1-2_LV_2003.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2003&amp;issue=3945</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3945" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3945" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3945" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2003&amp;issue=3945</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3945" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3945" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3945" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/11-12-2003/11-12_LV_2003.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2003&amp;issue=3930</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3930" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3930" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3930" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2003&amp;issue=3930</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3930" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3930" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3930" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/3-4-2003/3-4_LV_2003.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2003&amp;issue=3933</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3933" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3933" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3933" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2003&amp;issue=3933</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3933" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3933" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3933" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/5-6-2003/5-6_LV_2003.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2003&amp;issue=3934</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3934" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3934" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3934" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2003&amp;issue=3934</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3934" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3934" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3934" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/7-8-2003/7-8_LV_2003.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/arhiva/?year=2003&amp;issue=3937</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3937" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3937" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3937" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/archive/?year=2003&amp;issue=3937</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3937" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/archive/?year=2003&amp;issue=3937" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/arhiva/?year=2003&amp;issue=3937" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/issues/9-10-2003/9-10_LV_2003.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/prof-dr-sc-livije-kalogjera-20-10-1957-16-11-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-70.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-70.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/izv-prof-prim-dr-sc-marko-margaritoni-dr-med-20-1-1960-30-9-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-69.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-69.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/nagrde-nakaze-i-monstrumi-povijest-nazivlja-rijetkih-prirodenih-kongenitalnih-anomalija-na-stranicama-lijecnickog-vjesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-60.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-60.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/uloga-i-izazovi-anestezioloske-sluzbe-pri-masovnim-stradanjima/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-53.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-53.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/oksidacijski-stres-i-lipidna-peroksidacija-od-molekularnih-mehanizama-do-klinike/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-45.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-45.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/ultrazvucna-procjena-dijafragme-u-predvidanju-uspjesnosti-odvajanja-od-mehanicke-ventilacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-38.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-38.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/kontroverze-u-osteoporozi-lijecimo-li-kostanu-gustocu-ili-sprjecavamo-prijelome/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-29.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-29.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/hipopituitarizam-uzrokovan-zloporabom-kortikosteroida-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-23.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-23.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/ocjena-uspjesnosti-rekonstrukcije-velikoga-bocnog-defekta-nosa-primjenom-dvaju-modaliteta-paramedijalnoga-ceonog-reznja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-18.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-18.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/hrvatska-adaptacija-upitnika-za-probir-poremecaja-glasa-sivd-za-rano-otkrivanje-glasovnih-teskoca-kod-uciteljica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-8.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-8.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/1-2/maternalni-mortalitet-u-hrvatskoj-od-1994-do-2023-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2026/LV-148-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2026/LV-148-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/ispitivanje-odnosa-izmeu-pusenja-cigareta-i-reumatoidnog-artritisa-u-usporedbi-s-osteoartritisom-osmogodisnja-prospektivna-klinicka-opservacijska-kohortna-studija/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-71.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-71.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/validacija-hrvatske-verzije-skale-orijentacije-lijecnik-pacijent-ppos/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-78.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-78.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/apsces-prednje-trbusne-stijenke-kao-posljedica-perforiranog-divertikulitisa-sigmoidnog-kolona-bez-peritonitisa-rijetka-manifestacija-kompliciranog-divertikulitisa-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-84.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-84.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/racionalni-pristup-djetetu-s-povisenim-vrijednostima-aminotransferaza/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-90.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-90.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/gastrointestinalna-disfunkcija-u-kriticno-oboljelih-bolesnika/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-101.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-101.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/sokrat-da-komunikacijski-model-u-medicini-novi-paradigmatski-okvir-za-unaprjeenje-klinicke-i-organizacijske-komunikacije/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-115.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-115.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/medijacija-u-zdravstvenim-sporovima-alat-za-poboljsanje-komunikacije-i-kvalitete-skrbi/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-122.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-122.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/analiza-uzroka-smrti-americkih-predsjednika-jesu-li-politicari-obicni-smrtnici/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-129.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-129.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2026/3-4/prioritetni-pregledi-u-hematoloskoj-ambulanti-opce-bolnice-sibensko-kninske-zupanije/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2026/LV-148-143.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2026/LV-148-143.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/prim-dr-sc-kresimir-cavka-1953-2020/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/prim-dr-sc-kresimir-cavka-1953-2020/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/prim-dr-sc-kresimir-cavka-1953-2020/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-79.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-79.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/prim-mr-sc-ante-tukic-1932-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/prim-mr-sc-ante-tukic-1932-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/prim-mr-sc-ante-tukic-1932-2024/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-77.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/odgovor-na-pismo-uredniku-autora-zdravka-perka-i-suradnika-u-lijecnickom-vjesniku-14611-12/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-75.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-75.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/biomarkeri-u-jedinici-intenzivne-medicine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-57.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-57.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/obiljezja-fotografija-objavljenih-uz-medicinske-clanke-na-stranicama-lijecnickog-vjesnika-u-razdoblju-1877-1950/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-66.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-66.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/nefropatija-povezana-s-dabigatranom-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-45.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-45.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/izvantjelesno-uklanjanje-co2-u-akutnoj-egzacerbaciji-kopb-a/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-51.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-51.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/promjene-u-organizaciji-rada-i-pruzanju-zdravstvene-skrbi-pacijentima-u-obiteljskoj-medicini-u-hrvatskoj-za-vrijeme-pandemije-covid-19-rezultati-presjecne-studije-pricov-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-30.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-30.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/adherencija-bolesnika-pri-lijecenju-secerne-bolesti-u-obiteljskoj-medicini-u-republici-hrvatskoj-prema-istrazivanju-euroaspire-v/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-22.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-22.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/1-2/smjernice-za-terapijsku-primjenu-ketogene-dijete-kod-dojencadi-i-djece-oboljele-od-tvrdokornih-epilepsij/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2025/LV-147-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2025/LV-147-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/prof-prim-dr-sc-antun-bacic-dr-med-16-ozujka-1937-23-prosinca-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/prof-prim-dr-sc-antun-bacic-dr-med-16-ozujka-1937-23-prosinca-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/prof-prim-dr-sc-antun-bacic-dr-med-16-ozujka-1937-23-prosinca-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-162.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-162.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/doktor-house-izmedu-stvarnosti-i-fikcije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-149.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-149.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/ascites-u-ordinaciji-obiteljskog-lijecnika-vaznost-primjene-ultrazvuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-142.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-142.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/dislocirani-unutarmaternicni-ulozak-u-pacijentice-sa-sumnjom-na-tumorski-proces-mokracnog-mjehura-prikaz-slucaja-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-138.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-138.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/kriterij-odlucivanja-u-dentalnoj-medicini-zub-ili-implantat/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-131.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-131.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/kriobiopsije-perifernih-plucnih-nodusa-kod-razlicitih-modaliteta-navigacijske-bronhoskopije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-122.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-122.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/vaznost-obiljezja-lijeka-pri-odabiru-terapije-u-psorijaticnom-artritisu-i-aksijalnom-spondiloartritisu-stavovi-i-iskustva-ordinirajucih-lijecnika-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-101.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-101.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-dijagnosticku-obradu-tkivnih-uzoraka-nesitnostanicnih-karcinoma-pluca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-89.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-89.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/3-4/smjernice-za-primjenu-antibiotika-u-endodonciji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2025/LV-147-81.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2025/LV-147-81.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/prim-dr-sadika-bilus-1942-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/prim-dr-sadika-bilus-1942-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/prim-dr-sadika-bilus-1942-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/prim-dr-sadika-bilus-1942-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/prim-dr-sadika-bilus-1942-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/prim-dr-sadika-bilus-1942-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/prim-dr-sadika-bilus-1942-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/prim-dr-sadika-bilus-1942-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-234.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-234.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/doc-prim-dr-sc-zlatko-matulic-dr-med-1937-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-233.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-233.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/prof-dr-sc-livijo-balarin-1930-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-231.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-231.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-iii-anesteziologija-u-okolnostima-katastrofa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-229.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-229.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/urodena-pseudoartroza-kljucne-kosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/urodena-pseudoartroza-kljucne-kosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/urodena-pseudoartroza-kljucne-kosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/urodena-pseudoartroza-kljucne-kosti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/urodena-pseudoartroza-kljucne-kosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/urodena-pseudoartroza-kljucne-kosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/urodena-pseudoartroza-kljucne-kosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/urodena-pseudoartroza-kljucne-kosti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-223.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-223.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/akutni-abdomen-nakon-embolizacije-slezene-uslijed-imunosne-trombocitopenije-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-217.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-217.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/organizacijska-kultura-i-komunikacija-u-zdravstvenim-organizacijama-analiza-klinickih-bolnickih-centara-republike-hrvatske/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-207.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-207.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/ishodi-lijecenja-bolesnika-s-kronicnom-ugrozavajucom-ishemijom-ekstremiteta-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-199.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-199.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/covid-19-u-ordinaciji-obiteljske-medicine-iskustva-i-zapazanja-tijekom-pandemije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-187.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-187.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/jednodnevna-kirurgija-tijekom-pandemije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-195.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-195.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/5-6/smjernice-za-lijecenje-kronicne-opstruktivne-plucne-bolesti-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2025/LV-147-163.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2025/LV-147-163.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/mr-sc-silvana-plestina-dr-med-15-2-1971-14-4-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-314.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-314.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/doc-dr-sc-antoanela-carija-8-4-1970-28-5-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-313.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-313.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/prof-prim-dr-sc-rikard-stanic-dr-med-21-1-1933-25-4-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-312.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-312.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/koordiniranje-onkoloskih-i-onkoloski-suspektnih-bolesnika-u-opcoj-bolnici-sibensko-kninske-zupanije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-310.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-310.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/novosti-u-cijepljenju-protiv-pneumokoka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-303.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-303.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/skljocajuci-lakat/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/skljocajuci-lakat/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/skljocajuci-lakat/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/skljocajuci-lakat/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/skljocajuci-lakat/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/skljocajuci-lakat/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/skljocajuci-lakat/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/skljocajuci-lakat/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-292.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-292.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/nove-imunoterapijske-mogucnosti-u-lijecenju-akutne-mijeloicne-leukemije-uloga-monoklonskih-protutijela-i-blokade-imunosnih-kontrolnih-tocaka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-281.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-281.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/restrikcijska-kardiomiopatija-i-presadba-srca-u-djeteta-diferencijalna-dijagnoza-venookluzivne-plucne-hipertenzije-kao-izazov-u-dijagnostici-i-lijecenju-djeteta-s-restrikcijskom-kardimiopatijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-269.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-269.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/bilateralna-meandrirajuca-plucna-vena-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-265.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-265.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/dvadeset-godina-rada-savjetovalista-za-promicanje-spolnog-zdravlja-hrvatskog-zavoda-za-javno-zdravstvo/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-257.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-257.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/cimbenici-koji-utjecu-na-adherentnost-uzimanja-acetilsalicilne-kiseline-nakon-preboljeloga-akutnoga-koronarnog-sindroma-iskustvo-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-246.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-246.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/7-8/metodoloska-kvaliteta-i-transparentnost-hrvatskih-klinickih-smjernica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2025/LV-147-235.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2025/LV-147-235.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/prof-prim-dr-sc-ante-petricevic-dr-med-2-8-1942-16-6-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-372.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-372.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/rijetka-ali-medu-nama-zasto-i-dalje-propustamo-asmd/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-370.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-370.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/termini-kompjutorizirane-tomografije-i-propusteni-pregledi-kod-bolesnika-sa-zlocudnim-bolestima-u-opcoj-bolnici-sibensko-kninske-zupanije-u-razdoblju-izmedu-2017-i-2024/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-368.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-368.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/od-tvornice-jakoba-hlavke-do-instrumentarije-ususret-130-obljetnici-proizvodnje-medicinskih-instrumenata-i-opreme-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-359.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-359.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/zasto-imamo-najvecu-epidemiju-hripavca-u-posljednjih-sezdeset-i-pet-godina-u-primorsko-goranskoj-zupaniji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-351.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-351.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/ucinkovitost-vjezbi-na-bol-i-onesposobljenost-u-odraslih-bolesnika-s-kronicnom-nespecificnom-vratoboljom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-338.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-338.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/9-10/klasifikacija-dijagnosticki-postupnik-i-mjere-ishoda-u-bolesnika-s-krizoboljom-smjernice-hrvatskoga-vertebroloskog-drustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2025/LV-147-317.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2025/LV-147-317.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/ivo-caric-8-3-1954-4-3-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/ivo-caric-8-3-1954-4-3-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/ivo-caric-8-3-1954-4-3-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/ivo-caric-8-3-1954-4-3-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/ivo-caric-8-3-1954-4-3-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/ivo-caric-8-3-1954-4-3-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/ivo-caric-8-3-1954-4-3-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/ivo-caric-8-3-1954-4-3-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-433.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-433.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/ante-l-padjen-zagreb-4-2-1942-montreal-3-11-2025/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-432.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-432.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/gerontolosko-gerijatrijski-simpozij-u-trakoscanu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-431.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-431.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/temeljne-odrednice-i-izazovi-u-izobrazbi-iz-gerijatrije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-423.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-423.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/simpaticka-hiperaktivnost-nakon-traumatske-ozljede-mozga/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-416.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-416.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/prijedlozi-za-oportunisticki-probir-raka-vrata-maternice-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-408.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-408.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/metodoloski-postupak-prijevoda-prilagodbe-i-validacije-upitnika-na-primjeru-hrvatske-inacice-upitnika-reproknow/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-400.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-400.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/administrativna-prevalencija-endometrioze-u-hrvatskoj-u-razdoblju-od-2015-do-2023-procijenjena-temeljem-broja-recepata-propisanih-zenama-reproduktivne-dobi-za-lijekove-koji-sadrze-spolne-hormone-ra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-393.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-393.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/smjernice-klinickih-indikacija-za-transtorakalnu-ehokardiografiju-odraslih/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-375.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2025/LV-147-375.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2025/11-12/cestitka-5/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2025/11-12/cestitka-5/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2025/11-12/cestitka-5/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2025/LV-147-2025.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/prof-dr-sc-miroslav-hromadko-21-9-1925-26-4-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-75.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-75.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/10-kongres-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-73.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-73.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/harm-reduction-karika-koja-nedostaje-primjena-koncepta-smanjenja-steta-po-zdravlje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-70.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-70.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/zakljucci-sastanka-bolnica-u-okolnostima-katastrofa-rat-pandemije-potresi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-68.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-68.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/jednodnevna-kirurgija-postoje-li-granice-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-67.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-67.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/sestrinska-dokumentacija-kao-vazan-dio-medicinske-dokumentacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-62.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-62.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/povecani-lipoproteina-neovisni-cimbenik-kardiovaskularnog-rizika-preporuke-za-odredivanje-i-lijecenje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-49.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-49.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/prikaz-novih-metoda-intervencijskog-lijecenja-u-referentnom-centru-za-pedijatrijsku-kardiologiju-republike-hrvatske/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-39.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-39.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/oponasatelji-klinicke-slike-nasljednog-hereditarnog-angioedema/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-35.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-35.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/strucno-misljenje-o-parenteralnoj-primjeni-zeljeza-u-nehematoloskoj-klinickoj-praksi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-22.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-22.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/uspjesnost-kirurskog-lijecenja-primarnog-hiperparatireoidizma-uz-intraoperativno-mjerenje-pth-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-15.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-15.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/dijagnostika-post-covid-19-vestibularnih-poremecaja-retrospektivna-kohortna-studija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-8.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-8.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/1-2/rizici-i-okolnosti-ozljedivanja-iz-registra-ozljeda-kod-djece-i-mladih-u-splitsko-dalmatinskoj-zupaniji-u-razdoblju-od-1-sijecnja-2017-do-30-lipnja-2018/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2024/LV-146-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2024/LV-146-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/bubrezna-presadba-u-vaskularno-zahtjevnih-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-148.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-148.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/dijagnosticke-metode-za-bolesti-paratireoidnih-zlijezda/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-138.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-138.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/odstranjivanje-tuneliranoga-sredisnjeg-venskog-katetera-nakon-bubrezne-presadbe/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-134.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-134.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/deset-godina-programa-postavljanja-dijaliznih-katetera-u-zavodu-za-nefrologiju-klinicke-bolnice-merkur-izvjesce-jednog-sredista/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-130.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-130.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/periferna-arterijska-bolest-u-bolesnika-lijecenih-hemodijalizom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-122.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-122.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/informiranost-studenata-sveucilista-josipa-jurja-strossmayera-u-osijeku-o-opt-out-zakonu-o-doniranju-organa-nakon-mozdane-smrti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-103.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-103.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/postupnik-za-procjenu-i-lijecenje-gastroezofagealne-refluksne-bolesti-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijec/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-91.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-91.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/3-4/smjernice-za-lijecenje-benignih-bolesti-anorektalne-regije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2024/LV-146-77.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2024/LV-146-77.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/dva-portreta-celestina-medovica-kao-polaziste-u-razmatranju-mogucnosti-dijagnosticiranja-obostrane-blefaroptoze/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-231.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-231.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/raspodjela-reumatologa-u-hrvatskoj-izazovi-centralizacije-i-heterogenosti-reumatoloske-struke/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-219.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-219.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/servis-povezan-s-prijelomom-hrvatskog-drustva-za-fizikalnu-i-rehabilitacijsku-medicinu-hrvatskoga-lijecnickog-zbora-dokument-o-stajalistu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-201.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-201.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/arterijska-hipertenzija-u-kronicnoj-bubreznoj-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-195.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-195.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/promjena-paradigme-u-onkoloskoj-rehabilitaciji-nova-nacela-kinezioterapije-i-primjena-izvantjelesnoga-udarnog-vala/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-184.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-184.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/ishod-bolesnika-s-iga-nefropatijom-ovisno-o-modalitetu-lijecenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-175.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-175.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/kalcijneurinski-inhibitori-u-lijecenju-membranske-nefropatije-dugorocni-ishodi-pracenja-bubrezne-funkcije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-170.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-170.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/5-6/smjernice-za-dijagnostiku-i-lijecenje-odraslih-bolesnika-s-fabryjevom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2024/LV-146-157.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2024/LV-146-157.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/veteranski-centri-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/veteranski-centri-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/veteranski-centri-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/veteranski-centri-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/veteranski-centri-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/veteranski-centri-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/veteranski-centri-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/veteranski-centri-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-321.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-321.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/zdravstveni-krajobraz-kraljevinah-hrvatske-i-slavonije-i-milenijska-izlozba-u-budimpesti-1896-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-314.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-314.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/vaznost-trajne-medicinske-izobrazbe-iz-kardiopulmonalne-reanimacije-zdravstvenih-djelatnika-na-razini-primarne-zdravstvene-zastite-iskustvo-doma-zdravlja-osjecko-baranjske-zupanije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-303.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-303.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/prva-iskustva-u-hrvatskoj-s-rezum-terapijom-vodenom-parom-za-dobrocudno-uvecanje-prostate/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-299.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-299.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/genska-analiza-sustava-komplementa-u-odraslih-pacijenata-s-elementima-tromboticne-mikroangiopatije-prikaz-serije-slucajeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-291.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-291.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/24-satni-profili-krvnog-tlaka-u-bolesnika-s-bolescu-bubrega-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-284.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-284.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/straznji-sindrom-sraza-lakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/straznji-sindrom-sraza-lakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/straznji-sindrom-sraza-lakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/straznji-sindrom-sraza-lakta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/straznji-sindrom-sraza-lakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/straznji-sindrom-sraza-lakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/straznji-sindrom-sraza-lakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/straznji-sindrom-sraza-lakta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-274.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-274.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/probir-antitijela-non-hla-prvi-rezultati/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-269.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-269.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/prikaz-bolesnika-s-anca-vaskulitisom-lijecenih-terapijskom-izmjenom-plazme-u-opcoj-bolnici-zadar-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-264.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-264.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/7-8/smjernice-za-nutritivnu-potporu-kod-kronicnih-rana/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2024/LV-146-245.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2024/LV-146-245.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/prim-daniel-zivkovic-21-7-1926-23-12-2023/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/prim-daniel-zivkovic-21-7-1926-23-12-2023/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/prim-daniel-zivkovic-21-7-1926-23-12-2023/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-380.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-380.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-ii-vojno-civilna-i-ili-civilno-vojna-suradnja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-378.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-378.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/uloga-sestrinskoga-otpusnog-pisma-u-medicinskoj-dokumentaciji-pacijenta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-373.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-373.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/ucinkovite-strategije-i-prijedlog-plana-za-kardio-reno-metabolicko-zdravlje-naroda-strucno-misljenje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-357.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-357.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/javnozdravstvene-kampanje-u-prevenciji-raka-vrata-maternice-i-cijepljenju-protiv-humanog-papilomavirusa-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-350.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-350.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/implementacija-sustava-umjetne-inteligencije-u-radiologiji-povijesni-razvoj-trendovi-i-buduce-perspektive/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-346.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-346.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/hipnicka-glavobolja-sto-kornjaca-ima-s-tim/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-340.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-340.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/lokalni-aksijalni-reznjevi-u-rekonstrukciji-ekscizijskog-defekta-vlasista-u-bolesnika-uznapredovale-zivotne-dobi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-334.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-334.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/9-10/usporedba-ucinkovitosti-i-perzistencije-inhibitora-tnf-alfa-i-inhibitora-il-17-u-bolesnika-s-aksijalnim-spondiloartritisom-iskustva-jednoga-tercijarnog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2024/LV-146-325.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2024/LV-146-325.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/projekt-uvodenja-robotski-asistirane-kirurgije-u-klinicki-bolnicki-centar-split/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-455.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-455.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/zakljucci-ii-hrvatskog-simpozija-medicina-u-okolnostima-katastrofa-i-specificnosti-upravljanja-i-vodenja-uzroci-i-posljedice-katastrofa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-453.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-453.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/karolina-milobar-prva-licencirana-lijecnica-i-prva-autorica-na-stranicama-lijecnickog-vjesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-444.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-444.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/vasopressors-and-inotropes-in-sepsis/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/vasopressors-and-inotropes-in-sepsis/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/vasopressors-and-inotropes-in-sepsis/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/vasopressors-and-inotropes-in-sepsis/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/vasopressors-and-inotropes-in-sepsis/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/vasopressors-and-inotropes-in-sepsis/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/vasopressors-and-inotropes-in-sepsis/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/vasopressors-and-inotropes-in-sepsis/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-437.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-437.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/albumini-siva-zona-indikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/albumini-siva-zona-indikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/albumini-siva-zona-indikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/albumini-siva-zona-indikacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/albumini-siva-zona-indikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/albumini-siva-zona-indikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/albumini-siva-zona-indikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/albumini-siva-zona-indikacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-429.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-429.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/ucinak-intravenske-terapije-tekucinom-na-endotelnu-disfunkciju-u-zivotno-ugrozenih-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-419.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-419.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/utjecaj-anestezije-na-kirurski-stresni-odgovor/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-413.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-413.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/masivna-opstetricka-krvarenja-narativni-pregledni-rad/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-407.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-407.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/novonastala-pseudoaneurizma-potkljucne-arterije-u-politraumatiziranog-bolesnika-s-prijelomom-lijeve-kljucne-kosti-i-ozljedom-brahijalnog-pleksusa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-403.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-403.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/achalasia-complicated-with-bilateral-pneumonia-and-sepsis/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-397.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-397.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/end-of-life-decisions-and-palliative-care-in-surgical-intensive-care-units/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-391.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-391.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/skrb-na-kraju-zivota-o-skrbi-i-sire-sto-znamo-i-mozemo/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-387.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-387.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/uvodna-rijec-3/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/uvodna-rijec-3/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/uvodna-rijec-3/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/uvodna-rijec-3/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2024/11-12/uvodna-rijec-3/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/uvodna-rijec-3/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2024/11-12/uvodna-rijec-3/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/uvodna-rijec-3/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-385.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2024/LV-146-385.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2024/11-12/cestitka-4/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2024/11-12/cestitka-4/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2024/11-12/cestitka-4/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2024/LV-146-V.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/prof-dr-sc-theodor-durrigl-10-listopada-1926-20-srpnja-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/prof-dr-sc-theodor-durrigl-10-listopada-1926-20-srpnja-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/prof-dr-sc-theodor-durrigl-10-listopada-1926-20-srpnja-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-60-5034.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-61.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/prim-dr-tonica-turato-22-veljace-1923-20-srpnja-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/prim-dr-tonica-turato-22-veljace-1923-20-srpnja-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/prim-dr-tonica-turato-22-veljace-1923-20-srpnja-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-60.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-60.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/zakljucci-simpozija-medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-58.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-58.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/refraktorna-krvarenja-iz-multiplih-angiodisplazija-crijeva-uspjesno-lijecena-talidomidom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-55.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-55.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/osvrt-na-primjenu-neinvazivnog-prenatalnog-testiranja-slobodno-cirkulirajuce-dnk-fetusa-iz-krvi-majke/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-53.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-53.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/suvremene-spoznaje-o-deformacijama-kraljeznice-u-odraslih/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-43.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-43.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/novosti-u-dijagnostici-i-lijecenju-autoimunosne-hemoliticke-anemije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-32.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-32.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/mijelodisplasticni-sindromi-i-autoimunosni-fenomeni-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-27.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-27.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/inicijalni-rezultati-mikrokirurskog-lijecenja-varikokele-u-djece-i-adolescenata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-18.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-18.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/akusticke-osobine-traheoezofagealnog-i-ezofagealnog-glasa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-12.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-12.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/1-2/iskustva-s-galaktozemijom-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2023/LV-145-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2023/LV-145-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/vijesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/vijesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/vijesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/vijesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/vijesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/vijesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/vijesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/vijesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-160.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/in-memoriam-dr-vesna-solic-stipanicic-21-7-1942-7-3-2023/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-158.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-158.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/suvremeni-pristup-dijagnostici-i-lijecenju-nokturije-i-nocne-poliurije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-146.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-146.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/rekonstrukcija-punog-defekta-donje-usne-nakon-ablacije-tumora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-139.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-139.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/pocetna-iskustva-s-hero-graftom-za-hemodijalizu-u-klinickoj-bolnici-dubrava-prikaz-dvaju-slucajeva-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-130.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-130.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/sertoliformni-cistadenom-rete-testisa-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-125.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-125.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/samoprocijenjena-spremnost-za-racionalno-propisivanje-antimikrobnih-lijekova-medu-diplomantima-cetiriju-hrvatskih-medicinskih-fakulteta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-117.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-117.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-lijecenje-kaslja-kod-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-98.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-98.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/3-4/smjernice-za-prehranu-kod-secerne-bolesti-u-odrasloj-dobi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2023/LV-145-67.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2023/LV-145-67.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prof-prim-dr-sc-zoran-cala-dr-med-sibenik-27-2-1946-zagreb-20-9-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prof-prim-dr-sc-zoran-cala-dr-med-sibenik-27-2-1946-zagreb-20-9-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prof-prim-dr-sc-zoran-cala-dr-med-sibenik-27-2-1946-zagreb-20-9-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-234.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-234.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prim-mr-sc-zlatko-simunovic-dr-med-14-12-1935-5-4-2023/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prim-mr-sc-zlatko-simunovic-dr-med-14-12-1935-5-4-2023/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prim-mr-sc-zlatko-simunovic-dr-med-14-12-1935-5-4-2023/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-236.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-236.xml</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prof-dr-sc-marija-dominis-dr-med-1941-2023/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prof-dr-sc-marija-dominis-dr-med-1941-2023/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/in-memoriam-prof-dr-sc-marija-dominis-dr-med-1941-2023/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-232.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-232.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/eticki-kodeks-medicinskih-istrazivanja-s-djecom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-228.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-228.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/magnetnorezonantna-urografija-mru-i-funkcionalna-magnetnorezonantna-urografija-fmru-u-djecjoj-dobi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-221.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-221.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/reparacija-i-regeneracija-kostanog-tkiva-primjenom-bioaktivnog-materijala-u-endodontskoj-kirurgiji-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-216.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-216.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/jesu-li-bubrezne-malformacije-jedno-od-obiljezja-sindroma-men2b-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-212.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-212.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/akutno-bubrezno-ostecenje-nekontrolirana-arterijska-hipertenzija-i-posljedicna-kronicna-bubrezna-bolest-nakon-teske-infekcije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-204.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-204.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/regionalne-razlike-u-standardiziranim-stopama-mortaliteta-od-akutnog-i-ponovljenog-infarkta-miokarda-u-republici-hrvatskoj-od-2015-do-2019-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-191.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-191.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/mehanicka-svojstva-ortopedskih-celicnih-implantata-u-simuliranim-bioloskim-uvjetima/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-184.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-184.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/5-6/smjernice-za-lijecenje-astme-hrvatskoga-pulmoloskog-drustva-hrvatskoga-lijecnickog-zbora-i-hrvatskoga-torakalnog-drustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2023/LV-145-161.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2023/LV-145-161.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/neopioidna-anestezija-pacijenata-s-prekomjernom-tjelesnom-tezinom-kod-laparoskopske-uzduzne-resekcije-zeluca-dva-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-273.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-273.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/otezani-pedijatrijski-disni-put-na-primjeru-djeteta-s-orofacijalnim-rascjepom-probuditi-dijete-ili-nastaviti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-266.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-266.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/remimazolam-sigurnost-i-zadovoljstvo-bolesnika-za-proceduralnu-sedaciju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-261.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-261.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/jednodnevna-kirurgija-postoje-li-granice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-257.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-257.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/respiracijski-monitoring-je-preduvjet-za-sigurnu-primjenu-neinvazivne-ventilacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-252.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-252.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/kako-najbolje-iskoristiti-inteligentnu-mehanicku-ventilaciju-za-poboljsanje-ishoda-lijecenja-bolesnika-u-jedinici-intenzivne-medicine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-247.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-247.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/7-8/zbrinjavanje-disnog-puta-gdje-smo-danas/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2023/LV-145-241.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2023/LV-145-241.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/vijesti-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/vijesti-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/vijesti-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/vijesti-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-338.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/vijesti-3/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-3/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/vijesti-3/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-3/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/vijesti-3/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-3/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/vijesti-3/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/vijesti-3/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-335.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-335.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/vijest-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/vijest-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/vijest-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/vijest-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/vijest-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/vijest-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/vijest-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/vijest-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-334.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-334.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/rekonstrukcija-potpunog-defekta-donje-usne-udruzenog-s-defektom-brade/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-332.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-332.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/bjesnoca-i-postekspozicijska-antirabicna-profilaksa-u-primorsko-goranskoj-zupaniji-od-1986-do-2021-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-325.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-325.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/habitualna-straznja-luksacija-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/habitualna-straznja-luksacija-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/habitualna-straznja-luksacija-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/habitualna-straznja-luksacija-kuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/habitualna-straznja-luksacija-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/habitualna-straznja-luksacija-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/habitualna-straznja-luksacija-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/habitualna-straznja-luksacija-kuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-321.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-321.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/dugi-covid-ili-postakutne-posljedice-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-307.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-307.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/suvremeni-pristup-rehabilitaciji-oboljelih-od-parkinsonove-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-297.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-297.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/kriptorhizam-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/kriptorhizam-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/kriptorhizam-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/kriptorhizam-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/kriptorhizam-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/kriptorhizam-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/kriptorhizam-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/kriptorhizam-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-291.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-291.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/preoperativna-volumetrijska-analiza-povezana-je-s-vecom-ucinkovitosti-stereotakticke-evakuacije-cisticnih-mozdanih-lezija-i-apscesa-retrospektivna-usporedba-s-nevolumetrijskom-evakuacijom-u-jednom-ce/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-287.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-287.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/9-10/koristenje-testova-sekvenciranja-sljedece-generacije-u-rutinskoj-onkoloskoj-praksi-u-hrvatskoj-rezultati-nacionalno-reprezentativnog-istrazivanja-onkologa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2023/LV-145-281.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2023/LV-145-281.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/siguran-lijek-medicinski-proizvod-put-do-korisnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-407.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-407.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/kako-mjeriti-iskustvo-pacijenta-u-fizioterapijskoj-i-rehabilitacijskoj-skrbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-402.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-402.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/eu-projekt-izobrazbe-za-rad-u-jil-u-tijekom-pandemije-covid-19-c19-space/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-398.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-398.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/ocuvanje-zdravlja-i-radne-sposobnosti-osoblja-u-djelatnosti-zdravstva-kao-kljucni-cimbenik-kvalitete-zdravstvene-zastite/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-393.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-393.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/uloga-klinickih-smjernica-u-poboljsanju-zdravstvene-zastite/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-389.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-389.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/kultura-sigurnosti-pacijenta-kako-procijeniti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-383.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-383.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/kontrolne-liste-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-379.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-379.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/identifikacija-bolesnika-i-sprjecavanje-zamjene-identiteta-kao-standard-sigurnosti-bolesnika-u-procesu-zdravstvene-skrbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-372.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-372.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/rad-i-uloga-oecd-a-na-pokazateljima-kvalitete-i-ishoda-zdravstvene-zastite-implikacije-za-hrvatski-zdravstveni-sustav-u-svjetlu-pristupnog-procesa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-362.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-362.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/pokusaj-samoubojstva-i-samoubojstvo-kao-pokazatelj-kvalitete-i-sigurnosti-bolnickog-sustava-skrbi-za-psihicko-zdravlje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-355.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-355.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/izazovi-u-prikupljanju-dokaza-za-sigurno-koristenje-digitalnih-zdravstvenih-rjesenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-347.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-347.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/mjere-iskustva-koje-navodi-pacijent-pokazatelj-kvalitete-pruzene-zdravstvene-skrbi-iz-perspektive-pacijenta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-341.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-341.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/uvodna-rijec-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/uvodna-rijec-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/uvodna-rijec-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-339.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2023/LV-145-339.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2023/11-12/cestitka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2023/11-12/cestitka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2023/11-12/cestitka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2023/LV-145-V.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/prof-dr-sc-damir-gortan-1943-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/prof-dr-sc-damir-gortan-1943-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/prof-dr-sc-damir-gortan-1943-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-66.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-66.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/disfunkcija-osita-uzrokovana-mehanickom-ventilacijom-patofiziologija-i-terapijske-mogucnosti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-59.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-59.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/kozne-promjene-uzrokovane-nosenjem-zastitne-opreme-i-sredstvima-za-dezinfekciju-tijekom-pandemije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-52.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-52.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/usporedba-kratkorocnog-ishoda-nakon-laserske-hemoroidoplastike-i-klasicne-hemoroidektomije-po-morgan-milliganu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-47.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-47.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/epizodni-angioedem-s-eozinofilijom-gleichov-sindrom-dijagnosticki-izazov/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-44.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-44.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/klinicki-asimptomatska-intrakranijalna-ozljeda-nastala-transorbitalnim-prodorom-projektilnoga-stranog-tijela/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-39.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-39.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/vaznost-akusticke-analize-u-diferencijalnoj-dijagnostici-aduktorne-spasticne-i-misicne-tenzijske-disfonije-uz-fiberopticku-videolaringoskopiju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-32.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-32.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-eozinofilnim-ezofagitisom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-15.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-15.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/1-2/smjernice-za-radiolosko-dijagnosticiranje-i-pracenje-bolesnica-oboljelih-od-raka-dojke/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2022/LV-144-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/dr-dragomir-dokmanovic-19-8-1940-12-2-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/dr-dragomir-dokmanovic-19-8-1940-12-2-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/dr-dragomir-dokmanovic-19-8-1940-12-2-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-121.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-124.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/prim-dr-sc-gordana-kaic-1965-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/prim-dr-sc-gordana-kaic-1965-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/prim-dr-sc-gordana-kaic-1965-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-121-4975.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-121.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/utjecaj-nacionalnog-zatvaranja-uslijed-pandemije-bolesti-covid-19-na-ucestalost-javljanja-sekretornog-otitisa-u-djece-kbc-osijek/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-117.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-117.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/terapijske-mogucnosti-lijecenja-intersticijskih-bolesti-pluca-u-sklopu-sistemskih-reumatskih-bolesti-primjer-sistemske-skleroze/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-112.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-112.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/onkogeneza-povezana-s-hpv-om-u-tumorima-glave-i-vrata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-106.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-106.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/epigeneticki-biljezi-u-tumorima-glave-i-vrata-posebni-osvrt-na-tumore-orofarinksa-povezane-s-hpv-om/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-96.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-96.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/primjena-ultrabrze-videoendoskopije-u-laringektomiranih-bolesnika-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-90.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-90.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/transplantacija-bubrega-u-starijeg-bolesnika-organom-vrlo-starog-darovatelja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-87.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-87.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/longitudinalni-ekstenzivni-transverzalni-mijelitis-u-sistemskom-eritemskom-lupusu-prikaz-bolesnice-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-79.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-79.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/kirursko-lijecenje-gigantskih-bazocelularnih-karcinoma-lica-nase-iskustvo/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-72.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-72.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/3-4/preporuke-za-prevenciju-infekcije-humanim-papilomavirusima-hpv-u-primatelja-bubreznog-presatka-hrvatskog-drustva-za-nefrologiju-dijalizu-i-transplantaciju/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2022/LV-144-67.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2022/LV-144-67.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/dr-ivan-juricevski-7-3-1948-17-2-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dr-ivan-juricevski-7-3-1948-17-2-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dr-ivan-juricevski-7-3-1948-17-2-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-192.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-196.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/zlata-blazina-rodena-tomic-5-1-1926-29-11-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/zlata-blazina-rodena-tomic-5-1-1926-29-11-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/zlata-blazina-rodena-tomic-5-1-1926-29-11-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-192-4986.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-194.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/mr-sc-vesna-bosanac-1949-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/mr-sc-vesna-bosanac-1949-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/mr-sc-vesna-bosanac-1949-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-192-4987.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-192.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/kozne-promjene-u-oboljelih-od-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-190.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-190.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/vizualni-identitet-lijecnickog-vjesnika-od-osnutka-1877-godine-do-danas/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-173.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-173.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/utjecaj-pandemije-covid-19-na-prikupljanje-alogenicnih-krvotvornih-maticnih-stanica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-169.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-169.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dileme-u-radioterapiji-kemoterapiji-bolesnika-s-metastazama-u-limfne-cvorove-na-vratu-tumora-nepoznatoga-primarnog-sijela/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-163.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-163.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/dijete-i-pandemija-strucna-urednica-irena-bralic-medicinska-naklada-zagreb-ozujak-2022-isbn-978-953-368-037-8/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dijete-i-pandemija-strucna-urednica-irena-bralic-medicinska-naklada-zagreb-ozujak-2022-isbn-978-953-368-037-8/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dijete-i-pandemija-strucna-urednica-irena-bralic-medicinska-naklada-zagreb-ozujak-2022-isbn-978-953-368-037-8/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-161.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-161.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dezmoidni-tumor-u-lezistu-stitnjace-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-157.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-157.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/selektivna-disekcija-vrata-u-adolescenta-na-uredaju-za-izvantjelesnu-membransku-oksigenaciju-uloga-anesteziologa-prikaz-bolesnika-uz-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-150.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-150.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/pracenje-bolesnika-s-karcinomom-grkljana-nakon-zavrsetka-lijecenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-145.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-145.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/dijagnoza-debljine-kako-reci-istinu-a-ne-uvrijediti-presjecno-istrazivanje-koristenja-nazivlja-u-zdravstvenom-i-svakodnevnom-okruzenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-134.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-134.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/5-6/smjernice-hrvatskog-drustva-za-transfuzijsku-medicinu-za-odredivanje-rhd-krvne-grupe-i-primjenu-rhd-genotipizacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2022/LV-144-125.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2022/LV-144-125.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/prim-ante-rosin-dr-med-split-31-7-1939-split-30-4-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/prim-ante-rosin-dr-med-split-31-7-1939-split-30-4-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/prim-ante-rosin-dr-med-split-31-7-1939-split-30-4-2022/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-273.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-273.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/darko-marcinko-anko-antabak-i-suradnici-vjestacenja-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja-zagreb-medicinska-naklada-2022-isbn-978-953-368-044-6/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/darko-marcinko-anko-antabak-i-suradnici-vjestacenja-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja-zagreb-medicinska-naklada-2022-isbn-978-953-368-044-6/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/darko-marcinko-anko-antabak-i-suradnici-vjestacenja-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja-zagreb-medicinska-naklada-2022-isbn-978-953-368-044-6/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-272.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-272.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/marcel-kornfeld-zaboravljeni-patolog-i-cijenjeni-ucitelj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-266.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-266.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/anaplasticni-limfom-velikih-stanica-povezan-s-implantatima-za-dojku/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-254.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-254.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/poremecaji-motiliteta-zeluca-i-uloga-elektrogastrografije-u-njihovoj-procjeni/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-244.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-244.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/transnazalna-intrakranijska-ozljeda-nastala-prodorom-vegetacijskoga-stranog-tijela-kroz-nos-dijagnostika-i-lijecenje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-240.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-240.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/artroskopija-prednjeg-i-straznjeg-dijela-gleznja-u-istom-aktu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-227.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-227.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/distribucija-specijalista-kardiologije-po-zupanijama-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-217.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-217.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/uloga-lijecnickog-vjesnika-u-njegovanju-strukovnog-jezika-da-ne-ce-nas-govor-biti-pun-njemackih-a-i-cesto-suvisnih-latinskih-i-grckih-izraza-te-nase-pisane-radnje-vrviti-od-nesgrapnih-kova/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-207.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-207.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/7-8/smjernice-za-dijagnozu-i-lijecenje-infekcije-helicobacterom-pylori-u-djece-i-adolescenata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2022/LV-144-197.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2022/LV-144-197.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/prof-dr-sc-bozo-bota-dr-med-gornja-tijarica-13-sijecnja-1950-split-30-ozujka-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/prof-dr-sc-bozo-bota-dr-med-gornja-tijarica-13-sijecnja-1950-split-30-ozujka-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/prof-dr-sc-bozo-bota-dr-med-gornja-tijarica-13-sijecnja-1950-split-30-ozujka-2022/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-356.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2022/LV-144-356.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/prof-dr-sc-jure-slapnicar-dr-med-metkovic-22-3-1923-split-11-6-2022/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/prof-dr-sc-jure-slapnicar-dr-med-metkovic-22-3-1923-split-11-6-2022/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/prof-dr-sc-jure-slapnicar-dr-med-metkovic-22-3-1923-split-11-6-2022/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-355.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-355.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/dvostruki-piramidalni-rezanj-stitne-zlijezde/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-354.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-354.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/medicina-u-okolnostima-katastrofa-jesmo-li-spremni/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-352.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-352.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/buducnost-naroda-tu-je-na-kocki-eugenika-u-hrvatskoj-medicini-do-kraja-prvoga-svjetskog-rata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-340.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-340.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/informiranost-i-stavovi-lijecnika-o-cjepivu-protiv-hpv-a-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-331.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-331.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-covid-19-i-trudnoca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-323.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-323.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/analiza-rada-hitnoga-neuroloskog-prijma-klinickoga-bolnickog-centra-split-u-jednogodisnjem-razdoblju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-319.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-319.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/cijepljenje-protiv-sars-cov-2-odraslih-alergijskih-bolesnika-iskustva-klinickoga-bolnickog-centra-rijeka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-314.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-314.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/sistemska-mastocitoza-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-306.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-306.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnica-ka-oboljelih-od-invazivnog-raka-dojke-hod-rd-3/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-295.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-295.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/9-10/smjernice-za-lijecenje-atopijskog-dermatitisa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2022/LV-144-279.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2022/LV-144-279.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/vijest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/vijest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/vijest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/vijest/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/vijest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/vijest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/vijest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/vijest/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-420.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/in-memoriam/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/in-memoriam/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/in-memoriam/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/in-memoriam/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-418.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/in-memoriam-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/in-memoriam-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/in-memoriam-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/in-memoriam-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/in-memoriam-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-418.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/slikovna-dokumentacija-u-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/slikovna-dokumentacija-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/slikovna-dokumentacija-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/slikovna-dokumentacija-u-medicini/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/slikovna-dokumentacija-u-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/slikovna-dokumentacija-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/slikovna-dokumentacija-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/slikovna-dokumentacija-u-medicini/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-416.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-416.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/dugorocna-profilaksa-hereditarnog-angioedema/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-411.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-411.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/laringofaringealni-refluks-novosti-u-dijagnostici-i-lijecenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-402.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-402.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/kardiovaskularno-zdravlje-u-menopauzi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-392.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-392.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/klinicki-ishodi-transplantacije-srca-u-bolesnika-nakon-ugradnje-uredaja-centrimag/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-386.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-386.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/komplikacije-i-ogranicenja-laringoskopije-ultrabrzom-kamerom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-381.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-381.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/hipofosfatemija-kod-bolesnika-s-upalnim-bolestima-crijeva-nakon-parenteralne-nadoknade-zeljeza-prikaz-serije-slucajeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-374.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-374.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/utjecaj-pandemije-covid-19-na-djelatnost-klinike-za-stomatologiju-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-369.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-369.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/zadovoljstvo-radom-od-kuce-u-pandemiji-bolesti-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-365.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-365.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/depresivnost-anksioznost-i-stres-medu-studentima-medicine-tijekom-pandemije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-357.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2022/LV-144-357.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2022/11-12/cestitka-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2022/11-12/cestitka-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2022/11-12/cestitka-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2022/LV-144-V.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/izv-prof-dr-sc-aldo-ivancic-dr-med-1961-2020/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/izv-prof-dr-sc-aldo-ivancic-dr-med-1961-2020/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/izv-prof-dr-sc-aldo-ivancic-dr-med-1961-2020/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-78.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-78.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/doc-dr-sc-ivan-kraljic-dr-med-omisalj-31-ozujka-1933-zagreb-20-studenoga-2020/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/doc-dr-sc-ivan-kraljic-dr-med-omisalj-31-ozujka-1933-zagreb-20-studenoga-2020/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/doc-dr-sc-ivan-kraljic-dr-med-omisalj-31-ozujka-1933-zagreb-20-studenoga-2020/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-78.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-78.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/novosti-u-etiopatogenezi-dijagnostici-i-lijecenju-bolesnika-s-degenerativnim-promjenama-intervertebralnog-diska-slabinskog-dijela-kraljeznice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-63.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-63.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/drukciji-pristup-lijecenju-ostecenog-meniska-sacuvajmo-menisk/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-51.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-51.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/sindrom-kubitalnog-kanala/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/sindrom-kubitalnog-kanala/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/sindrom-kubitalnog-kanala/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/sindrom-kubitalnog-kanala/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/sindrom-kubitalnog-kanala/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/sindrom-kubitalnog-kanala/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/sindrom-kubitalnog-kanala/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/sindrom-kubitalnog-kanala/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-42.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-42.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/kontrastni-ultrazvuk-u-dijagnostici-intrarenalnog-refluksa-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-35.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-35.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/large-nested-varijanta-urotelnog-karcinoma-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-31.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-31.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/anestezioloske-tehnike-u-jednodnevnoj-kirurgiji-za-zahvate-kod-displazije-vrata-maternice-iskustva-u-kbc-u-sestre-milosrdnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-25.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-25.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/dvjesto-osam-uzastopnih-artroskopija-lakta-analiza-indikacija-i-komplikacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-14.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-14.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/uloga-citologije-u-otkrivanju-preinvazivnih-i-invazivnih-promjena-stidnice-ovisno-o-nacinu-uzimanja-uzorka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-6.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-6.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/1-2/lijecenje-malih-tumora-bubrega-ablacijskim-metodama/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2021/LV-143-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/dr-jozo-mihaljevic-15-5-1961-30-1-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/dr-jozo-mihaljevic-15-5-1961-30-1-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/dr-jozo-mihaljevic-15-5-1961-30-1-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-141.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-141.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/prof-dr-asaf-durakovic-16-5-1940-16-12-2020/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/prof-dr-asaf-durakovic-16-5-1940-16-12-2020/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/prof-dr-asaf-durakovic-16-5-1940-16-12-2020/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-139.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-139.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/arteritis-divovskih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/arteritis-divovskih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/arteritis-divovskih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/arteritis-divovskih-stanica/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/arteritis-divovskih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/arteritis-divovskih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/arteritis-divovskih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/arteritis-divovskih-stanica/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-130.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-130.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/razumijevanje-prevencija-i-lijecenje-refeeding-sindroma-uloga-tiamina/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-120.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-120.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-113.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-113.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/traumatska-protrahirana-hematurija-i-pseudoaneurizma-segmentalne-arterije-bubrega-u-16-godisnjeg-djecaka-lijecena-endovaskularnom-embolizacijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-108.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-108.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/gordon-holmesov-sindrom-prvi-put-dijagnosticiran-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-103.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-103.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/rekonstrukcija-postranicnog-defekta-donje-usne-kombinacijom-dvaju-klizajucih-reznjeva/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-98.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2021/LV-143-98.XML</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/gigantski-brzorastuci-lipom-retziusovog-prostora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-95.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-95.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/adherencija-i-propisivanje-statina-u-primarnoj-prevenciji-unutar-primarne-zdravstvene-zastite/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-90.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-90.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/3-4/utjecaj-pandemije-covid-19-na-rad-patologije-i-citologije-u-klinickom-bolnickom-centru-rijeka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2021/LV-143-81.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2021/LV-143-81.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/prim-dr-edvard-perusko/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/prim-dr-edvard-perusko/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/prim-dr-edvard-perusko/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-227.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-227.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/uloga-nealkoholne-masne-bolesti-jetre-u-bakterijskim-infekcijama-i-sepsi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-220.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-220.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/uloga-magnetske-rezonancije-srca-u-dijagnostickoj-obradi-bolesnika-s-kardiomiopatijama/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-209.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-209.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/cjepiva-za-koronavirusnu-bolest-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-192.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-192.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/rijedak-slucaj-liposarkoma-u-mladog-muskarca-smjestenog-na-vratu-u-regiji-6-prikaz-slucaja-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-188.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-188.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/spermatocitni-tumor-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/spermatocitni-tumor-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/spermatocitni-tumor-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/spermatocitni-tumor-prikaz-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/spermatocitni-tumor-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/spermatocitni-tumor-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/spermatocitni-tumor-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/spermatocitni-tumor-prikaz-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-184.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-184.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/gallstone-ileus-sigmoidnog-kolona-prikaz-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-181.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-181.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/mehanizam-nastanka-prijeloma-nadlakticne-kosti-zagrebacke-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-174.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-174.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/5-6/potpuni-i-djelomicni-anomalni-utok-pulmonalnih-vena-10-godisnja-retrospektivna-studija-dijagnostickih-i-terapijskih-postupaka-te-ishoda-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2021/LV-143-163.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2021/LV-143-163.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-1-dio/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-143.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-143.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/vizualna-memorija-struke-pogled-na-fotoalbume-otorinolaringoloske-klinike-sacuvane-u-hrvatskom-muzeju-medicine-i-farmacije-hrvatske-akademije-znanosti-i-umjetnosti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-310.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-310.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/telemetrija-umjetne-puznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/telemetrija-umjetne-puznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/telemetrija-umjetne-puznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/telemetrija-umjetne-puznice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/telemetrija-umjetne-puznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/telemetrija-umjetne-puznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/telemetrija-umjetne-puznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/telemetrija-umjetne-puznice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-305.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-305.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/suvremeni-pristup-etiologiji-dijagnostici-i-terapiji-laringofaringealnog-refluksa-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-294.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-294.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/karcinom-glave-i-vrata-trenutne-mogucnosti-i-perspektive-u-lijecenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-284.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-284.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/rekonstrukcije-baze-lubanje-nakon-endoskopske-endonazalne-kirurgije-analiza-164-slucaja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-277.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-277.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/ucinkovitost-prednizona-u-lijecenju-ratnih-blast-ozljeda-unutarnjeg-uha/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-273.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-273.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/dugorocni-rezultati-transtemporalne-kirurgije-intrakanalikularnoga-vestibularnog-svanoma/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-267.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-267.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/metastaziranje-papilarnog-karcinoma-stitnjace-u-lateralne-regije-vrata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-262.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-262.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/akusticka-i-perceptivna-analiza-glasa-u-bolesnika-s-puberfonijom-prije-i-nakon-glasovne-terapije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-257.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-257.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-perioperativnih-cimbenika-na-funkcionalni-i-estetski-status-podlaktice-nakon-odizanja-slobodnoga-radijalnog-reznja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-248.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-248.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/utjecaj-pandemije-covid-19-na-rad-klinike-za-bolesti-uha-nosa-i-grla-i-kirurgiju-glave-i-vrata-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-241.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-241.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/klinika-za-bolesti-uha-nosa-grla-i-kirurgiju-glave-i-vrata-medicinskog-fakulteta-u-zagrebu-prvih-sto-godina-1921-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-231.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2021/LV-143-231.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/7-8/uvodna-rijec/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/uvodna-rijec/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/uvodna-rijec/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/uvodna-rijec/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/7-8/uvodna-rijec/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/7-8/uvodna-rijec/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/7-8/uvodna-rijec/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/7-8/uvodna-rijec/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2021/LV-143-229.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/doc-dr-sc-ante-trosic-dr-med-pirovac-4-7-1942-ettlingen-2-7-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-394.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-394.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/manometrija-visoke-rezolucije-u-dijagnostici-bolesti-jednjaka-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-393.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-393.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/utjecaj-buke-na-sluh-glazbenika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/utjecaj-buke-na-sluh-glazbenika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/utjecaj-buke-na-sluh-glazbenika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/utjecaj-buke-na-sluh-glazbenika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/utjecaj-buke-na-sluh-glazbenika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/utjecaj-buke-na-sluh-glazbenika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/utjecaj-buke-na-sluh-glazbenika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/utjecaj-buke-na-sluh-glazbenika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-386.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-386.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/poboljsanje-ventilacije-u-bolesnice-s-akutnim-respiratornim-distres-sindromom-stavljanjem-u-pronacijski-polozaj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-381.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-381.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/poremecaji-glasa-u-djece-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-375.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-375.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/pcr-testiranje-na-sars-cov-2-u-domu-zdravlja-zagreb-centar-u-2020-godini-pregled-kriterija-upucivanja-i-dobivenih-rezultata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-367.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-367.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/izvanbolnicke-upale-pluca-u-djece-preporuke-hrvatskog-drustva-za-pedijatrijsku-pulmologiju-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-349.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-349.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/9-10/smjernice-za-dijagnostiku-i-lijecenje-bolesnika-s-vratoboljom-2-dio/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2021/LV-143-327.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2021/LV-143-327.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/dusko-matas-8-3-1933-26-8-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/dusko-matas-8-3-1933-26-8-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/dusko-matas-8-3-1933-26-8-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/dusko-matas-8-3-1933-26-8-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/dusko-matas-8-3-1933-26-8-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/dusko-matas-8-3-1933-26-8-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/dusko-matas-8-3-1933-26-8-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/dusko-matas-8-3-1933-26-8-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-490.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-492.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/dr-marijan-zlatko-magdic-1-9-1946-26-10-2021/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-490.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-490.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/ni-med-cvetjem-ni-pravice-slicnosti-i-razlike-zakona-o-zastiti-osoba-s-dusevnim-smetnjama-i-zakona-o-zastiti-pucanstva-od-zaraznih-bolesti-treba-li-nam-zakon-o-zastiti-osoba-sa-zaraznim-bol/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-478.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-478.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/uloga-hiperbaricne-oksigenoterapije-hbot-u-lijecenju-oboljelih-od-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-473.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-473.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/audiovestibularni-simptomi-infekcije-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-470.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-470.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/kolposkopija-u-dijagnostici-premalignih-i-malignih-promjena-vrata-maternice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-463.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-463.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/ruptura-apscesa-jetre-s-posljedicom-plinske-embolije-u-sustavu-portalne-vene/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-457.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-457.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/zoonoze-u-zenicko-dobojskoj-zupaniji-i-federaciji-bosne-i-hercegovine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-451.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-451.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/smjernice-za-farmakolosko-lijecenje-epilepsije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-429.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-429.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-jajovoda-i-potrbusnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-416.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-416.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-zlocudnih-tumora-tijela-maternice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-404.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-404.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/klinicke-smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-395.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2021/LV-143-395.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/cestitka-predsjednika-hlz-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/cestitka-predsjednika-hlz-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/cestitka-predsjednika-hlz-a/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-V.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2021/11-12/begic-drazen-psihopatologija-cetvrto-dopunjeno-i-obnovljeno-izdanje-zagreb-medicinska-naklada-2021-789-stranica-isbn-78-953-368-007-1/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2021/11-12/begic-drazen-psihopatologija-cetvrto-dopunjeno-i-obnovljeno-izdanje-zagreb-medicinska-naklada-2021-789-stranica-isbn-78-953-368-007-1/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2021/11-12/begic-drazen-psihopatologija-cetvrto-dopunjeno-i-obnovljeno-izdanje-zagreb-medicinska-naklada-2021-789-stranica-isbn-78-953-368-007-1/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2021/LV-143-450.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/kvartarna-prevencija-predijabetes-rizik-bolest-ili-suvisna-dijagnoza-bolesti-koje-ne-donose-veliku-opasnost-ne-treba-draziti-ljekarijama-platon-5-st-pr-n-e-u-timej-matica-hrvatska-2017/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-29.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-29.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/uloga-parklandske-formule-u-lijecenju-opsezne-duboke-opekline-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-24.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-24.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/perioperativno-zbrinjavanje-djeteta-s-otvorenim-arterijskim-duktusom-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-21.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-21.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/anestezija-i-analgezija-za-metodu-faucs-carskog-reza-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-17.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-17.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/uloga-kontinuirane-metode-bubreznoga-nadomjesnog-lijecenja-u-bolesnika-s-teskom-rabdomiolizom-i-multiorganskim-zatajenjem-nastalim-zbog-zlouporabe-metandriola/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-14.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-14.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/anestezioloski-pristup-pacijentima-s-transplantiranim-srcem-pri-nekardijalnim-operacijama-prikaz-bolesnice-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-11.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-11.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/sindrom-kratkog-crijeva-kod-septicnih-bolesnika-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-6.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-6.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/1-2/euglikemijska-dijabeticka-ketoacidoza-inducirana-empagliflozinom-inhibitorom-kotransportera-natrija-i-glukoze-2-nakon-resekcijskog-zahvata-na-plucima-u-bolesnice-s-tipom-2-secerne-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2020/LV-142-2.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2020/LV-142-2.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/pobjede-i-porazi-borbe-s-pandemijama-virusnih-bolesti-tijekom-posljednjih-stotinu-godina/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-107.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-107.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/spanjolska-gripa-kao-uzrok-smrti-u-gradu-zagrebu-1918-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-104.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-104.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/kompjutorizirana-tomografija-plucnih-komplikacija-izvanbolnicke-pneumonije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-93.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-93.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/specificnosti-respiratorne-potpore-bolesnicima-oboljelima-od-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-89.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-89.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/smjernice-za-osobe-sa-secernom-bolescu-i-zdravstvene-djelatnike-koji-skrbe-o-oboljelima-od-secerne-bolesti-u-republici-hrvatskoj-u-vrijeme-covid-19-pandemije-radne-skupine-hrvatskog-drustva-za-dijabet/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-85.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-85.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/espen-ovo-strucno-misljenje-i-prakticne-smjernice-za-nutritivnu-potporu-bolesnika-s-infekcijom-sars-cov-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-75.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-75.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/covid-19-i-djeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-i-djeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/covid-19-i-djeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-i-djeca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/covid-19-i-djeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-i-djeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/covid-19-i-djeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-i-djeca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-64.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-64.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/3-4/covid-19-pet-mjeseci-kasnije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-pet-mjeseci-kasnije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/covid-19-pet-mjeseci-kasnije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-pet-mjeseci-kasnije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/3-4/covid-19-pet-mjeseci-kasnije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-pet-mjeseci-kasnije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/3-4/covid-19-pet-mjeseci-kasnije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/3-4/covid-19-pet-mjeseci-kasnije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2020/LV-142-55.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2020/LV-142-55.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-primjene-razlicitih-tehnika-anestezije-na-imunosni-odgovor-organizma-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-170.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-170.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/sindrom-transuretralne-resekcije-predstojne-zlijezde-kostur-iz-ormara-i-dalje-vreba/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-160.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-160.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/regionalne-anestezioloske-tehnike-lijecenja-karcinomske-boli/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-155.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-155.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/hemodinamski-monitoring-od-invazivnog-nadzora-do-personaliziranog-pristupa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-148.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-148.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/neocekivana-otezana-ekstubacija-zbog-mehanickih-uzroka-nakon-parotidektomije-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-144.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-144.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/perzistentna-lijeva-gornja-suplja-vena-prepoznata-nakon-postavljanja-centralnoga-venskog-katetera-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-140.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-140.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/trend-i-razvoj-epiduralne-analgezije-i-epiduralne-anestezije-u-rodilistu-kbc-a-sestre-milosrdnice-tijekom-proslih-deset-godina/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-135.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-135.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/utjecaj-intrapartalne-analgezije-petidinom-ili-tramadolom-na-opstetricke-ishode-usporedbeno-dvostruko-slijepo-randomizirano-prospektivno-intervencijsko-istrazivanje/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-129.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-129.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/preporuke-za-primjenu-neuroaksijalne-anestezije-i-perifernih-zivcanih-blokova-tijekom-pandemije-koronavirusne-bolesti-2019-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-123.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2020/LV-142-123.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/elektrokonvulzivna-terapija-osamdeset-godina-iskustva-u-hrvatskoj-i-u-svijetu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-251.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/genitalne-hpv-infekcije-u-trudnoci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-244.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/penoplastika-i-vakuum-terapija-u-djece-s-fournierovom-gangrenom-penisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-239.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/glavobolja-uzrokovana-prekomjernom-upotrebom-lijekova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-230.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/medikamentozni-prekid-nezeljene-trudnoce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-222.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/laparoskopska-duodenoduodenostomija-u-novorodenceta-s-anularnim-pankreasom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-218.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/prikaz-slucaja-novorodenceta-s-gastroshizom-i-duplikaturom-zucnog-mjehura/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-215.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/dugorocna-skrb-za-pacijenta-nakon-transplantacije-jetre-iz-perspektive-obiteljskog-lijecnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-204.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/vrijednost-dodatnoga-ultrazvucnog-pregleda-nakon-magnetskom-rezonancijom-otkrivene-sumnjive-promjene-u-dojci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-199.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/psihicko-zdravlje-lijecnika-u-hrvatskoj-za-vrijeme-pandemije-covid-19/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-189.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/7-8/izmjene-i-dopune-preporuka-za-dijagnostiku-i-lijecenje-bolesnika-s-incidentalomom-nadbubrezne-zlijezde-2019-godina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2020/LV-142-185.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/dr-vlasta-girotto-13-travnja-1935-28-svibnja-2020/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/dr-vlasta-girotto-13-travnja-1935-28-svibnja-2020/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/dr-vlasta-girotto-13-travnja-1935-28-svibnja-2020/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-356.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-356.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/vjestacenje-stupnja-ostecenja-organizma-temeljem-bolesti-hrvatskih-branitelja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-355.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-355.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/kontinuum-u-stjecanju-kompetencija-za-rad-u-obiteljskoj-medicini-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-348.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-348.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/suradljivost-bolesnika-s-adolescentnom-idiopatskom-skoliozom-tijekom-konzervativnog-lijecenja-pregled-istrazivanja-i-iskustva-multidisciplinarnog-tima-klinike-za-ortopediju-klinickoga-bolnic/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-343.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-343.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/glomerularne-bolesti-prije-i-nakon-transplantacije-bubrega/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-330.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-330.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/posteriorna-kortikalna-atrofija-izazov-za-oftalmologe/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-323.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-323.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/ucinkovitost-i-sigurnost-tjelovjezbe-u-idiopatskim-upalnim-miopatijama-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-315.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-315.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/klinicka-obiljezja-i-prezivljenje-bolesnika-s-malignim-mezoteliomom-pleure-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-306.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-306.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/povezanost-depresije-i-stigme-u-oboljelih-od-raka-pluca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-301.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-301.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/mjesto-i-vaznost-neklinickih-bolnickih-centara-u-lijecenju-bolesnika-sa-zlocudnim-bolestima-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-296.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-296.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/strategije-za-eliminaciju-hepatitisa-c-u-hrvatskoj-studija-modeliranja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-285.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-285.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/9-10/smjernice-za-vestibularnu-rehabilitaciju-jednostranih-i-obostranih-vestibularnih-ostecenja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2020/LV-142-271.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2020/LV-142-271.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/in-memoriam-davorka-dusek/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/in-memoriam-davorka-dusek/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/in-memoriam-davorka-dusek/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-432.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-432.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/manjak-lizosomske-kisele-lipaze-rijetka-nasljedna-bolest-prerusena-u-nealkoholnu-bolest-masne-jetre-s-dislipidemijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-430.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-430.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/tuberkuloza-i-nalicje-grada-fotografije-zagrebacke-stambene-bijede-iz-zbirke-vladimira-cepulica/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-420.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-420.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/novosti-u-mkb-11-u-podrucju-seksualnog-zdravlja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-414.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-414.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/patofizioloske-osnove-i-indikacijsko-podrucje-primjene-lasera-male-snage-u-lijecenju-akutne-i-kronicne-boli/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-410.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-410.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/uloga-inhibitora-renin-angiotenzin-aldosteronskog-sustava-u-patogenezi-koronavirusne-bolesti-covid-19/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-405.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-405.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/adenokarcinom-dvanaesnika-u-oboljelog-od-celijakije-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-398.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-398.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/anestezioloski-pristup-bolesniku-s-transplantiranim-plucima-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-395.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-395.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/procjena-ucinka-periferne-laserske-iridotomije-na-biometrijske-parametre-prednjeg-segmenta-oka-u-bolesnika-s-pigmentnim-glaukomom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-389.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-389.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/prijetransfuzijsko-ispitivanje-i-transfuzijsko-lijecenje-pri-primjeni-monoklonskog-protutijela-anti-cd38/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-377.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-377.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/eltrombopag-u-lijecenju-aplasticne-anemije-u-hrvatskoj-krohem-ova-studija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-372.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-372.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/klinicke-prakticne-smjernice-za-perioperacijsku-i-poslijeoperacijsku-skrb-o-arterijsko-venskim-fistulama-i-umetcima-za-hemodijalizu-u-odraslih-sazetak-europske-najbolje-bubrezne-prakse/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-359.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2020/LV-142-359.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/11-12/cestitka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/11-12/cestitka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/11-12/cestitka/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2020/LV-142-V.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2020/5-6/prof-dr-sc-vladimir-gruden-dr-med-24-lipnja-1939-11-sijecnja-2020-doc-dr-sc-bruno-salamon-dr-med-6-listopada-1928-3-srpnja-1996-prim-rudolf-rudi-muhvic-dr-med-28-srpnja-1930-19-ozujka-2020/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2020/5-6/prof-dr-sc-vladimir-gruden-dr-med-24-lipnja-1939-11-sijecnja-2020-doc-dr-sc-bruno-salamon-dr-med-6-listopada-1928-3-srpnja-1996-prim-rudolf-rudi-muhvic-dr-med-28-srpnja-1930-19-ozujka-2020/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2020/5-6/prof-dr-sc-vladimir-gruden-dr-med-24-lipnja-1939-11-sijecnja-2020-doc-dr-sc-bruno-salamon-dr-med-6-listopada-1928-3-srpnja-1996-prim-rudolf-rudi-muhvic-dr-med-28-srpnja-1930-19-ozujka-2020/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2020/LV-142-176.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/leone-glembay-psihijatrijska-i-forenzicka-razmatranja-knjizevnog-lika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-40.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-40.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/uloga-inhibitora-cdk4-6-u-lijecenju-hormonski-ovisnoga-metastatskog-raka-dojke-negativnog-na-her-2/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-33.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-33.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/subakutna-disekcija-aorte-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-29.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-29.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/transplantacija-podijeljenoga-potkovicastog-bubrega-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-24.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-24.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/iktalna-bradikardija-s-asistolijom-u-epilepticara-prikaz-dvoje-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-20.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-20.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/prijelomi-podlaktice-u-zagrebacke-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-14.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-14.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/1-2/smjernice-hrvatskog-drustva-za-hematologiju-hlz-a-i-krohem-a-za-zbrinjavanje-anemije-uzrokovane-manjkom-zeljeza/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2019/LV-141-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2019/LV-141-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/primopredaja-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/primopredaja-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/primopredaja-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/primopredaja-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/primopredaja-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/primopredaja-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/primopredaja-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/primopredaja-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-106.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-106.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/13-%ce%b2-d-glukan-u-dijagnostici-igi-ja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-97.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-97.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/skljocavi-palac-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/skljocavi-palac-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/skljocavi-palac-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/skljocavi-palac-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/skljocavi-palac-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/skljocavi-palac-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/skljocavi-palac-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/skljocavi-palac-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-91.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-91.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/osteonekroza-koljena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/osteonekroza-koljena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/osteonekroza-koljena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/osteonekroza-koljena/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/osteonekroza-koljena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/osteonekroza-koljena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/osteonekroza-koljena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/osteonekroza-koljena/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-81.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-81.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/kardiomiopatije-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/kardiomiopatije-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/kardiomiopatije-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/kardiomiopatije-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/kardiomiopatije-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/kardiomiopatije-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/kardiomiopatije-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/kardiomiopatije-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-68.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-68.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/kirursko-lijecenje-kronicnoga-pilonidalnog-sinusa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-63.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-63.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/3-4/smjernice-za-prevenciju-pneumokoknih-bolesti-cijepljenjem-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2019/LV-141-57.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2019/LV-141-57.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/prirodena-manjkavost-pulmonalne-valvule-i-dis-funkcija-atipicnog-arterijskog-duktusa-izvor-sirokog-spektra-kardiovaskularnih-anomalija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-162.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-162.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/klinicka-slika-kasne-novorodenacke-sepse-i-dalje-ozbiljan-diferencijalnodijagnosticki-problem/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-150.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-150.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/terapija-povrsinskim-negativnim-tlakom-i-drt-om-integra-za-avulzijske-ozljede-donjih-ekstremiteta-prikaz-dvoje-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-146.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-146.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/prvi-slucaj-perkutane-epikardijalne-ablacije-ventriku-larne-tahikardije-u-bolesnika-s-neishemijskom-bolesti-srca-u-nasoj-zemlji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-138.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-138.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/abernethyjeva-malformacija-kao-rijetka-indikacija-za-transplantaciju-jetre-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-134.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-134.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/dugorocni-ucinci-transplantacije-alogenih-krvotvornih-maticnih-stanica-kod-prezivjelih-bolesnika-u-klinickome-bolnickom-centru-zagreb/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-124.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-124.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/5-6/henoch-schonleinov-purpurni-nefritis-u-djece-iskustva-dvaju-tercijarnih-centara-za-pedijatrijsku-i-adolescentnu-reumatologiju-republike-hrvatske-u-razdoblju-od-2006-do-2017-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2019/LV-141-115.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/5-6-2019/LV-141-115.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/bolesnik-s-mijelodisplasticnim-sindromom-u-hitnoj-sluzbi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-247.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-247.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/prognosticki-cimbenici-u-mijelodisplasticnom-sindromu-iskustvo-jednog-centra/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-238.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-238.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/izrazaj-cirkulirajuceg-mikrornk-u-mijelodisplasticnom-sindromu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-233.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-233.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/ekspresija-mikrornk-mirnk-u-mijelodisplasticnom-sindromu-mds/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-226.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-226.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/morfologija-mijelodisplasticnih-mijeloproliferativnih-neoplazma-mds-mpn/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-220.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-220.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/protocna-citometrija-u-mijelodisplasticnom-sindromu-korak-naprijed/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-214.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-214.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/mijelodisplasticni-sindrom-nove-spoznaje-i-stara-morfologija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-209.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-209.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/funkcionalne-vrtoglavice-u-svjetlu-novoutemeljenog-entiteta-per-zistentne-posturalno-percepcijske-vrtoglavice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-196.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-196.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/7-8/smjernice-za-farmakoterapiju-epilepsija-u-djece-i-adolescenata-hrvat-skog-drustva-za-djecju-neurologiju-hlz-a/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2019/LV-141-181.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2019/LV-141-181.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/mitralna-i-trikuspidalna-valvuloplastika-u-bolesnice-s-mijelodisplasticnim-sindromom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-304.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/mijelodisplasticni-sindrom-u-bolesnice-s-nelijecenom-kronicnom-limfoproliferativnom-neoplazmom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-300.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/ucinkovitost-uporabe-maternicne-cetkice-pri-dobivanju-uzoraka-i-dijagnostici-endometrijskih-lezija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-294.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/metastaziranje-endometrijskog-karcinoma-u-jajnik-ili-istodobni-primarni-karcinomi-endometrija-i-jajnika-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-289.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/citoloska-dijagnostika-endometrijskih-poremecaja-prikazi-bolesnica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-284.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/prica-o-klinickoj-citologiji-u-klinickoj-bolnici-merkur/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-273.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/trenutacna-prevalencija-vaznoga-nutritivnog-rizika-medu-onkoloskim-bolesnicima-u-republici-hrvatskoj-istrazivanje-sekcije-mladih-onkologa-hrvatskog-drustva-za-internisticku-onkologiju-hrvats/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-262.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/9-10/smjernice-za-profilakticko-lijecenje-botulinskim-toksinom-tipa-a-u-bolesnika-s-kronicnom-migrenom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2019/LV-141-255.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/ne-hodgkinov-limfom-otkriven-retiniranom-endokapsulom-u-stenoziranome-tankom-crijevu-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-366.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-366.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/hereditarna-hemoragijska-teleangiektazija-pregled-literature-i-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-361.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-361.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/biopsija-dojke-sirokom-iglom-vodena-tomosintezom-prikaz-metode-i-vlastitih-rezultata/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-352.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-352.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-testisa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-343.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-343.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-bubrega/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-336.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-336.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-mokracnog-mjehura/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-326.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-326.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2019/11-12/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-s-rakom-prostate/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2019/LV-141-313.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2019/LV-141-313.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/enteralna-prehrana-gdje-smo-danas-u-farmakonutriciji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2018/LV-140-50.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2018/LV-140-50.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/stenoza-spinalnog-kanala-slabinske-kraljeznice-od-epidemiologije-do-rehabilitacije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2018/LV-140-34.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2018/LV-140-34.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/imunizacija-djece-s-kongenitalnim-srcanim-grjeskama-klinicki-i-kriticki-osvrt/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2018/LV-140-24.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2018/LV-140-24.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/totalna-tiroidektomija-kao-kirurska-metoda-lijecenja-hipertireoze-nasa-iskustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2018/LV-140-18.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2018/LV-140-18.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/transplantacija-srca-u-djece-u-hrvatskoj-nasa-prva-iskustva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2018/LV-140-7.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2018/LV-140-7.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/1-2/smjernice-za-neinvazivnu-mehanicku-ventilaciju-pri-lijecenju-kronicne-respiracijske-insuficijencije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2018/LV-140-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/1-2-2018/LV-140-1.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/ponavljane-luksacije-peronealnih-tetiva-prikaz-uzastopne-serije-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-129.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-129.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/transplantacija-krvotvornih-maticnih-stanica-u-djeteta-s-fanconijevom-anemijom-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-126.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-126.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/alvaradov-sustav-bodovanja-u-djece-s-akutnom-upalom-crvuljka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-120.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-120.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-klinicku-prehranu-kod-upalnih-bolesti-crijeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-106.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-106.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-dojke-gin/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-92.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-92.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/smjernice-za-provodenje-dijagnostickih-pretraga-prije-pocetka-lijecenja-onkoloskog-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-i-dio-tumori-urogenit/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-77.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-77.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/nastava-kemije-i-biokemije-na-medicinskom-fakultetu-u-zagrebu-u-doba-frana-bubanovica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-174.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/etika-u-transplantaciji-solidnih-organa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/etika-u-transplantaciji-solidnih-organa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/etika-u-transplantaciji-solidnih-organa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/etika-u-transplantaciji-solidnih-organa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/etika-u-transplantaciji-solidnih-organa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/etika-u-transplantaciji-solidnih-organa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/etika-u-transplantaciji-solidnih-organa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/etika-u-transplantaciji-solidnih-organa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-167.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/angiosarkom-desne-pretklijetke-kao-uzrok-tamponade-srca-i-letalnog-ishoda-u-tridesettrogodisnje-bolesnice-prikaz-nalaza-obdukcije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-163.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/svjetlostanicni-papilarni-karcinom-bubreznih-stanica-u-bolesnika-s-urotelnim-papilarnim-karcinomom-bubrezne-nakapnice-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-159.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/prikaz-dvaju-bolesnika-s-izoliranom-neijatrogenom-ozljedom-zucnog-mjehura/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-156.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/karakterizacija-jetrenih-tumora-kontrastnim-ultrazvukom-rezultati-iz-tercijarnog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-150.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/standardizirani-nalaz-citoloske-analize-urina-smjernice-hrvatskog-drustva-za-klinicku-citologiju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-147.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/5-6/pariska-klasifikacija-the-paris-system-tps-for-reporting-urine-cytology-prikaz-dijagnostickih-kategorija-u-citologiji-urina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2018/LV-140-143.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/obrazovanje-medicinskih-sestara-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-229.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-229.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/artroskopija-prvoga-metatarzofalangealnog-zgloba/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-221.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-221.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/procjena-prijeanestezijskog-rizika-u-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-212.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-212.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/rezultati-lijecenja-3d-terapijom-i-model-eliminacije-infekcije-hcv-om-u-republici-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-205.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-205.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/epifizeoliza-distalne-tibije-u-zagrebacke-djece/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-200.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-200.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/povezanost-pojave-peritumoralnih-pukotina-u-duktalnom-invazivnom-karcinomu-dojke-s-miofibroblasticnom-reakcijom-strome/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-190.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-190.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/7-8/preporuke-za-prevenciju-i-lijecenje-pothranjenosti-u-bolesnika-s-kronicnom-opstruktivnom-plucnom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2018/LV-140-183.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/7-8-2018/LV-140-183.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/prisilni-smjestaj-okrivljenika-kao-dusevno-oboljelih-osoba-ustavni-i-konvencijski-standardi-u-praksi-hrvatskih-sudova/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2018/LV-140-267.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2018/LV-140-267.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/celijakija-nedovoljno-prepoznat-javnozdravstveni-problem/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2018/LV-140-261.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2018/LV-140-261.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/prikaz-bolesnice-s-reumatoidnim-artritisom-i-visestrukim-osteoporotskim-prijelomima/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2018/LV-140-257.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2018/LV-140-257.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/opstrukcija-tankog-crijeva-stranim-tijelom-u-bolesnika-s-crohnovom-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2018/LV-140-254.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2018/LV-140-254.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/100-godina-nakon-prve-splenektomije-u-imunosnoj-trombocitopeniji-je-li-laparoskopska-splenektomija-jos-i-danas-dobra-terapijska-metoda-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2018/LV-140-248.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2018/LV-140-248.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/9-10/smjernice-za-dijagnosticiranje-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-debelog-crijeva/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2018/LV-140-241.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/9-10-2018/LV-140-241.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/gripa-mikrobiologija-imunologija-i-epidemiologija-za-lijecnika-koji-razmislja-o-cijepljenju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-321.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-321.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/epiduralna-anestezija-za-carski-rez-u-bolesnice-s-arteriovenskom-malformacijom-mozga-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-317.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-317.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/mezenhimni-tumor-ili-sindrom-amnijske-brazde-u-novorodenceta-dijagnosticka-dilema/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-314.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-314.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/dvostruka-pregradena-desna-klijetka-prikriveni-pratitelj-ventrikularnoga-septalnog-defekta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-307.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-307.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/bendamustin-umjesto-karmustina-pri-kondicioniranju-kod-autologne-transplantacije-krvotvornih-maticnih-stanica-usporedba-toksicnosti-i-infektivnih-komplikacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-303.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-303.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/epidemioloski-i-klinicki-aspekti-mikobakterioze-pluca-u-sisacko-moslavackoj-zupaniji/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-293.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-293.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-zeluca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-285.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-285.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/11-12/vegetarijanska-i-veganska-prehrana-u-djecjoj-dobi-smjernice-hrvatskog-drustva-za-pedijatrijsku-gastroenterologiju-hepatologiju-i-prehranu-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2018/LV-140-279.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/11-12-2018/LV-140-279.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/seksualna-medicina-multidisciplinarna-supspecijalizacija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-3.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/xml/3-4-2018/LV-140-140.XML</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2018/3-4/alkaptonurija-prilika-za-eticka-razmatranja-anonimnosti-na-slikama/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2018/LV-140-2018.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/autonomna-disrefleksija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/autonomna-disrefleksija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/autonomna-disrefleksija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/autonomna-disrefleksija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/autonomna-disrefleksija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/autonomna-disrefleksija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/autonomna-disrefleksija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/autonomna-disrefleksija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-38.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/ispitivanje-kvalitete-zivota-u-pacijenata-s-glaukomom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-32.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/hbsag-serokonverzija-u-lijecenju-kronicnog-hepatitisa-b-pegiliranim-interferonom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-29.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/prijelomi-bedrene-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-24.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-v-dio-melanom-sarkomi-tumori-sredisnjega-zivcanog-sustava-rak-pluca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-17.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iv-dio-planocelularni-rak-glave-i-vrata-rak-jednjaka-rak-zeluca-rak-debelog-i-zavrs/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-12.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/1-2/smjernice-za-dijagnozu-i-lijecenje-bolesnika-s-mijelodisplasticnim-sindromom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2017/LV-139-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/smjernice-za-lijecenje-stenoze-karotidne-arterije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-51.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/prijelomi-distalnog-radijusa-u-djece-uzroci-i-mjesta-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-56.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/uzroci-smrti-u-bolesnika-sa-sistemskim-eritemskim-lupusom-uloga-sistemske-bolesti-i-komorbiditeta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-61.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/postupnici-za-periproceduralno-zbrinjavanje-i-zbrinjavanje-krvarenja-u-bolesnika-lijecenih-novim-oralnim-antikoagulantnim-lijekovima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-67.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/odredivanje-gradusa-adenokarcinoma-prostate-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2016-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-72.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/klinicki-pristup-ginekomastiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/klinicki-pristup-ginekomastiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/klinicki-pristup-ginekomastiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/klinicki-pristup-ginekomastiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/klinicki-pristup-ginekomastiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/klinicki-pristup-ginekomastiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/klinicki-pristup-ginekomastiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/klinicki-pristup-ginekomastiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-75.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/transkateterska-implantacija-aortalnog-zalistka-tavi-u-lijecenju-bolesnika-s-teskom-aortalnom-stenozom-prikaz-metode-i-rezultata-u-klinickome-bolnickom-centru-zagreb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-82.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/3-4/pravo-jehovinih-svjedoka-na-ostvarivanje-kirurske-zdravstvene-zastite-u-republici-hrvatskoj-prema-vrijedecim-zakonima-de-lege-lata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2017/LV-139-91.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/klinicka-imunoterapija-raka-blokadom-molekularnih-interakcija-negativne-povratne-sprege/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-168.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/straznja-idiopatska-fascikularna-ljevoventrikularna-tahikardija-osjetljiva-na-verapamil-belhassenova-tahikardija-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-163.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/bolesnici-s-povisenom-koncentracijom-kreatin-kinaze-u-reumatoloskoj-ambulanti-prikaz-skupine-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-158.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/indikacijske-smjernice-za-fetalnu-ehokardiografiju-i-njihov-utjecaj-na-prenatalnu-dijagnozu-srcane-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-150.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/usporedba-pojavnosti-hiperuricemije-i-gihta-na-otoku-korculi-i-otoku-visu-s-gradom-splitom-i-njegovom-okolicom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-144.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/vaznost-nezadovoljstva-tijelom-u-ranoj-i-kasnoj-adolescenciji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-136.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-rano-prepoznavanje-dijagnostiku-i-terapiju-neurogene-orofaringealne-disfagije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-118.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/5-6/smjernice-za-geneticko-savjetovanje-i-testiranje-na-nasljedni-rak-dojke-i-jajnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2017/LV-139-107.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/iznenadna-i-neocekivana-smrt-u-epilepsiji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-240.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/nedostatak-uvida-kod-oboljelih-od-shizofrenije-definicija-etioloski-koncepti-i-terapijske-implikacije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-234.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/endokrini-disruptori-i-debljina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/endokrini-disruptori-i-debljina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/endokrini-disruptori-i-debljina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/endokrini-disruptori-i-debljina/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/endokrini-disruptori-i-debljina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/endokrini-disruptori-i-debljina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/endokrini-disruptori-i-debljina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/endokrini-disruptori-i-debljina/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-230.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/prolazni-neonatalni-dijabetes-uzrokovan-novom-aktivirajucom-mutacijom-kcnj11-gena-i-uspjesno-prevodenje-na-terapiju-sulfonilurejom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-224.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/alkaptonurija-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/alkaptonurija-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/alkaptonurija-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/alkaptonurija-prikaz-bolesnice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/alkaptonurija-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/alkaptonurija-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/alkaptonurija-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/alkaptonurija-prikaz-bolesnice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-222.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/kvaliteta-zivota-bolesnika-s-kronicnom-venskom-insuficijencijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-216.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/fludarabin-ciklofosfamid-i-rituksimab-fcr-u-lijecenju-bolesnika-s-kronicnom-limfocitnom-leukemijom-kll-iskustvo-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-210.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/hrvatski-medicinski-casopisi-i-standardi-dobre-uredivacke-prakse-analiza-uputa-autorima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-204.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/alat-za-objavu-klinickih-smjernica-dokument-right/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-199.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-dijagnostiku-i-lijecenje-primarne-imunosne-trombocitopenije-u-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-192.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/7-8/smjernice-za-lijecenje-pneumonija-iz-opce-populacije-u-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2017/LV-139-177.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/endokrinoloski-aspekti-sindroma-policisticnih-jajnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-298.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/suvremena-rehabilitacija-odraslih-osoba-sa-stecenim-ostecenjem-sluha/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-292.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/video-head-impulse-test-ocni-ekg/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/video-head-impulse-test-ocni-ekg/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/video-head-impulse-test-ocni-ekg/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/video-head-impulse-test-ocni-ekg/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/video-head-impulse-test-ocni-ekg/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/video-head-impulse-test-ocni-ekg/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/video-head-impulse-test-ocni-ekg/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/video-head-impulse-test-ocni-ekg/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-286.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/procjena-sastava-tijela-u-bolesnika-s-tipom-1-secerne-bolesti-metodom-bioelektricne-impedancije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-280.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/usporedba-ucinkovitosti-vjezba-za-stabilizaciju-sakroilijakalnih-zglobova-s-nosenjem-potpornog-pojasa-radi-smanjenja-simptoma-sakroilijakalne-disfunkcije-u-trudnoci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-277.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/kirursko-lijecenje-preponske-kile-ambulantno-ili-bolnicki/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-273.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/ultrazvucni-nadzor-posteriornog-pristupa-kod-mr-artrografija-ramena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-268.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-iskra-za-dijagnostiku-i-lijecenje-prostatitisa-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-254.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/9-10/smjernice-za-dijagnostiku-i-lijecenje-gnojnog-hidradenitisa-hidradenitis-suppurativa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2017/LV-139-247.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/dijagnosticka-metoda-navigacijske-transkranijalne-magnetske-stimulacije-ntms-u-preoperativnome-neurokirurskom-planiranju-operacije-elokventnih-regija-kore-mozga/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2017/LV-139-391.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/prva-biopsija-mozga-u-hrvatskoj-vodena-neuronavigacijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2017/LV-139-388.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/utjecaj-gestacijske-dobi-i-broja-pregleda-fetalnom-ehokardiografi-jom-na-poboljsanu-dijagnostiku-prirodenih-srcanih-bolesti-kod-fetusa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2017/LV-139-379.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/ambulantna-kirurgija-dnevne-bolnice-kirurske-klinike/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2017/LV-139-375.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-malih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2017/LV-139-371.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2017/11-12/smjernice-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2017/LV-139-365.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/granulomatoza-s-poliangiitisom-gpa-i-lokaliziranim-zahvacanjem-gornjega-disnog-sustava-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-54.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/pracenje-bolesnika-s-klasicnim-hodgkinovim-limfomom-nakon-lijecenja-suvremena-saznanja-i-nedoumice-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-47.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/mikcijska-urosonografija-pojacana-kontrastom-cevus-u-dijagnostici-vezikoureteralnog-refluksa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-39.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/prvi-rezultati-dijagnosticke-primjene-endobronhalnog-ultrazvuka-u-klinickoj-bolnici-dubrava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-34.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/timpanicna-frontalna-i-aksilarna-temperatura-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-30.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-za-dijagnozu-lijecenje-i-pracenje-bolesnikaca-oboljelih-od-melanoma-koze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-22.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/1-2/hrvatske-smjernice-za-farmakolosko-lijecenje-secerne-bolesti-tipa-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2016/LV-138-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/odgovor-zdravstvenog-sustava-republike-hrvatske-na-migrantsku-krizu-u-razdoblju-od-16-rujna-do-31-prosinca-2015/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-99.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/uloga-tranzicijske-klinike-u-zdravstvenoj-zastiti-adolescenata-s-kronicnom-upalnom-bolesti-crijeva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-93.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/racionalna-primjena-serumskih-tumorskih-biljega-u-dijagnostici-i-lijecenju-solidnih-tumora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-85.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/lijecenje-ostecenja-probavne-cijevi-primjenom-endoskopske-stezaljke-prikaz-serije-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-79.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/prijelomi-nadlakticne-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-74.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/doprinos-fiberbronhoskopije-dijagnostici-plucne-tuberkuloze-u-inicijalnim-direktno-negativnim-uzorcima-sputuma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-69.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/3-4/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-1-dio-rak-dojke-rak-tijela-maternice-rak-vrata-maternice-rak-jajnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2016/LV-138-63.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/pristup-bolesniku-s-nealkoholnom-masnom-bolesti-jetre/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-159.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/gigantocelularni-aortitis-dijagnosticiran-petct-om-paraneoplasticki-sindrom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-152.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/ima-li-tendoskopija-mjesto-u-kirurskom-lijecenju-nedostatnosti-funkcije-tetive-tibijalis-posteriora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-144.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/razlike-sociodemografskih-karakteristika-percepcije-boli-u-oboljelih-od-raka-pluca-nemalih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-137.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/patoloske-promjene-bubreznih-arterija-u-bolesnika-s-karcinomom-bubreznih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-133.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-prepoznavanje-i-lijecenje-nedostatka-vitamina-d-u-odraslih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-121.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/5-6/smjernice-za-prevenciju-pracenje-i-lijecenje-poremecaja-kostano-mineralnog-metabolizma-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2016/LV-138-107.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/miniperkutana-nefrolitotripsija-nasa-prva-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-208.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/rascjep-prsne-kosti-prikaz-troje-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-204.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/vlasiste-kao-donor-transplantata-djelomicne-debljine-koze-u-lijecenju-masivne-termalne-ozljede/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-200.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/pusenje-cigareta-medu-adolescentima-u-distriktu-brcko-u-bosni-i-hercegovini-presjecna-studija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-194.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/epidemioloske-karakteristike-tetanusa-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-188.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/zadovoljstvo-mladih-lijecnika-u-republici-hrvatskoj-idemo-li-u-pravom-smjeru/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-179.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-iii-dio-neuroendokrine-neoplazme-hepatocelularni-karcinom-rak-gusterace-rak-zucnih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-173.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/7-8/pracenje-onkoloskih-bolesnika-klinicke-preporuke-hrvatskog-drustva-za-internisticku-onkologiju-hlz-a-ii-dio-rak-bubrega-rak-mokracnog-mjehura-rak-prostate-rak-testisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2016/LV-138-167.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/hepatitis-e-u-hrvatskoj-smjernice-za-dijagnostiku-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-289.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/preporuke-za-perioperacijsko-gladovanje-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-282.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/poremecaji-hemostaze-u-bolesnika-s-cirozom-jetre/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-272.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/mogucnosti-i-ogranicenja-seksualne-aktivnosti-nakon-ugradnje-totalne-endoproteze-kuka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-266.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/hipokaliemijska-metabolicka-alkaloza-prikaz-6-slucajeva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-260.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/fibrilacija-atrija-i-hemodinamski-nestabilna-tahikardija-sirokih-qrs-kompleksa-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-255.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/egzotermna-reakcija-sadrenja-analiza-triju-vrsta-sadrenih-zavoja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-250.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/evolucija-rezistencije-na-beta-laktamske-antibiotike-u-enterobacter-spp-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-240.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/9-10/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-jednjaka-i-ezofagogastricnog-prijelaza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2016/LV-138-233.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/nealkoholna-masna-bolest-jetre-multisistemska-bolest/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-353.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/suvremeni-pristup-ne-hodgkinovu-limfomu-plastene-zone-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-345.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/aritmogena-kardiomiopatija-desne-klijetke-jesmo-li-suvremenim-dijagnostickim-i-terapijskim-pristupom-izbjegli-tragediju-u-obitelji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-339.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/inicijalna-iskustva-u-provodenju-terapije-povrsnim-negativnim-tlakom-pri-lijecenju-djecjih-opeklina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-335.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/test-za-procjenu-kopb-a-cat-u-plucnoj-rehabilitaciji-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-328.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/prve-hrvatske-smjernice-za-dijagnostiku-lijecenje-i-pracenje-osoba-s-prijevremenom-ejakulacijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-321.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2016/11-12/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2015-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2016/LV-138-305.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/usutski-virus-novi-flavivirus-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-46.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/privrzenost-i-seksualno-samopoimanje-u-oblikovanju-seksualnog-zadovoljstva-i-zadovoljstva-partnerskom-vezom-pregled-istrazivanja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-41.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/hormonsko-nadomjesno-lijecenje-i-venske-tromboembolije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-34.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/klinicke-karakteristike-bolesnika-s-dvostrukim-pilorusom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-30.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/uspjesna-primjena-adalimumaba-u-bolesnice-oboljele-od-reumatoidnog-artritisa-i-primarne-bilijarne-ciroze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-27.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/sindrom-plucne-fibroze-udruzene-s-emfizemom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-22.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/prvi-opis-karbapenemaze-u-osjecko-baranjskoj-zupaniji-u-unesenom-izolatu-enterobactera-cloacae-in-vitro-osjetljivom-na-karbapeneme/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-17.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/koarktacija-aorte-kod-djece-u-10-godisnjoj-klinickoj-epidemioloskoj-studiji-dijagnosticko-i-terapijsko-razmatranje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-9.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/1-2/preporuke-za-pracenje-prevenciju-i-lijecenje-proteinsko-energijske-pothranjenosti-u-bolesnika-s-kronicnom-bubreznom-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2015/LV-137-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/tragom-fragmenta-dnevnickog-zapisa-iz-prvoga-svjetskog-rata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-116.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/straznji-sindrom-sraza-gleznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/straznji-sindrom-sraza-gleznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/straznji-sindrom-sraza-gleznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/straznji-sindrom-sraza-gleznja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/straznji-sindrom-sraza-gleznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/straznji-sindrom-sraza-gleznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/straznji-sindrom-sraza-gleznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/straznji-sindrom-sraza-gleznja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-109.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/endemska-nefropatija-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/endemska-nefropatija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/endemska-nefropatija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/endemska-nefropatija-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/endemska-nefropatija-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/endemska-nefropatija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/endemska-nefropatija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/endemska-nefropatija-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-100.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/minimalno-invazivna-kirurgija-slabinske-kraljeznice-u-lijecenju-hernije-intervertebralnog-diska/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-96.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/kalcificirajuca-uremijska-arteriolopatija-klinicka-slika-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-91.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/prva-sinkrona-resekcija-jetre-u-sklopu-citoreduktivne-kirurgije-peritonektomije-i-hipec-a-u-hrvatskoj-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-87.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/manjak-lizosomske-kisele-lipaze-u-djece-vlastita-iskustva-i-nova-mogucnost-enzimskoga-nadomjesnog-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-81.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/prijelom-palcane-kosti-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-76.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/osobitosti-djecje-tuberkuloze-u-klinickome-bolnickom-centru-split-u-razdoblju-od-1990-do-2012/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-70.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/3-4/klinicke-preporuke-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-nepoznata-primarnog-podrijetla/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2015/LV-137-65.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/strategija-uporabe-i-odrzavanja-klinickoga-bolnickog-centra-rijeka-sukladno-kljucnim-pokazateljima-uspjesnosti-strateskog-odrzavanja-zdravstvenih-ustanova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-196.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/sitnopolje-i-analiza-genskog-izrazaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-188.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/amiodaron-i-funkcija-stitnjace/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/amiodaron-i-funkcija-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/amiodaron-i-funkcija-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/amiodaron-i-funkcija-stitnjace/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/amiodaron-i-funkcija-stitnjace/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/amiodaron-i-funkcija-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/amiodaron-i-funkcija-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/amiodaron-i-funkcija-stitnjace/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-181.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/vats-timektomija-u-lijecenju-miastenije-gravis-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-177.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/goodpastureov-sindrom-prikazi-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-171.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/izduzeni-sluznicno-podsluznicni-polip-debelog-crijeva-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-168.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/prijelom-klavikule-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-163.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/pretkazatelji-lose-pripreme-bolesnika-za-kolonoskopiju-monocentricno-prospektivno-ispitivanje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-156.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/razlike-u-ucestalosti-pojave-sindroma-izgaranja-u-nastavnika-pretklinicara-i-klinicara-medicinskog-fakulteta-u-mostaru/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-150.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/5-6/klinicke-upute-hrvatskoga-onkoloskog-drustva-za-dijagnozu-lijecenje-i-pracenje-bolesnicaka-oboljelih-od-invazivnog-raka-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2015/LV-137-143.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/dr-aleksandar-dorsner-prvi-bolnicki-otorinolarinolog-u-splitu-i-dalmaciji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-246.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/kojim-ppd-hiperreaktorima-treba-dati-profilaksu-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-241.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/povezanost-debljine-i-karcinoma-gusterace/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-236.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/subungvalna-egzostoza-palca-stopala-prikaz-osmogodisnje-djevojcice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-233.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/operacija-primarnog-tumora-mozga-u-budnom-stanju-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-229.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/ucestalost-peripartalnih-histerektomija-u-pet-hrvatskih-bolnica-tijekom-sesnaestogodisnjeg-razdoblja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-223.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/utjecaj-disekcije-vrata-na-odgovarajuce-motoricke-i-osjetne-zivce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-219.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/pompeova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-216.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/7-8/smjernice-za-lijecenje-mukopolisaharidoze-mps-vi-u-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2015/LV-137-213.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/nekompaktna-lijeva-klijetka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/nekompaktna-lijeva-klijetka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/nekompaktna-lijeva-klijetka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/nekompaktna-lijeva-klijetka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/nekompaktna-lijeva-klijetka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/nekompaktna-lijeva-klijetka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/nekompaktna-lijeva-klijetka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/nekompaktna-lijeva-klijetka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-318.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/upala-srednjeg-uha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/upala-srednjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/upala-srednjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/upala-srednjeg-uha/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/upala-srednjeg-uha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/upala-srednjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/upala-srednjeg-uha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/upala-srednjeg-uha/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-311.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/prijelomi-kostiju-sake-u-djece-okolnosti-i-uzroci-nastanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-306.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/kompleksni-regionalni-bolni-sindrom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/kompleksni-regionalni-bolni-sindrom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/kompleksni-regionalni-bolni-sindrom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/kompleksni-regionalni-bolni-sindrom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/kompleksni-regionalni-bolni-sindrom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/kompleksni-regionalni-bolni-sindrom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/kompleksni-regionalni-bolni-sindrom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/kompleksni-regionalni-bolni-sindrom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-297.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/hemoglobin-a1c-i-kvaliteta-skrbi-za-oboljele-od-secerne-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-292.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/nenamjerno-otrovanje-biljkom-mrazovcem-colchicum-autumnale-prikaz-dvojice-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-288.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/c1q-nefropatija-prikazi-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-283.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/autologna-transplantacija-perifernih-maticnih-stanica-u-refraktornom-ili-relapsnom-ne-hodgkinovu-limfomu-difuznoga-b-velikostanicnog-tipa-iskustvo-jednog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-276.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/9-10/bikuspidalna-aortalna-valvula-i-grjeske-izlaznog-trakta-lijeve-klijetke-u-djece-sindrom-bikuspidalne-aortopatije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2015/LV-137-267.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/osnivanje-muzeja-za-povijest-zdravstva-u-hrvatskoj-1944-godine-i-uloga-njegova-prvog-kustosa-stanka-sielskog/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-377.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/fizikalna-svojstva-sadrenih-zavoja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-372.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/dojenacke-kolike-noviji-pristup-starom-problemu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-367.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/perkutana-skleroterapija-jednostavnih-cista-bubrega-vodena-ultrazvukom-primarni-uspjeh-i-sigurnost-procedure/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-364.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-slezene-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-361.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/ucestalost-i-kirurska-vaznost-piramidalnog-reznja-i-tuberkula-stitne-zlijezde-prospektivna-studija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-357.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-populacijske-i-klinicke-epidemioloske-studije-prirodenih-srcanih-grjesaka-1995-2011-primjena-pokazatelja-abc-i-kardiokirurskog-modela-rachs-1-za-procjenu-kvalitete-zbrinjavanj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-348.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-odraslih-bolesnika-oboljelih-od-glioma-sredisnjega-zivcanog-sustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-343.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2015/11-12/hrvatske-smjernice-za-dijagnostiku-i-lijecenje-benignoga-paroksizmalnog-pozicijskog-vertiga-bppv-a/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2015/LV-137-335.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/informacijski-mrezni-servis-potpora-knjiznice-u-provodenju-prakse-utemeljene-na-znanstvenim-dokazima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-49.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/povezanost-aleksitimije-i-morbiditeta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/povezanost-aleksitimije-i-morbiditeta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/povezanost-aleksitimije-i-morbiditeta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/povezanost-aleksitimije-i-morbiditeta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/povezanost-aleksitimije-i-morbiditeta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/povezanost-aleksitimije-i-morbiditeta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/povezanost-aleksitimije-i-morbiditeta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/povezanost-aleksitimije-i-morbiditeta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-44.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/mjerenje-arterijskoga-tlaka-ne-mari-za-male-stvari-i-ostat-ce-male-stvari-preporuke-hrvatskoga-referalnog-centra-za-hipertenziju-centra-izvrsnosti-europskog-drustva-za-hipertenziju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-33.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/kapilaroskopija-u-reumatoloskoj-praksi-iskustvo-jednog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-28.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/rijetki-tumor-pluca-u-djecjoj-dobi-inflamatorni-miofibroblasticni-tumor/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-25.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/od-nejasne-vrucice-do-visceralne-lismenijaze-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-22.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/radovi-doktorskih-kandidata-s-medicinskog-fakulteta-sveucilista-u-zagrebu-u-hrvatskim-casopisima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-18.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/1-2/hrvatski-postupnik-za-dijagnostiku-i-terapiju-infekcije-helicobacterom-pylori/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2014/LV-136-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/pristanak-obavijestenog-pacijenta-s-posebnim-osvrtom-na-hrvatsku/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-104.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/karbapenemaze-gram-negativnih-bakterija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/karbapenemaze-gram-negativnih-bakterija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/karbapenemaze-gram-negativnih-bakterija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/karbapenemaze-gram-negativnih-bakterija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/karbapenemaze-gram-negativnih-bakterija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/karbapenemaze-gram-negativnih-bakterija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/karbapenemaze-gram-negativnih-bakterija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/karbapenemaze-gram-negativnih-bakterija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-94.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/indikacije-i-kontraindikacije-za-primjenu-trombocitnih-transfuzija-u-bolesnika-s-trombocitopenijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-90.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/ortotopna-transplantacija-bubrega-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-87.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/krvarenje-iz-nadbubrezne-zlijezde-u-perinatalnom-periodu-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-84.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/ucestalost-sindroma-burnout-kod-lijecnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-78.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/prevalencija-simptoma-alergijskih-bolesti-u-mlade-skolske-djece-na-podrucju-medimurske-zupanije-isaac-faza-i/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-73.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/cistinska-urolitijaza-preporuke-za-dijagnostiku-lijecenje-i-prevenciju-recidiva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-68.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/3-4/hrvatski-postupnik-za-prevenciju-zelucanog-raka-eradikacijom-infekcije-helicobacterom-pylori/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2014/LV-136-59.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/program-vjezbi-za-kronicnu-krizobolju-koji-se-temelji-na-zajednickim-klinickim-obiljezjima-bolesni/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-156.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/kvartarna-prevencija-kao-temelj-racionalnog-pristupa-pacijentu-u-obiteljskoj-medicini/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-152.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/uroloska-disfunkcija-u-osoba-s-ozljedom-kraljeznicne-mozdine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-147.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/epidemioloska-slika-psihijatrijskih-hospitalizacija-u-opcoj-bolnici-bjelovar/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-140.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/upotreba-periferno-uvedenoga-centralnog-venskog-katetera-picc-u-bolesnika-sa-zlocudnim-hematoloskim-bolestima-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-136.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/fabryjeva-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-133.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/gaucherova-bolest-smjernice-za-dijagnozu-i-lijecenje-odraslih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-130.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/5-6/smjernice-za-dijagnostiku-i-lijecenje-hereditarnog-angioedema/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2014/LV-136-117.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-230.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/klinicka-obiljezja-vaskulitisa-povezanih-s-antineutrofilnim-citoplazmatskim-protutijelima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-226.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/nova-klasifikacija-vaskulitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/nova-klasifikacija-vaskulitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/nova-klasifikacija-vaskulitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/nova-klasifikacija-vaskulitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/nova-klasifikacija-vaskulitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/nova-klasifikacija-vaskulitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/nova-klasifikacija-vaskulitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/nova-klasifikacija-vaskulitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-224.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/sindrom-vaskulitisa-uvod/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/sindrom-vaskulitisa-uvod/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/sindrom-vaskulitisa-uvod/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/sindrom-vaskulitisa-uvod/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/sindrom-vaskulitisa-uvod/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/sindrom-vaskulitisa-uvod/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/sindrom-vaskulitisa-uvod/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/sindrom-vaskulitisa-uvod/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-224-4575.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/transplantacija-bubrega-u-bolesnika-s-lupusnim-nefritisom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-219.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/lijecenje-lupusnog-nefritisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-lupusnog-nefritisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/lijecenje-lupusnog-nefritisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-lupusnog-nefritisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/lijecenje-lupusnog-nefritisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-lupusnog-nefritisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/lijecenje-lupusnog-nefritisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-lupusnog-nefritisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-215.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/lijecenje-rezistentnih-primarnih-glomerulopatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-209.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/klasifikacija-glomerulopatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/klasifikacija-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/klasifikacija-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/klasifikacija-glomerulopatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/klasifikacija-glomerulopatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/klasifikacija-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/klasifikacija-glomerulopatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/klasifikacija-glomerulopatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-201.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/marihuana-u-medicinske-svrhe-javnozdravstveni-aspekt/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-192.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/descendentni-nekroticni-medijastinitis-iskustvo-jednog-centra/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-186.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/7-8/hrvatske-smjernice-za-perioperativnu-enteralnu-prehranu-kirurskih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2014/LV-136-179.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/javnozdravstvena-sluzba-i-zdravstveni-djelatnici-u-bakru-tijekom-xviii-i-xix-stoljeca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-296.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/osobitosti-anestezije-kod-ortopedskih-zahvata-u-bolesnika-s-osteogenesis-imperfecta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-291.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/medicinske-vjezbe-za-bolesnike-s-kronicnom-krizoboljom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-278.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/i-peronealne-tetive-postoje-zar-ne/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/i-peronealne-tetive-postoje-zar-ne/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/i-peronealne-tetive-postoje-zar-ne/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/i-peronealne-tetive-postoje-zar-ne/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/i-peronealne-tetive-postoje-zar-ne/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/i-peronealne-tetive-postoje-zar-ne/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/i-peronealne-tetive-postoje-zar-ne/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/i-peronealne-tetive-postoje-zar-ne/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-269.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/kongenitalne-koronarne-arterijske-fistule-klinicko-i-terapijsko-razmatranje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-261.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/analiza-informacijskih-potreba-i-nacina-uporabe-informacijskih-izvora-na-uzorku-lijecnika-hrvatske-klinicke-bolnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-256.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/klinicka-ocitovanja-dijagnoza-i-lijecenje-pacijenata-s-temporalnim-arteritisom-u-klinickome-bolnickom-centru-rijeka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-253.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/9-10/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-bolnih-stanja-vratne-i-prsne-kraljeznice-minimalno-invazivnim-postupcima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2014/LV-136-245.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/prevencija-kronicnih-bolesti-i-stanja-u-djece-2-dio-naglasci-s-xiv-simpozija-preventivne-pedijatrije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2014/LV-136-346.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/astma-potaknuta-naporom-u-sportasa-pregledni-clanak/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2014/LV-136-339.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/prijelom-lubanjskih-kostiju-i-kefalhematom-u-novorodenceta-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2014/LV-136-335.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/samoubojstva-na-podrucju-bjelovarsko-bilogorske-zupanije-u-prijeratnom-ratnom-i-poratnom-razdoblju-te-razdoblju-ekspanzije-i-recesije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2014/LV-136-324.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/11-12/smjernice-za-zbrinjavanje-hiperglikemije-u-odraslih-hospitaliziranih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2014/LV-136-315.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/140-godina-hlz-a-53-godine-amzh/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/0-supplement-2014/LV-136-405.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zagreb/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/0-supplement-2014/LV-136-400.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-zadar/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/0-supplement-2014/LV-136-396.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2014/0%20Supplement/hrvatski-lijecnicki-zbor-podruznica-vukovar/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/0-supplement-2014/LV-136-395.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/osvrt-na-organizaciju-kongresa-higijenicara-u-opatiji-1950-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-41.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/sindrom-misica-piriformisa-etiologija-patogeneza-klinicke-manifestacije-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-34.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/novi-primarni-zlocudni-tumori-nakon-dijagnoze-raka-dojke-meduodnos-naslijeda-rizicnih-cimbenika-i-modaliteta-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-27.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/uloga-neoadjuvantne-kemoterapije-kod-uznapredovalog-raka-jajnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-21.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/lijecenje-empijema-prsista-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/lijecenje-empijema-prsista-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/lijecenje-empijema-prsista-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/lijecenje-empijema-prsista-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/lijecenje-empijema-prsista-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/lijecenje-empijema-prsista-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/lijecenje-empijema-prsista-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/lijecenje-empijema-prsista-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-15.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/zdjelicni-diskontinuitet-u-revizijskoj-artroplastici-kuka-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-7.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/1-2/treating-acute-kidney-injury-using-continuous-and-intermittent-renal-replacement-therapy/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2013/LV-135-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/zasto-ograniciti-uporabu-duhanskih-proizvoda/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2013/LV-135-104.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/treba-li-odlucivati-izmedu-komplikacije-i-strucne-pogreske/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2013/LV-135-100.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/procjena-tromboembolijskog-rizika-i-rizika-od-krvarenja-u-bolesnika-s-nereumatskom-atrijskom-fibrilacijom-primjenom-bodovnih-sustava-cha2ds2-vasc-i-hasbled/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2013/LV-135-86.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/akutni-koronarni-sindrom-poslije-uboda-strsljena-kounisov-sindrom-tipa-ii-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2013/LV-135-82.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/prvi-slucaj-radiofrekventne-ablacije-ventrikularne-tahikardije-kod-bolesnika-s-ishemijskom-kardiomiopatijom-u-nasoj-zemlji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2013/LV-135-77.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/3-4/dijagnostika-i-lijecenje-limfoma-drugi-hrvatski-konsenzus/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2013/LV-135-63.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/stvorena-je-jedna-veoma-lijepa-ustanova-koja-sluzi-svim-osiguranicima-u-slucaju-bolesti-osnutak-i-razvoj-merkurova-sanatorija-u-zagrebu-do-1945-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-172.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/trosak-lijecenja-komplikacija-secerne-bolesti-ucinak-poboljsanja-kontrole-glikemije-krvnog-tlaka-i-lipidnog-statusa-na-pojavu-komplikacija-i-troskove-lijecenja-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-162.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/infekcija-virusom-zapadnog-nila-re-emergentna-bolest-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-156.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/transplantacija-krvotvornih-maticnih-stanica-u-lijecenju-autoimunosnih-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-150.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/porodicna-hiperkolesterolemija-mislimo-li-dovoljno-o-ovoj-teskoj-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-145.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/ekstrakorporalna-fotofereza-u-lijecenju-kronicne-reakcije-transplantata-protiv-primatelja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-139.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/anksioznost-i-depresivnost-u-starijih-osoba-pojavnost-i-povezanost-s-koristenjem-zdravstvene-zastite/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-134.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/5-6/antikoagulantno-lijecenje-u-bolesnika-s-trajnom-fibrilacijom-atrija-medicina-utemeljena-na-dokazima-i-klinicka-praksa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2013/LV-135-129.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/prevencija-kronicnih-bolesti-i-stanja-u-djece-naglasci-s-xiii-simpozija-preventivne-pedijatrije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2013/LV-135-213.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/psihogeni-neepilepticki-napadaji-u-djece-prikaz-dviju-bolesnica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2013/LV-135-209.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/analiza-oralnih-lezija-u-pacijenata-upucenih-u-specijalisticku-praksu-oralne-medicine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2013/LV-135-205.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/analiza-limfnog-cvora-cuvara-u-bolesnica-s-ranim-invazivnim-rakom-dojke-klinicki-bolnicki-centar-rijeka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2013/LV-135-201.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/smjernice-za-dijagnostiku-i-lijecenje-vulgarne-psorijaze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2013/LV-135-195.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/7-8/prve-hrvatske-smjernice-za-dijagnostiku-i-lijecenje-krizobolje-i-lumboishialgije-minimalno-invazivnim-procedurama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2013/LV-135-187.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/lijecenje-teske-astme/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/lijecenje-teske-astme/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/lijecenje-teske-astme/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/lijecenje-teske-astme/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/lijecenje-teske-astme/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/lijecenje-teske-astme/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/lijecenje-teske-astme/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/lijecenje-teske-astme/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-268.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/enteralna-prehrana-u-kronicnom-zatajenju-crijeva-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-264.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/psihosocijalni-cimbenici-razvoja-perimenopauzalnih-tegoba/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-257.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/artroskopija-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/artroskopija-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/artroskopija-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/artroskopija-kuka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/artroskopija-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/artroskopija-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/artroskopija-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/artroskopija-kuka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-246.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/difuzni-infantilni-hepatalni-hemangioendoteliom-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-242.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-jajnika-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora-t/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-235.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-maternice-hrvatskoga-onkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-230.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/9-10/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnica-oboljelih-od-raka-vrata-maternice-hrvatskogaonkoloskog-drustva-i-hrvatskog-drustva-za-ginekologiju-i-opstetriciju-hrvatskoga-lijecnickog/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2013/LV-135-225.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/40-godina-neuroloskog-intenzivnog-lijecenja-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-330.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/pasivno-pusenje-aktivni-ubojica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/pasivno-pusenje-aktivni-ubojica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/pasivno-pusenje-aktivni-ubojica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/pasivno-pusenje-aktivni-ubojica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/pasivno-pusenje-aktivni-ubojica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/pasivno-pusenje-aktivni-ubojica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/pasivno-pusenje-aktivni-ubojica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/pasivno-pusenje-aktivni-ubojica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-326.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/acute-on-chronic-liver-failure-aclf-novi-entitet-u-hepatologiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-322.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/prikaz-rijetko-videnog-oblika-otpornosti-na-karbapeneme-u-vrste-enterobacter-cloacae/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-316.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/komunikacija-s-kirurskim-pacijentima-starije-zivotne-dobi-putem-interneta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-310.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/usporedba-vrijednosti-paratiroidnog-hormona-pri-operacijama-stitne-zlijezde-ultrazvucnim-rezacem-i-konvencionalnim-metodama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-306.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-prostate-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-298.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-mokracnog-mjehura-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-292.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2013/11-12/klinicke-upute-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-testisa-hrvatskoga-onkoloskog-drustva-i-hrvatskoga-uroloskog-drustva-hrvatskoga-lijecnickog-zbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2013/LV-135-287.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/coccygodynia-etiologija-patogeneza-klinicke-karakteristike-dijagnoza-i-terapija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-49.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/mezenhimske-maticne-stanice-imunomodulatorne-znacajke-i-klinicka-primjena/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-42.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/ekscentricne-vjezbe-u-lijecenju-sindroma-prenaprezanja-sustava-za-kretanje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-29.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/intraduktalna-papilarna-mucinozna-novotvorina-gusterace-prikaz-slucaja-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-25.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/zasto-lijeceni-hipertonicari-ne-postuju-nase-savjete-doprinos-inicijativi-crash/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-20.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/stentiranje-diseciranih-karotidnih-arterija-kao-minimalno-invazivna-metoda-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-12-4455.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/preemptivna-transplantacija-bubrega-u-djece-iskustvo-kbc-a-zagreb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-9.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-raka-bubrega/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-5.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-invazivnog-raka-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/poznati-lijecnici-koji-su-boravili-na-hrvatskoj-obali-na-prijelazu-u-20-stoljece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-112.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/je-li-hipertrigliceridemija-cimbenik-rizika-od-koronarne-bolesti-srca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-105.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/hormonska-terapija-raka-prostate-ima-li-jos-dilema/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-94.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/oporavak-nakon-dugotrajne-mehanicke-cirkulatorne-potpore-u-bolesnika-s-kronicnim-zatajivanjem-srca-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-90.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/mjerenje-inspiracijskog-protoka-zraka-pri-odabiru-oblika-inhalacijskog-lijeka-za-astmu-i-kopb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-84.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/rezultati-lijecenja-prijeloma-potkoljenice-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-78.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/primarna-perkutana-koronarna-intervencija-ppci-bez-kardiokirurske-potpore-u-regiji-iskustvo-iz-splita/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-75.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/procjena-publicisticke-produktivnosti-klinike-za-unutrasnje-bolesti-medicinskog-fakulteta-i-klinickoga-bolnickog-centra-zagreb/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-69.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/smjernice-hrvatskoga-endokrinoloskog-drustva-za-dijagnostiku-i-lijecenje-akromegalije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-65.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/poneretvlje-kao-patoloski-topos-tisak-i-politizacija-sjecanja-na-doba-kolere-1886-g/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-186.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/transradijalni-pristup-u-intervencijskoj-kardiologiji-quod-licet-femoralisti-non-licet-radialisti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-178.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-cjepiva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-cjepiva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/alergijske-reakcije-na-cjepiva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-cjepiva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/alergijske-reakcije-na-cjepiva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-cjepiva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/alergijske-reakcije-na-cjepiva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-cjepiva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-173.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-hranu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-hranu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/alergijske-reakcije-na-hranu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-hranu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/alergijske-reakcije-na-hranu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-hranu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/alergijske-reakcije-na-hranu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/alergijske-reakcije-na-hranu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-168.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/viroloska-dijagnostika-reemergentnih-infekcija-virus-dengue/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-164.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/metastaze-karcinoma-dojke-u-zeludac-i-debelo-crijevo-prikaz-dviju-bolesnica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-159.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/ucinkovitost-fiksne-kombinacije-dorzolamid-2timolol-05-kod-bolesnika-s-primarnim-glaukomom-otvorenog-kuta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-155.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/usporedna-urinarna-baktericidna-aktivnost-oralnih-antibiotika-prema-gram-pozitivnim-urinarnim-patogenima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-148.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/5-6/hrvatske-smjernice-za-lijecenje-egzokrine-pankreasne-insuficijencije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2012/LV-134-141.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/matija-vlacic-ilirik-mladi-profesor-filozofije-i-aristotelovske-logike-i-profesor-prakticne-medicine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-242.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/placebo-u-lijecenju-boli/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/placebo-u-lijecenju-boli/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/placebo-u-lijecenju-boli/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/placebo-u-lijecenju-boli/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/placebo-u-lijecenju-boli/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/placebo-u-lijecenju-boli/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/placebo-u-lijecenju-boli/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/placebo-u-lijecenju-boli/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-233.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/ligament-koji-zasluzuje-pozornost-medijalni-patelofemoralni-ligament/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-224.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/genetska-podloga-asepticke-nestabilnosti-totalne-endoproteze-zgloba-kuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-218.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/idiopatski-eozinofilni-pleuralni-izljev-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-215.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/anksioznost-i-depresivnost-kod-onkoloskih-bolesnika-u-sveucilisnoj-klinickoj-bolnici-mostar/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-208.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/7-8/smjernice-u-citoloskoj-dijagnostici-stitnjace-hrvatskoga-drustva-za-klinicku-citologiju/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2012/LV-134-203.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/projekt-hranafina-hrvatsko-anatomsko-i-fiziolosko-nazivlje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-297.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/helicobacter-pylori-i-inzulinska-rezistencija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-292.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/kongenitalni-hiperinzulinizam-novosti-o-nastanku-dijagnosticiranju-i-lijecenju-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-286.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/retrogradna-balonska-dilatacija-kao-minimalno-invazivni-oblik-lijecenja-stenoze-uretera/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-281.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/kirursko-lijecenje-bolesti-stitne-zlijezde-u-djecjoj-dobi-prikaz-nasih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-276.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/biopsija-dojke-pod-kontrolom-ultrazvuka-retrospektivna-studija-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-270.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/lokalno-invazivni-papilarni-karcinom-stitnjace-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-266.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/klinicke-smjernice-za-dijagnostiku-lijecenje-i-pracenje-bolesnika-s-neinvazivnim-rakom-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-259.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/9-10/smjernice-hrvatskog-drustva-za-hematologiju-i-transfuzijsku-medicinu-u-dijagnosticko-terapijskom-postupku-za-trombocitopeniju-izazvanu-heparinom-hit/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2012/LV-134-253.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/huntingtonova-bolest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/huntingtonova-bolest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/huntingtonova-bolest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/huntingtonova-bolest/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/huntingtonova-bolest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/huntingtonova-bolest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/huntingtonova-bolest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/huntingtonova-bolest/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-346.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/vestibularni-neuronitis-patofiziologija-dijagnoza-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-340.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/membranski-glomerulonefritis-novosti-u-patogenezi-i-lijecenju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-328.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/kako-poboljsati-transfuzijsko-lijecenje-bolesnika-podvrgnutih-ugradnji-totalnih-endoproteza-kuka-i-koljena/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-322.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/karcinosarkom-sigmoidnoga-debelog-crijeva-s-mikropapilarnom-slikom-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-318.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/kapilarni-hemangiom-testisa-prikaz-dvanaestogodisnjeg-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-316.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/psiholoska-prilagodba-na-kronicni-stres-roditelja-djece-s-intelektualnim-teskocama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-310.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/11-12/djeca-s-ozljedama-lijecena-u-bolnickim-ambulantama-hitnog-prijma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2012/LV-134-305.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/1-2/holt-oramov-sindrom-vaznost-rane-dijagnoze-i-multidisciplinarnog-pristupa-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2012/LV-134-12.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2012/3-4/cervikogena-disfagija-teskoce-s-gutanjem-uzrokovane-funkcijskim-i-organskim-poremecajima-vratne-kraljeznice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2012/LV-134-92.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/deset-godina-od-objave-ispitivanjathe-heart-outcomes-prevention-evaluation-study-hope-znacenje-rezultata-na-primjenu-inhibitoraangiotenzin-konvertirajuceg-enzima-u-klinickoj-praksi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-69.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/zasto-kada-tko-gdje-i-kakou-trazenju-kontakata-oboljelih-od-tuberkuloze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-65.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/klinicka-i-etiopatogenetska-uloga-plazminogenskoga-i-metaloproteinaznoga-sustava-u-tumorskome-rastu-pericelularna-razgradnja-medustanicnoga-matriksa-i-tumorski-rast/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-56.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/vertebrobazilarna-insuficijencija-i-opstrukcijska-apneja-tijekom-spavanja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-50.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/manjak-vitamina-b12-u-djece-podcijenjena-opasnost-u-svjetlu-novih-spoznaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-39.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/endoskopska-transsfenoidalna-hipofizna-kirurgija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-31.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/ponavljani-polihondritis-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-27.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/kirursko-lijecenje-haluksa-valgusa-vlastitom-metodom-operacijska-tehnika-i-prikaz-100-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-20.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/smanjenje-incidencije-infekcija-mokracnog-sustava-u-kateteriziranih-bolesnika-nakon-edukacije-zdravstvenih-radnika-uvodenja-postupnika-i-nadzornih-lista/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-15.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/1-2/smjernice-za-reanimaciju-europskog-vijeca-za-reanimatologiju-2010-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2011/LV-133-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/eticki-pristup-znanstvenim-istrazivanjima-u-kojima-se-koriste-pohranjeni-bioloski-materijali-pacijenata-i-njihovi-medicinski-podatci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-133.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/smjernice-europskoga-kardioloskog-drustva-za-dijagnosticiranje-i-lijecenje-plucne-embolije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-133-4402.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/novosti-i-perspektive-u-invazivnom-lijecenju-u-vertebrologiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-125.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/novosti-u-patofiziologiji-radioloskoj-dijagnostici-i-konzervativnom-lijecenju-bolnih-stanja-i-deformacija-kraljeznice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-116.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/snizeni-hdl-kolesterol-vazan-cimbenik-rizika-od-kardiovaskularnih-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-111.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/sugamadeks-novi-antagonist-misicnih-relaksatora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-106.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/nesteroidni-antireumatici-i-arterijska-hipertenzija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-101.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/moze-li-lacidipin-uzrokovati-poremecaje-osjeta-mirisa-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-98.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/videoasistirana-ekstirpacija-fibroadenoma-dojke-s-neposrednim-obostranim-povecanjem-dojki-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-96.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/bolesti-koje-se-prenose-krpeljima-na-podrucju-hrvatske/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-89.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/3-4/distribucija-prirodenih-srcanih-grjesaka-u-hrvatskoj-i-analiza-ishoda-lijecenja-hrvatska-epidemioloska-studija-2002-2007/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2011/LV-133-81.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/klinicki-i-patofizioloski-obrasci-upale-vanjskog-zvukovoda-s-osvrtom-na-problematicne-slucajeve/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-204.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/vitamin-d-vitamin-proslosti-hormon-buducnosti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-194.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/leiomiomatozni-karcinom-bubreznih-stanica-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-190.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/kostano-hrskavicni-prijelom-ivera-kao-posljedica-akutne-luksacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-187.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/pridrzavanje-klasifikacijskih-kriterija-american-european-consensus-group-za-sjogrenov-sindrom-u-diferencijalnoj-dijagnostici-kserostomije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-180.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/uloga-alfa-blokatora-kod-kronicnog-prostatitisa-tipa-iii/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-177.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/prijedlog-postupnika-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-gastrointestinalnih-stromalnih-tumora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-170.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/5-6/smjernice-za-higijenu-ruku-u-zdravstvenim-ustanovama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2011/LV-133-155.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/uloga-oksidacijskog-stresa-i-zeljeza-u-patofiziologiji-rozaceje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-288.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/visceralna-debljina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/visceralna-debljina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/visceralna-debljina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/visceralna-debljina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/visceralna-debljina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/visceralna-debljina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/visceralna-debljina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/visceralna-debljina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-284.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/alergijski-intersticijski-nefritis-uzrokovan-lijekovima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-276.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/liraglutid-u-lijecenju-secerne-bolesti-tipa-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-269.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/prekomjerna-dnevna-pospanost-kao-moguci-suicidalni-ekvivalent-u-osobe-oboljele-od-depresivnog-poremecaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-263.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/laparoskopsko-odstranjenje-zucnog-mjehura-u-bolesnika-s-ventrikuloperitonealnim-kateterom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-260.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/anterogradna-skrotalna-skleroterapija-u-lijecenju-varikokele/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-256.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/alat-za-ocjenu-rada-u-cilju-poboljsanja-kvalitete-u-bolnicama-prva-iskustva-u-provodenju-programa-path-u-hrvatskim-bolnicama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-250.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/razvoj-interventne-dijagnostike-u-referentnom-centru-za-pedijatrijsku-kardiologiju-rh-retrospektivna-studija-1996-2009/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-241.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/7-8/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-i/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2011/LV-133-231.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/cetrdeset-godina-ugradnje-totalne-endoproteze-zgloba-kuka-u-hrvatskoj-u-klinici-za-ortopediju-zagreb-ortopedska-operacija-20-stoljeca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-343.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/aspirinska-rezistencija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/aspirinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/aspirinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/aspirinska-rezistencija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/aspirinska-rezistencija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/aspirinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/aspirinska-rezistencija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/aspirinska-rezistencija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-337.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/lumbosakralni-fasetni-sindrom-funkcijski-i-organski-poremecaji-lumbosakralnih-fasetnih-zglobova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-330.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/trzajna-ozljeda-vratne-kraljeznice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-327.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/endoskopska-mukozna-resekcija-sesilnih-polipoidnih-lezija-debelog-crijeva-dvogodisnja-retrospektivna-analiza-prikaz-tehnike-indikacija-i-komplikacija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-322.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/histrelin-acetat-prvi-lhrh-agonist-s-primjenom-jednom-na-godinu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-320.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/fibrilarni-glomerulonefritis-i-imunotaktoidna-glomerulopatija-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-315.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/analiza-dobne-distribucije-i-stupnja-lokalne-prosirenosti-raka-dojke-kod-bolesnica-operiranih-u-11-godisnjem-razdoblju-u-klinickoj-bolnici-dubrava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-312.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/usporedba-cijena-sekundarne-prevencije-i-lijecenja-mozdanog-udara-cost-effectiveness-analiza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-308.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/9-10/hrvatske-smjernice-za-prehranu-osoba-starije-dobi-dio-ii-klinicka-prehrana/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2011/LV-133-299.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/kongresi-hrvatskoga-lijecnickog-zbora-u-povodu-neobjavljena-zbornika-x-kongresa-u-zadru-25-28-rujna-1996/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-411.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/zasto-se-zanemaruje-klortalidon-tijazidski-antihipertenziv-izbora/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-408.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/uloga-mutacije-gena-kras-u-kolorektalnom-karcinomu-prediktivni-cimbenik-odgovora-na-lijecenje-inhibitorima-egfr-a/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-403.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/usporedba-nove-i-stare-dijagnostike-latentne-tuberkulozne-infekcije-quantiferon-i-ppd/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-396.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/dijagnosticki-pristup-pracenje-i-lijecenje-citomegalovirusne-cmv-infekcije-nakon-alogene-transplantacije-krvotvornih-maticnih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-389.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/multipli-primarni-tumori/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/multipli-primarni-tumori/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/multipli-primarni-tumori/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/multipli-primarni-tumori/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/multipli-primarni-tumori/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/multipli-primarni-tumori/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/multipli-primarni-tumori/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/multipli-primarni-tumori/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-384.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/lijecenje-histiocitoze-langerhansovih-stanica-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-376.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/etiologija-nodoznog-eritema-u-bolesnika-u-reumatoloskoj-ambulanti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-370.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-kolorektalnog-raka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-366.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2011/11-12/klinicke-upute-za-dijagnozu-lijecenje-i-pracenje-bolesnika-oboljelih-od-karcinoma-pluca-nemalih-stanica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2011/LV-133-361.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/hrvatski-lijecnicki-zbor-u-razdoblju-tranzicije-1989-1997/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-43.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/organizacija-zastite-mentalnog-zdravlja-u-zajednici/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-38.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/molekularna-osnova-raka-dojke-vezana-uz-gene-brca1-i-brca2-karakteristike-i-ciljana-terapija/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-34.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/uloga-proteina-porodice-bcl-2-u-psorijazi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-31.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/hipotermija-nakon-kardijalnog-aresta-premalo-upotrebljavana-metoda-koja-spasava-zivote/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-25.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/utjecaj-manualne-terapije-vratne-kraljeznice-na-tipicnu-trigeminalnu-neuralgiju-prikaz-bolesnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-21.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/akutna-pseudoopstrukcija-kolona-s-komplikacijom-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-18.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/ultrazvucne-karakteristike-bubrega-u-djece-i-adolescenata-s-dijabetesom-melitusom-tipa-1/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-13.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/uporaba-sukcinil-kolina-medu-hrvatskim-anesteziolozima-je-li-taj-lijek-zaista-odbacen/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-8.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/1-2/hrvatske-smjernice-za-primjenu-enteralne-prehrane-u-crohnovoj-bolest/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2010/LV-132-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/pogreske-u-historiografiji-civilne-bolnice-u-splitu-u-povodu-postavljanja-spomen-ploce-na-nekadasnjoj-bolnickoj-zgradi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-115.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/sindrom-ukocene-osobe-moersch-woltman/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-110.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/sinovijalna-hondromatoza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/sinovijalna-hondromatoza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/sinovijalna-hondromatoza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/sinovijalna-hondromatoza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/sinovijalna-hondromatoza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/sinovijalna-hondromatoza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/sinovijalna-hondromatoza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/sinovijalna-hondromatoza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-102.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/moze-li-uvodenje-postupnika-za-postavljanje-intrauterinoga-uloska-smanjiti-promjenu-mikrobioloske-flore-spolnoga-sustava-u-zena-koje-ga-rabe/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-99.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/fiksne-kombinacije-antihipertenzivnih-lijekova-nove-mogucnosti-lijecenja-arterijske-hipertenzije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-94.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/niske-doze-sulfonilureje-kao-uspjesna-zamjena-za-inzulin-u-lijecenju-neonatalnog-dijabetesa-uzrokovanog-aktivirajucom-mutacijom-kir6-2/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-90.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/fournierova-gangrena-nase-iskustvo-sa-17-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-86.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/ima-li-u-hrvatskoj-krivotvorenih-lijekova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-81.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/utjecaj-ekonomske-recesije-na-trziste-rada-sustava-zdravstva-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-76.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/3-4/dijagnostika-i-lijecenje-incidentaloma-nadbubrezne-zlijezde-preporuke-referentnog-centra-ministarstva-zdravstva-za-bolesti-nadbubrezne-zlijezde/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2010/LV-132-71.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/znameniti-karlovacki-lijecnik-dr-milan-nemicic-1844-1930/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-177.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/anafilaksija-potaknuta-naporom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/anafilaksija-potaknuta-naporom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/anafilaksija-potaknuta-naporom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/anafilaksija-potaknuta-naporom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/anafilaksija-potaknuta-naporom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/anafilaksija-potaknuta-naporom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/anafilaksija-potaknuta-naporom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/anafilaksija-potaknuta-naporom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-173.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/lijecenje-egzacerbacija-astme-u-odraslih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-168.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/sistemska-skleroza-patogeneza-klinicke-manifestacije-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-162.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/patohistoloska-dijagnostika-karcinoma-prostate-s-pomocu-biopsije-iglom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-155.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/reverzibilna-posteriorna-leukoencefalopatija-ili-tumor-mozga-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-151.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/tolosa-huntov-sindrom-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-147.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/utjecaj-tecaja-higijenskog-minimuma-na-kvalitetu-ugostiteljskih-objekata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-144.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/nadoknada-troska-lijeka-u-hrvatskoj-je-li-se-moglo-uciniti-vise/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-134.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/5-6/postupnik-za-dijagnostiku-lijecenje-i-pracenje-oboljelih-od-neuroendokrinih-tumora-gusterac/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2010/LV-132-127.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/hinko-lehner-prvi-hrvatski-logoped/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-257.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/standardizacija-optotipa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/standardizacija-optotipa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/standardizacija-optotipa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/standardizacija-optotipa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/standardizacija-optotipa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/standardizacija-optotipa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/standardizacija-optotipa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/standardizacija-optotipa/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-252.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/sustavna-terapija-u-lijecenju-psorijaze-lijekovi-predbioloske-ere/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-246.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/artroskopija-lakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/artroskopija-lakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/artroskopija-lakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/artroskopija-lakta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/artroskopija-lakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/artroskopija-lakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/artroskopija-lakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/artroskopija-lakta/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-238.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/laparoskopska-parcijalna-pericistektomija-ehinokokne-ciste-jetre-po-papadimitriouu-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-235.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/haemosiderosis-bulbi-kod-pacijenta-s-mijelodisplasticnim-sindromom-mds-raeb-1/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-232.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-recidiva-konvulzija-poslije-prvoga-febrilnog-napadaja-rezultati-dvogodisnjeg-promatranja/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-227.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/ucestalost-i-karakteristike-dispepsije-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-222.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/medicina-utemeljena-na-znanstvenim-dokazima-stavovi-zdravstvenog-osoblja-jedne-klinicke-bolnice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-218.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/7-8/smjernice-iskra-za-antimikrobnu-profilaksu-u-kirurgiji-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2010/LV-132-203.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/pretece-i-razvoj-visokoskolske-medicinske-izobrazbe-u-dalmaciji-od-individualne-inicijative-do-osnutka-medicinskog-studija-u-splitu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-309.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/dijete-u-suvremenome-hrvatskom-drustvu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-303.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/utjecaj-debljine-na-rizik-od-osteoporotskih-prijeloma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-298.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/uloga-dijagnostickog-ultrazvuka-u-razlikovanju-patomorfoloskih-promjena-kod-humeroskapularnog-periartritisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-293.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/ucinci-pneumoperitoneuma-na-jetrenu-funkciju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-288.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/akutna-upala-jezicne-tonzile/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/akutna-upala-jezicne-tonzile/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/akutna-upala-jezicne-tonzile/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/akutna-upala-jezicne-tonzile/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/akutna-upala-jezicne-tonzile/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/akutna-upala-jezicne-tonzile/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/akutna-upala-jezicne-tonzile/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/akutna-upala-jezicne-tonzile/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-285.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/prirodena-hipoplazija-donjeg-dijela-lijevoga-m-psoasa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-283.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/nuspojave-inhibitora-3-hidroksi-3-metil-glutaril-koenzim-a-reduktaze-prijavljene-agenciji-za-lijekove-i-medicinske-proizvode/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-277.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/rezultati-lijecenja-suprakondilarnih-prijeloma-humerusa-s-pomakom-ulomaka-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-272.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/9-10/4-smjernice-o-dijagnostici-i-lijecenju-debljine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2010/LV-132-269.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/krstenje-u-nuzdi-medikohistoriografsko-videnje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-376.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/zbrinjavamo-li-ispravno-odrasle-bolesnike-s-astmom-u-obiteljskoj-medicini/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-370.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/lijecenje-alopecije-areate-suvremeni-principi-i-perspektive/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-365.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/uloga-stanicne-citotoksicnosti-posredovane-perforinom-u-psorijazi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-361.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/radioaktivni-jod-131-ili-kirurski-zahvat-u-lijecenju-gravesove-hipertireoze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-355.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/prikaz-bolesnika-s-kombiniranim-penetrirajucim-ozljedama-srca-trbuha-i-trupa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-352.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/analiza-samoubojstava-na-podrucju-bjelovarsko-bilogorske-zupanije-u-razdoblju-od-1988-do-2005-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-345.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/smjernice-za-prevenciju-kontrolu-i-lijecenje-infekcija-koje-uzrokuje-meticilin-rezistentni-staphylococcus-aureus-mrsa-izmjena-i-dopuna-poglavlja-7-0-lijecenje-bolesnika-s-mrsa-infekcijo/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-340.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2010/11-12/dijagnosticko-terapijski-pristup-u-bolesnika-s-esencijalnom-trombocitemijom-smjernice-hrvatske-kooperativne-grupe-za-hematoloske-bolesti-krohem/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2010/LV-132-333.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/reevaluacija-epistemickog-utemeljenja-baglivijeve-lijecnicke-doktrine-i-njegove-anatomsko-fizioloske-teorije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-34.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/stent-endovaskularna-proteza-mrezica-ili-podupirac-sto-bi-na-sve-to-rekao-britanski-stomatolog-charles-stent-1807-1885/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-30.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/troficki-sindrom-trigeminalnog-zivca-dijagnoza-lijecenje-i-prognoza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-27.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/debljina-cimbenik-rizika-i-prediktor-razvoja-osteoartritisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-22.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/visokorezolutni-b-mod-i-doplerski-ultrazvuk-u-dijagnostici-crohnove-bolesti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-18.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/tako-tsubo-kardiomiopatija-reverzibilna-disfunkcija-lijeve-klijetke-koja-oponasa-akutni-infarkt-miokarda-sa-st-elevacijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-14.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/ucestalost-prijeloma-kuka-u-hrvatskoj-u-pacijenata-u-dobi-od-65-i-vise-godina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-9.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/bubrezne-promjene-u-vaskulitisu-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-4.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/1-2/preporuke-hrvatskih-strucnih-drustava-o-lijecenju-makrovaskularnih-i-mikrovaskularnih-komplikacija-u-bolesnika-s-metabolickim-sindromom-i-secernom-bolesti-tipa-2-lijecenje-preostaloga-kardio/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2009/LV-131-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/kirurska-sluzba-u-bjelovaru-tijekom-ii-svjetskog-rata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-93.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/manje-soli-vise-zdravlja-hrvatska-inicijativa-za-smanjenje-prekomjernog-unosa-kuhinjske-soli-crash/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-87.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/sindrom-misica-iliopsoasa-funkcionalni-poremecaji-skracenje-spazam-i-slabost-strukturno-nepromijenjenog-misica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-81.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/nuspojave-i-interakcije-fluorokinolona/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/nuspojave-i-interakcije-fluorokinolona/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/nuspojave-i-interakcije-fluorokinolona/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/nuspojave-i-interakcije-fluorokinolona/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/nuspojave-i-interakcije-fluorokinolona/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/nuspojave-i-interakcije-fluorokinolona/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/nuspojave-i-interakcije-fluorokinolona/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/nuspojave-i-interakcije-fluorokinolona/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-74.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/nove-opticke-endoskopske-tehnike-u-ranoj-detekciji-tumora-probavnog-trakta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-69.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/spontana-okluzija-fistule-izmedu-desne-koronarne-arterije-i-desne-klijetke-u-dojenceta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-65.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/novorodencad-male-porodne-mase-u-pet-hrvatskih-zupanija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-58.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/pojavnost-velikih-nezeljenih-srcanozilnih-dogadaja-nakon-kardiokirurskih-zahvata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-54.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/3-4/hrvatske-smjernice-za-prevenciju-mucnine-i-povracanja-uzrokovanih-kemoterapijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2009/LV-131-49.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/prve-lijecnice-u-bjelovaru-porodnicarka-i-kirurginje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-155.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/kuhinjska-sol-skriveni-otrov-u-svakodnevnoj-hrani/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-146.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/dijabeticka-nefropatija-i-primarne-bolesti-glomerula/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-141.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/uloga-taksana-u-kemoterapiji-raka-dojke-ima-li-novosti-nakon-15-godisnjeg-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-133.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/dvostruka-hipofiza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/dvostruka-hipofiza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/dvostruka-hipofiza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/dvostruka-hipofiza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/dvostruka-hipofiza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/dvostruka-hipofiza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/dvostruka-hipofiza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/dvostruka-hipofiza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-130.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/nekrotizirajuci-fascitis-natkoljenice-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-126.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/neuroradioloska-dijagnostika-hospitaliziranih-bolesnika-psihijatrijske-bolnice-vrapce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-122.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/utjecaj-fibrinoliticke-i-heparinske-terapije-u-akutnom-infarktu-miokarda-na-gastrointestinalno-krvarenje-kod-asimptomatskih-ulkusnih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-119.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/5-6/iskra-smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2009/LV-131-105.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/dr-erwin-treu-prvi-stalni-oftalmolog-u-splitu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-233.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/medicinska-pogreska-profesionalna-odgovornost-za-stete-u-bosni-i-hercegovini/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-229.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/strucna-medicinska-pogreska-slovenska-stajalista-i-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-226.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/dijabeticka-nefropatija-i-prevencija-kronicnog-bubreznog-zatajenja-uzrokovanog-dijabetickom-nefropatijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-218.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/dopler-jetrene-cirkulacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/dopler-jetrene-cirkulacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/dopler-jetrene-cirkulacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/dopler-jetrene-cirkulacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/dopler-jetrene-cirkulacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/dopler-jetrene-cirkulacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/dopler-jetrene-cirkulacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/dopler-jetrene-cirkulacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-211.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/vaznost-elektrogastrografije-u-dijagnostici-poremecaja-motiliteta-zeluca-u-djecjoj-dobi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-207.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/marden-walkerov-sindrom-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-203.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/plucna-histiocitoza-langerhansovih-stanica-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-199.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/neepidermoidni-tumori-larinksa-15-godisnje-iskustvo-u-nasoj-ustanovi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-196.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/malarija-u-hrvatskoj-u-razdoblju-od-1987-do-2006/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-192.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/7-8/smjernice-iskra-za-grlobolju-dijagnosticki-i-terapijski-pristup-hrvatske-nacionalne-smjernice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2009/LV-131-181.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/udruzenje-lijecnika-hrvatskog-primorja-i-gorskog-kotara/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-286.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/debljina-medicinski-i-javnozdravstveni-problem/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-279.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/dismenoreja-izazvana-poremecajima-lumbosakralne-kraljeznice-patogeneza-dijagnoza-i-terapija-s-posebnim-naglaskom-na-spinalnu-manipulativnu-terapiju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-275.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/dijagnosticko-terapijski-postupnik-za-muskarce-kojih-partnerice-imaju-hpv-genitalnu-infekciju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-269.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/mikrobioloska-dijagnostika-trihineloze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/mikrobioloska-dijagnostika-trihineloze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/mikrobioloska-dijagnostika-trihineloze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/mikrobioloska-dijagnostika-trihineloze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/mikrobioloska-dijagnostika-trihineloze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/mikrobioloska-dijagnostika-trihineloze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/mikrobioloska-dijagnostika-trihineloze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/mikrobioloska-dijagnostika-trihineloze/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-265.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/prikaz-uskim-spektrom-nova-paradigma-u-gastrointestinalnoj-videoendoskopiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-260.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/kolesterolska-embolizacija-i-bubrezna-insuficijencija-prikaz-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-254.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/aplikacija-trombina-vodena-ultrazvucno-u-lijecenju-pseudoaneurizme-femoralne-arterije-prikaz-troje-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-251.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/operativno-zavrseni-porodi-u-klinici-za-ginekologiju-i-akuserstvo-u-tuzli-bosna-i-hercegovina-u-razdoblju-1986-2005-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-248.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/9-10/stvarni-volumen-tjelesne-vode-u-bolesnika-lijecenih-peritonealnom-dijalizom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2009/LV-131-243.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/prva-operacija-na-otvorenom-srcu-u-hipotermiji-u-hrvatskoj-izvedena-1957-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-301.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/smjernice-hrvatskog-drustva-za-stitnjacu-za-racionalnu-dijagnostiku-poremecaja-funkcije-stitnjace/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-328.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/nuspojave-radioterapije-u-usnoj-supljini-dijagnostika-prevencija-i-terapijske-smjernice/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-324.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/prikupljanje-krvotvornih-maticnih-stanica-iz-periferne-krvi/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-315.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/aloartroplastika-koljena-u-bolesnika-s-transplantiranim-srcem-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-311.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/transplantacija-bubrega-u-bolesnika-s-urinarnom-diverzijom/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-308.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/traumatska-ozljeda-brahijalnog-pleksusa-s-ozljedom-krvnih-zila-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-306.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2009/11-12/regionalna-raspodjela-lijecnika-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2009/LV-131-301-4331.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/revaskulariziranje-koronarnih-bolesnika-u-hrvatskoj/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-41.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/uporaba-lijekova-u-trudnoci-u-zagrebu/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-43.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/zdravstvo-grada-zagreba-prije-jednog-stoljeca-1907-1909/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-35.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/regionalizacija-neonatalnog-intenzivnog-lijecenja-rezultati-i-iskustva-klinike-za-ginekologiju-i-porodnistvo-kbc-a-rijeka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-30.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/eticke-dvojbe-suvremene-psihijatrije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-26.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/postprandijalna-hiperglikemija-kao-cimbenik-rizika-u-nastanku-endotelne-disfunkcije-mogucnosti-prevencije/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-21.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/bolest-sitnih-stranih-cestica-asepticka-nestabilnost-totalne-endoproteze-zgloba-kuka/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-16.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/adenom-bazalnih-stanica-nosnog-septuma-prikaz-bolesnika/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-13.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/lijecenje-haluksa-valgusa-u-klinici-za-ortopediju-u-razdoblju-od-1981-do-2000-godine/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-7.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/prenatalna-genotipizacija-rhd-lokusa-s-pomocu-lancane-reakcije-polimerazom-u-fetusa-s-rizikom-od-hemoliticke-bolesti/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-4.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/1-2/klinicko-patoloska-obiljezja-mikropapilarne-varijante-urotelnog-karcinoma-mokracnog-mjehura/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2008/LV-130-1.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/bolesnik-sa-inzulinomom-koji-se-prezentirao-kao-paroksizmalni-nocni-poremecaj-sa-spontanim-oporavkom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-104.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/poremeceno-spavanje-u-osoba-s-dugogodisnjim-ratnim-ptsp-om-procijenjeno-cjelonocnom-polisomnografijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-101.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/adenotonzilektomija-u-lijecenju-poremecaja-disanja-tijekom-spavanja-u-djecjoj-dobi-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-97.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/kirursko-lijecenje-poremecaja-disanja-tijekom-spavanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-91.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/navike-spavanja-studenata-medicine-lijecnika-i-medicinskih-sestara-utjecaj-dobi-spola-nocnog-rada-i-konzumacije-kofeina/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-87.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/opstrukcijska-apneja-tijekom-spavanja-i-anestezija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-78.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/poremecaji-disanja-tijekom-spavanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/poremecaji-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/poremecaji-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/poremecaji-disanja-tijekom-spavanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/poremecaji-disanja-tijekom-spavanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/poremecaji-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/poremecaji-disanja-tijekom-spavanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/poremecaji-disanja-tijekom-spavanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-69.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/psihoneuroimunologija-regulacija-imunosti-na-razini-organizma-kao-cjeline/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-62.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/sentinelna-limfadenektomija-kod-planocelularnih-karcinoma-larinksa-i-hipofarinksa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-58.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/3-4/rano-otkrivanje-ostecenja-sluha-u-novorodencadi-metodom-automatskog-ispitivanja-otoakusticke-emisije-u-rodilistu-opce-bolnice-virovitica/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2008/LV-130-55.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/medicinski-casopisi-i-otvoreni-pristup/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2008/LV-130-151.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/polimorfizam-trombocitnog-glikoproteina-iba-kao-genski-cimbenik-rizika-od-koronarne-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2008/LV-130-146.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/anagrelid-u-lijecenju-bolesnika-s-esencijalnom-trombocitemijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2008/LV-130-141.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/kriptokokni-meningitis-kao-dijagnosticki-problem-u-bolesnika-sa-sustavnim-eritemskim-lupusom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2008/LV-130-136.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/poslijeoperacijska-drenaza-nakon-aloartroplastike-kuka-i-koljena-odstranjivanje-drenaze-nakon-24-ili-nakon-48-sati/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2008/LV-130-133.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/5-6/smjernice-za-dijagnosticiranje-i-lijecenje-arterijske-hipertenzije-prakticne-preporuke-hrvatske-radne-skupine-i-osvrt-na-smjernice-eshesc-2007/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2008/LV-130-115.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/indikacije-za-tonzilektomiju-u-djece-do-16-godina-u-klinici-za-otorinolaringologiju-i-kirurgiju-glave-i-vrata-kb-sestre-milosrdnice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-201.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/inkretini-u-lijecenju-secerne-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-195.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/centralna-bol-nakon-mozdanog-udara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/centralna-bol-nakon-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/centralna-bol-nakon-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/centralna-bol-nakon-mozdanog-udara/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/centralna-bol-nakon-mozdanog-udara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/centralna-bol-nakon-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/centralna-bol-nakon-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/centralna-bol-nakon-mozdanog-udara/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-191.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/minimalno-invazivna-aortna-kirurgija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/minimalno-invazivna-aortna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/minimalno-invazivna-aortna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/minimalno-invazivna-aortna-kirurgija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/minimalno-invazivna-aortna-kirurgija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/minimalno-invazivna-aortna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/minimalno-invazivna-aortna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/minimalno-invazivna-aortna-kirurgija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-187.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/neonatalna-aloimuna-trombocitopenija-u-hrvatskoj-od-1997-do-2007-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-183.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/ultrazvucni-rezac-u-kirurgiji-glave-i-vrata-nase-iskustvo-sa-161-bolesnikom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-178.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/7-8/utjecaj-elektrokonverzije-na-vrijednosti-troponina-i-i-mozdanog-natriuretskog-peptida-nt-probnp-u-bolesnika-s-perzistentnom-fibrilacijomundulacijom-atrija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2008/LV-130-175.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/zvonimir-susic-velikan-hrvatske-neuropsihijatrije-20-stoljeca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2008/LV-130-252.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/evaluacija-rada-klinike-za-neurologiju-klinicke-bolnice-split-u-jednogodisnjem-razdoblju-u-odnosu-na-nacionalne-standarde/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2008/LV-130-248.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/transseksualnost-zivot-u-krivom-tijelu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2008/LV-130-237.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/cervikogena-angina-bol-u-prsima-uzrokovana-neprepoznatom-hernijacijom-diska-u-segmentu-c6-c7-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2008/LV-130-234.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/ostecenje-gastroduodenalne-sluznice-i-tezina-koronarne-ateroskleroze-u-bolesnika-s-koronarnom-bolescu-srca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2008/LV-130-228.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/9-10/dijagnosticke-i-terapijske-smjernice-za-diferencirani-karcinom-stitnjace-hrvatskog-drustva-za-stitnjacu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2008/LV-130-213.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/kirurzi-ranarnici-u-bjelovaru-i-bjelovarskom-zavicaju-u-xviii-xix-stoljecu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-311.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/kvaliteta-zdravstvene-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/kvaliteta-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/kvaliteta-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/kvaliteta-zdravstvene-skrbi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/kvaliteta-zdravstvene-skrbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/kvaliteta-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/kvaliteta-zdravstvene-skrbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/kvaliteta-zdravstvene-skrbi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-306.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/strucne-i-eticke-kvalitete-medicinskog-vjestaka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-305.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/razlika-izmedu-pogreske-i-komplikacije-u-naknadi-stete/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-302.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/medicinsko-vjestacenje-u-opstetriciji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-297.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/vrste-postupaka-za-utvrdivanje-profesionalne-odgovornosti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-293.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/pravni-aspekti-medicinskog-vjestacenja-i-neimovinske-stete-u-okviru-gradanskopravne-odgovornosti-lijecnika-za-stetu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-288.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/osnovna-obiljezja-odgovornosti-za-stete-u-medicini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-282.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/medicinski-pristup-odgovornosti-lijecnika-za-stete-koje-nastaju-pri-pruzanju-medicinskih-usluga/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-279.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2008/11-12/osvrt-na-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2008/LV-130-273.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/zdravstvena-ispravnost-pitke-vode-iz-privatnih-zdenaca-u-zagrebu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-39.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/lipoprotein-lipaza-fizioloske-i-patofizioloske-uloge-te-genske-varijante-u-hrvatskoj-populaciji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-32.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/uzroci-i-klinicka-prezentacija-fizicke-boli-u-djecjoj-dobi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-25.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/vertebrogena-bol-u-prsima-pseudoangina-pektoris-etiopatogeneza-klinicka-slika-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-20.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/pseudocistogastrostomija-vodena-endoskopskim-ultrazvukom-novi-pristup-starom-terapijskom-problemu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-17.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/anorexia-nervosa-stanje-zivotne-ugrozenosti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-11.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/etapno-lijecenje-u-zbrinjavanju-strijelnih-ozljeda/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-8.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/rekurentne-aftozne-ulceracije-analiza-predisponirajucih-cimbenika-u-68-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-4.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/1-2/c-reaktivni-protein-i-laktat-dehidrogenaza-kao-samostalni-prognosticki-cimbenici-tezine-akutnog-pankreatitisa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2007/LV-129-1.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/perinatalna-zastita-u-hrvatskoj-jucer-danas-sutra/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-87.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/sindrom-nemirnih-nogu-wittmaack-ekbom-tako-cest-a-nedovoljno-poznat-poremecaj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-84.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/lijecenje-leukemije-vlasastih-stanica-kladribinom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-80.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/spontana-aortokavalna-fistula/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/spontana-aortokavalna-fistula/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/spontana-aortokavalna-fistula/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/spontana-aortokavalna-fistula/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/spontana-aortokavalna-fistula/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/spontana-aortokavalna-fistula/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/spontana-aortokavalna-fistula/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/spontana-aortokavalna-fistula/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-76.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/depresivna-psihoza-inducirana-ciklosporinom-u-bolesnice-s-transplantiranom-jetrom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-74.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/obostrani-karcinom-bubreznih-stanica-i-istodobni-urotelni-karcinom-nakapnice-i-mokracovoda-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-70.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/trajna-spojna-kruzna-tahikardija-pjrt-i-dilatacijska-kardiomiopatija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-66.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/klinicke-i-laboratorijske-odlike-dijabetesa-tipa-1-u-djece-u-vrijeme-postavljanja-dijagnoze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-61.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/utjecaj-nekih-sociodemografskih-varijabla-na-pojavnost-negativnih-oblika-ponasanja-u-radnom-okruzju-medicinskih-sestara-i-tehnicara/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-54.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/3-4/hrvatski-nacionalni-konsenzus-o-dijagnostici-i-lijecenju-debljine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2007/LV-129-51.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/prijedlog-programa-ranog-otkrivanja-raka-vrata-maternice-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-158.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/artroskopska-kirurgija-gleznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/artroskopska-kirurgija-gleznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/artroskopska-kirurgija-gleznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/artroskopska-kirurgija-gleznja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/artroskopska-kirurgija-gleznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/artroskopska-kirurgija-gleznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/artroskopska-kirurgija-gleznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/artroskopska-kirurgija-gleznja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-152.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/infekcije-izazvane-netuberkuloznim-mikobakterijama/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-146.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/teska-kronicna-bolest-i-liaison-psihijatrija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-143.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/laparoskopska-transgastricna-cistogastrostomija-pseudociste-gusterace-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-138.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/leukocitoklasticki-vaskulitis-u-primarnome-sjogrenovu-sindromu-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-134.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/trogodisnji-djecak-homozigot-za-porodicnu-hiperkolesterolemiju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-130.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/ucestalost-osteoporoze-u-muskaraca-u-hrvatskoj-rezultati-ultrazvucne-denzitometrije-petne-kosti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-123.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/sto-zele-specijalizirati-studenti-seste-godine-medicinskog-fakulteta-u-zagrebu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-118.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/5/dijagnostika-i-lijecenje-limfoma-hrvatski-konsenzus/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-2007/LV-129-111.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/cirkumcizija-kulturni-identitet-i-medicinska-kontroverza/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-241.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/mjesto-betaadrenergickih-blokatora-u-suvremenom-lijecenju-arterijske-hipertenzije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-237.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/cervikogena-glavobolja-etiopatogeneza-karakteristike-dijagnoza-diferencijalna-dijagnoza-i-terapija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-230.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/klinicke-znacajke-tremora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/klinicke-znacajke-tremora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/klinicke-znacajke-tremora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/klinicke-znacajke-tremora/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/klinicke-znacajke-tremora/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/klinicke-znacajke-tremora/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/klinicke-znacajke-tremora/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/klinicke-znacajke-tremora/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-223.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/hipertenzija-literaturni-prikaz-dijagnostickog-i-terapijskog-pristupa-u-djecjoj-dobi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-214.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/nesteroidni-protuupalni-lijekovi-i-ozbiljne-gastrointestinalne-nuspojave/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-205.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/rekonstrukcija-marginalnog-defekta-srednje-trecine-uske/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-201.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/laparoskopska-dekapsulacija-prirodene-ciste-slezene/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-199.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/osteohondritis-disekans-gleznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/osteohondritis-disekans-gleznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/osteohondritis-disekans-gleznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/osteohondritis-disekans-gleznja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/osteohondritis-disekans-gleznja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/osteohondritis-disekans-gleznja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/osteohondritis-disekans-gleznja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/osteohondritis-disekans-gleznja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-191.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/analiza-prijeoperacijske-donacije-autologne-krvi-za-ugradnju-revizijskih-endoproteza-kuka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-186.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/6-7/klinicka-i-epidemioloska-obiljezja-prolapsa-mitralne-valvule-u-djece/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-7-2007/LV-129-181.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/in-memoriam-dr-zeljko-mataija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-dr-zeljko-mataija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-dr-zeljko-mataija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-dr-zeljko-mataija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-dr-zeljko-mataija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-dr-zeljko-mataija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-dr-zeljko-mataija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-dr-zeljko-mataija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-311.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/kvantitativna-klinicka-reumatologija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/kvantitativna-klinicka-reumatologija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/kvantitativna-klinicka-reumatologija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/kvantitativna-klinicka-reumatologija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/kvantitativna-klinicka-reumatologija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/kvantitativna-klinicka-reumatologija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/kvantitativna-klinicka-reumatologija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/kvantitativna-klinicka-reumatologija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-314.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-krsto-babic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-krsto-babic/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-prim-dr-krsto-babic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-krsto-babic/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-prim-dr-krsto-babic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-krsto-babic/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-prim-dr-krsto-babic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-krsto-babic/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-313.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-duro-frisic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-duro-frisic/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-prim-dr-duro-frisic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-duro-frisic/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-prim-dr-duro-frisic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-duro-frisic/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/in-memoriam-prim-dr-duro-frisic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/in-memoriam-prim-dr-duro-frisic/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-312.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/prikaz-knjige-iz-forenzicne-psihijatrije-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/prikaz-knjige-iz-forenzicne-psihijatrije-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/prikaz-knjige-iz-forenzicne-psihijatrije-2/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-310.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/incidencija-metabolickog-sindroma-u-bolesnika-s-akutnim-koronarinim-incidentom-u-klinickoj-bolnici-mostar-2005-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-309.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/usporedba-niskomolekularnih-heparina-i-nefrakcioniranih-heparina-u-lijecenju-bolesnika-na-hemodijalizi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-305.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/nedostatak-vitamina-d-u-postmenopauzalnih-zena-koje-se-lijece-zbog-osteoporoze/" />
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-304.pdf</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/projekti-i-izgradnja-kirurskoga-paviljona-bjelovarske-bolnice/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-299.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/dugotrajni-ucinci-dojenja-na-zdravlje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-293.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/prirodeni-poremecaji-glikozilacije-i-projekt-euroglycanet/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-286.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/antifosfolipidni-sindrom-od-dijagnoze-do-lijecenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-281.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/ucinci-biljnih-sterola-na-hiperkolesterolemiju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-276.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/fast-track-kirurgija-ubrzana-multimodalna-rehabilitacija-kirurskih-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-269.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/utjecaj-psihoterapije-na-mozdanu-cirkulaciju-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-265.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/razlike-u-mortalitetu-bolesnika-hospitaliziranih-zbog-akutnog-infarkta-miokarda-u-kbc-u-zagreb-ovisno-o-nacinu-lijecenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-260.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/8-9/presjecno-istrazivanje-cross-sectional-study-uporabe-lijekova-u-trudnoci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/8-9-2007/LV-129-253.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/izmedu-brijacnice-i-bolnice-uloga-kirurga-ranarnika-u-osijeku-u-razdoblju-od-1687-do-1746-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-367.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/arterijska-hipertenzija-i-prehrana/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/arterijska-hipertenzija-i-prehrana/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/arterijska-hipertenzija-i-prehrana/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/arterijska-hipertenzija-i-prehrana/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/arterijska-hipertenzija-i-prehrana/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/arterijska-hipertenzija-i-prehrana/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/arterijska-hipertenzija-i-prehrana/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/arterijska-hipertenzija-i-prehrana/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-364.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/izvanbolnicki-meticilin-rezistentni-staphylococcus-aureus-molekularna-evolucija-karakteristike-i-znacenje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-355.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/uloga-omega-3-masnih-kiselina-iz-riba-u-prevenciji-kardiovaskularnih-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-350.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/terapijski-pristup-neutropenicnom-bolesniku-s-vrucicom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-344.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/magnetnorezonantna-kolangiopankreatografija-mrcp/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-336.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/cista-straznjeg-roga-medijalnog-meniskusa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-333.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/prijelomi-zbog-zamora-rebara-u-veslaca-prikaz-triju-slucajeva-i-pregled-literature/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-327.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/sposobnost-osoba-s-mentalnim-poremecajem-za-davanje-informiranog-pristanka-u-biomedicinskim-istrazivanjima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-322.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/10-11/smjernice-hrvatskoga-pulmoloskog-drustva-za-dijagnosticiranje-i-lijecenje-astme-u-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/10-11-2007/LV-129-315.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/nikola-tesla-i-u-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/nikola-tesla-i-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/nikola-tesla-i-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/nikola-tesla-i-u-medicini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/nikola-tesla-i-u-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/nikola-tesla-i-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/nikola-tesla-i-u-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/nikola-tesla-i-u-medicini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-415.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/botulinum-toksin-tipa-a-i-kolinergicni-sustav/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-407.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/motoricko-polje-za-govor-nekad-i-danas-od-klasicnoga-modularnog-sredista-do-cvorne-i-supramodalne-sastavnice-visestrukih-neuronskih-mreza/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-401.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/klasicni-oblik-fabryjeve-bolesti-bez-angiokeratoma-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-396.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/primarni-limfomi-sredisnjega-zivcanog-sustava-prikaz-vlastitih-iskustava/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-391.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/erlotinib-u-lijecenju-bolesnika-s-uznapredovalim-karcinomom-pluca-nemalih-stanica-iskustvo-klinicke-bolnice-za-plucne-bolesti-jordanovac/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-387.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2007/12/hrvatske-smjernice-za-primjenu-eikozapentaenske-kiseline-i-megestrol-acetata-u-sindromu-tumorske-kaheksije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/12-2007/LV-129-381.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/prikaz-knjige-anita-vulic-protic-depresivnost-u-djece-i-adolescenata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/prikaz-knjige-anita-vulic-protic-depresivnost-u-djece-i-adolescenata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/prikaz-knjige-anita-vulic-protic-depresivnost-u-djece-i-adolescenata/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-198.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/dr-dubravka-mauzer/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/dr-dubravka-mauzer/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/dr-dubravka-mauzer/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-197.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/prim-dr-branimir-pavesic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/prim-dr-branimir-pavesic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/prim-dr-branimir-pavesic/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-196.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/dr-zeljko-markovic/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/dr-zeljko-markovic/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/dr-zeljko-markovic/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-195.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/prim-dr-sc-nenad-giunio/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/prim-dr-sc-nenad-giunio/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/prim-dr-sc-nenad-giunio/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-194.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/kirursko-lijecenje-primarnog-limfedema-penisa-i-skrotuma/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-192.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/laparoskopska-kolorektalna-kirurgija-2/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-190.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/pubmed-prepoznaje-hrvatski/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/pubmed-prepoznaje-hrvatski/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/pubmed-prepoznaje-hrvatski/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/pubmed-prepoznaje-hrvatski/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/pubmed-prepoznaje-hrvatski/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/pubmed-prepoznaje-hrvatski/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/pubmed-prepoznaje-hrvatski/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/pubmed-prepoznaje-hrvatski/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-189.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/psiholoska-istrazivanja-o-prirodi-ekspertnog-znanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-56.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/upalne-bolesti-crijeva-i-trudnoca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-49.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/osobitosti-skupljanja-autolognih-krvotvornih-maticnih-stanica-iz-periferne-krvi-u-pedijatrijskih-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-43.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/rituksimab-u-lijecenju-b-stanicnih-ne-hodgkinovih-limfoma/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-37.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/fulvestrant-novi-lijek-u-hormonskoj-terapiji-raka-dojke/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-31.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/komplementarne-metode-vodenja-poroda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/komplementarne-metode-vodenja-poroda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/komplementarne-metode-vodenja-poroda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/komplementarne-metode-vodenja-poroda/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/komplementarne-metode-vodenja-poroda/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/komplementarne-metode-vodenja-poroda/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/komplementarne-metode-vodenja-poroda/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/komplementarne-metode-vodenja-poroda/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-25.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/intrahioidna-cista-duktusa-tiroglosusa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-23.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/neprepoznati-paragangliom-straznjeg-medijastinuma-anestezioloski-rizik/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-20.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/korelacije-tjelesne-visine-i-tezine-djece-pri-upisu-u-1-razred-osnovne-skole-i-pokazatelja-rasta-djece-pri-rodenju-s-tjelesnom-visinom-roditelja/" />
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-13.pdf</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/1-2/smjernice-iz-kardiopulmonalne-reanimacije-europskog-vijeca-za-reanimatologiju-2005/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2006/LV-128-3.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/zene-i-medicinsko-umijece-povijesni-ogled/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-114.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/razine-natrija-u-vodama-dalmacije-tijekom-2003-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-105.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/alternative-hormonskomu-lijecenju-u-postmenopauzi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-99.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/uloga-genskih-cimbenika-u-etiopatogenezi-psorijaze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-96.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/patofiziologija-ishemijsko-reperfuzijske-ozljede/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-87.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/laparoskopsko-lijecenje-akutnog-kolecistitisa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-84.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/uloga-magnetske-rezonancije-u-fetalnoj-medicini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-79.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/mikrocelularni-karcinom-pluca-u-bolesnika-s-hepatosplenicnim-t-stanicnim-limfomom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-76.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/bolesnici-lijeceni-zbog-karcinoma-prostate-u-zupanijskoj-bolnici-cakovec-u-protekle-dvije-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-72.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/3-4/epidemioloske-karakteristike-hepatitisa-b-u-splitsko-dalmatinskoj-zupaniji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2006/LV-128-65.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/harmonizacija-laboratorijske-medicine-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-183.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/stroncij-ranelat-nova-paradigma-za-lijecenje-postmenopauzalne-osteoporoze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-180.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/procjena-glomerularne-filtracije-s-pomocu-prediktivnih-jednadzbi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-174.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/c-reaktivni-protein-u-procjeni-kardiovaskularnog-rizika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-167.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/imatinib-u-lijecenju-gastrointestinalnih-stromalnih-tumora-iskustva-kbc-a-zagreb/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-161.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/doplerehokardiografska-procjena-dijastolicke-funkcije-lijeve-klijetke/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-153.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/rekonstrukcija-traumatskog-defekta-gornje-trecine-uske/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-150.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/sindrom-karpalnog-kanala-medicinske-i-ekonomske-prednosti-pravodobnog-operativnog-lijecenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-143.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/5-6/amputacije-nogu-uzrokovane-tumorima-i-proteticka-rehabilitacija-u-hrvatskoj-od-2000-do-2004-godine/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2006/LV-128-139.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/zakladna-bolnica-na-jelacicevu-trgu-u-zagrebu-1804-1931-prigodom-75-obljetnice-rusenja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-242.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/ljudski-ili-zivotinjski-kostani-ostatci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-238.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/alfaadrenergicki-blokatori-kao-pomocno-sredstvo-u-lijecenju-akutne-urinarne-retencije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-233.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/srcanozilne-bolesti-nakon-transplantacije-bubrega/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-228.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/90y-ibritumomab-tiuksetan-u-bolesnika-s-refraktornim-folikularnim-limfomom-ili-u-relapsu-nakon-rituksimaba/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-226.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/uloga-endoskopskog-ultrazvuka-u-bolestima-probavnog-sustava-u-eri-naprednih-tehnika-kompjutorizirane-tomografije/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-217.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/hernija-lumbalnog-diska-repozicijski-ucinak-rotacijske-manipulacije-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-213.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/bilateralna-rekonstrukcija-dojke-peteljkastim-miokutanim-reznjem-misica-latisimusa-dorzi-nakon-neuspjesne-primarne-obostrane-rekonstrukcije-dojke-s-ocuvanjem-koze-uz-izrazenu-kapsularnu-kontrakciju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-210.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/vaznost-sistemskih-infekcija-izazvanih-bakterijom-streptococcus-bovis/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-206.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/7-8/odredivanje-gradusa-urotelnog-karcinoma-prema-klasifikaciji-svjetske-zdravstvene-organizacije-iz-2004/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2006/LV-128-201.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/anafilakticka-reakcija-kao-nuspojava-primjene-opcih-anestetika-i-misicnih-relaksansa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-317.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/neurofibromatoza-tip-2-centralna-neurofibromatoza-ili-bilateralni-akustiki-neuromi-vestibularni-vanomi-od-fenotipa-do-gena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-309.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/upotreba-magnetske-rezonancije-u-dijagnozi-i-prognozi-multiple-skleroze/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-295.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/cervikogena-proprioceptivna-vrtoglavica-etiopatogeneza-klinicka-slika-dijagnostika-i-terapija-s-posebnim-naglaskom-na-manualnu-terapiju/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-288.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/laparoskopska-kirurgija-kod-akutne-ozljede-trbuha/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-285.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/srcani-natriureticki-peptidi-u-zatajivanju-srca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-279.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/radioloski-prikaz-primarnog-limfoma-kosti-retrospektivna-studija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-274.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/primarna-pigmentna-nodularna-adrenokortikalna-bolest-kao-uzrok-cushingova-sindroma-u-sklopu-carneyeva-kompleksa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-268.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/p53-bcl-2-i-ki-67-u-dijagnostici-inzularnog-karcinoma-stitnjace-prikaz-bolesnika-s-pregledom-literature/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-264.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/9-10/epidemiologija-osteoporoze-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2006/LV-128-261.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/mjerenje-arterijskog-tlaka-zivinim-tlakomjerom-vise-od-tehnike/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-333.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/mjesto-i-uloga-endotela-u-hipertenziji-i-aterosklerotskim-procesima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-396.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/utjecaj-abdominalne-debljine-na-vrijednosti-tlaka-u-bolesnika-s-esencijalnom-hipertenzijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-393.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/klinicke-osobitosti-bolesnika-s-renovaskularnom-hipertenzijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-387.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/laparoskopsko-lijecenje-funkcionalno-aktivnih-tumora-nadbubrezne-zlijezde/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-384.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-381.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-u-bolesnika-s-bubreznim-transplantatom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-379.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/arterijska-hipertenzija-nakon-transplantacije-bubrega/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-374.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/regulacija-krvnog-tlaka-u-bolesnika-na-dijalizi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-369.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/hipertenzija-i-trudnoca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/hipertenzija-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-i-trudnoca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/hipertenzija-i-trudnoca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/hipertenzija-i-trudnoca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/hipertenzija-i-trudnoca/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-357.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-povisenog-krvnog-tlaka-u-akutnim-neuroloskim-bolestima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-351.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/kronicna-bolest-bubrega-i-statini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/kronicna-bolest-bubrega-i-statini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/kronicna-bolest-bubrega-i-statini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/kronicna-bolest-bubrega-i-statini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/kronicna-bolest-bubrega-i-statini/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/kronicna-bolest-bubrega-i-statini/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/kronicna-bolest-bubrega-i-statini/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/kronicna-bolest-bubrega-i-statini/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-345.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/protuaterosklerotski-ucinci-antihipertenziva/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-342.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/antihipertenzivni-lijekovi-i-rizik-od-novonastale-secerne-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-337.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/metabolicki-sindrom-u-bolesnika-s-hipertenzijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-334.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2006/11-12/lijecenje-i-kontrola-arterijske-hipertenzije-u-hrvatskoj-bel-ah-istrazivanje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2006/LV-128-329.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/preventivne-mjere-poboljsanja-zdravstvene-ispravnosti-vode-iz-individualnih-vodoopskrbnih-objekata-na-podrucjima-razorenim-ratom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-47.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/klub-hrvatskih-branitelja-iz-domovinskog-rata-lijecenih-od-ptsp-a-kao-oblik-psihosocijalne-rehabilitacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-44.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/osteoporoza-uzrokovana-glukokortikoidima-pregled-i-prijedlog-smjernica-za-prevenciju-i-lijecenje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-36.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/disfunkcija-sakroilijakalnog-zgloba-klinicka-slika-dijagnostika-i-manualna-terapija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-30.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/spiralna-ct-angiografija-u-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/spiralna-ct-angiografija-u-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/spiralna-ct-angiografija-u-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/spiralna-ct-angiografija-u-praksi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/spiralna-ct-angiografija-u-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/spiralna-ct-angiografija-u-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/spiralna-ct-angiografija-u-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/spiralna-ct-angiografija-u-praksi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-24.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/intoksikacija-bunikom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/intoksikacija-bunikom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/intoksikacija-bunikom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/intoksikacija-bunikom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/intoksikacija-bunikom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/intoksikacija-bunikom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/intoksikacija-bunikom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/intoksikacija-bunikom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-22.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/beta-laktamaze-i-njihova-uloga-u-rezistenciji-ii-dio-beta-laktamaze-u-21-stoljecu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-12.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/perinatalni-ishod-viseplodnih-trudnoca-u-rodilistima-knin-i-livno-1990-2002-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-7.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/1-2/vrijednost-istrazivanja-dodatnih-prognostickih-cimbenika-u-kombinaciji-s-nottinghamskim-prognostickim-indeksom-u-bolesnica-s-karcinomom-dojke/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2005/LV-127-3.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/smjernice-za-hormonsko-lijecenje-u-zena-u-perimenopauzi-i-postmenopauzi-stajaliste-izvrsnog-povjerenstva-medunarodnog-drustva-za-menopauzu/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-94.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/najnovije-spoznaje-o-genskoj-osnovi-melanoma/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-89.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/mjesto-i-uloga-kardioloske-rehabilitacije-u-suvremenoj-kardiologiji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-86.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/endotelna-funkcija-u-klinickoj-praksi/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-82.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/ucinkovitost-moksifloksacina-u-lijecenju-respiratornih-infekcija-hrvatsko-postmarketinsko-istrazivanje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-77.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/antibiotska-profilaksa-infekcijskog-endokarditisa-u-stomatologiji-kardioloska-praksa/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-75.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/primarni-uspjeh-i-6-mjesecni-ishod-bolesnika-s-akutnim-infarktom-miokarda-sa-st-elevacijom-u-kbc-u-zagreb-kod-kojih-je-primijenjena-metoda-direktnog-stentinga/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-69.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/3-4/ucestalost-istodobne-primjene-statina-s-inhibitorima-citokroma-p-450-u-hrvatskoj/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2005/LV-127-65.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/uloga-lijecnika-kod-nasilja-nad-zenama-u-obitelji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-146.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/biokemijski-pokazatelji-pregradnje-kosti-klinicka-primjena-i-ogranicenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-139.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/vaznost-sveukupnog-dijagnostickog-pristupa-u-klasifikaciji-adenoma-hipofize-upute-svjetske-zdravstvene-organizacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-134.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/hemoroidi-dijagnoza-i-terapijske-mogunosti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-129.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/oftalmoloske-promjene-u-bolesnika-zarazenih-virusom-humane-imunodeficijencije-prije-i-nakon-uvodenja-vrlo-djelotvornog-antiretrovirusnog-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-123.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/ozljeda-vidnog-zivca-sa-stajalista-medicinskog-vjestacenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-121.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/utjecaj-glukoze-apsorbirane-iz-dijalizata-na-tjelesnu-tezinu-peritonejskom-dijalizom-lijecenih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-116.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/uznapredovala-ishemija-miokarda-kod-bolesnika-sa-secernom-bolescu-rani-rezultati-kirurskog-lijecenja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-112.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/6/vodic-za-ocjenu-recenziju-znanstvenog-clanka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/6-2005/LV-127-107.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-tumora-sustava-za-kretanje-u-djece-i-odraslih/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-203.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-djecjoj-ortopediji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-197.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopediji-u-podrucju-koljenskog-zgloba/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-193.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-kod-totalnih-endoproteza-kuka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-189.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-kirurgiji-ramena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-185.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitna-stanja-u-ortopedskoj-problematici-sake-podlaktice-i-lakta/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-181.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/hitno-upucivanje-u-ortopedsku-ambulantu-sto-mozemo-unaprijediti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-178.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/artroplastika-koljenskog-zgloba-monokondilarnom-endoprotezom-model-repicci/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-172.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/7-8/nepozeljne-interakcije-antihipertenziva-i-nesteroidnih-antireumatika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2005/LV-127-168.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/splitsko-sumporno-ljekovito-vrelo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/splitsko-sumporno-ljekovito-vrelo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/splitsko-sumporno-ljekovito-vrelo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/splitsko-sumporno-ljekovito-vrelo/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/splitsko-sumporno-ljekovito-vrelo/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/splitsko-sumporno-ljekovito-vrelo/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/splitsko-sumporno-ljekovito-vrelo/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/splitsko-sumporno-ljekovito-vrelo/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-241.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/sto-treba-znati-o-kontaktnoj-preosjetljivosti-na-lokalne-glukokortikoide/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-237.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/zdravo-starenje-i-produktivno-umirovljenje/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-231.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/regionalna-anestezija-da-ili-ne/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/regionalna-anestezija-da-ili-ne/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/regionalna-anestezija-da-ili-ne/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/regionalna-anestezija-da-ili-ne/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/regionalna-anestezija-da-ili-ne/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/regionalna-anestezija-da-ili-ne/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/regionalna-anestezija-da-ili-ne/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/regionalna-anestezija-da-ili-ne/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-226.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/rijedak-uzrocnik-keratitisa-acanthamoeba-spp/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-223.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/hiperlipidemijas-diseminiranim-eruptivnim-ksantomima-i-hiperglikemija-izazvani-psihickim-stresom-prikaz-bolesnika/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-220.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/evaluacija-poremecaja-protoka-u-mikrocirkulaciji-kod-dijabeticara-tipa-2-lasersko-doplerskim-mjeracem-protoka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-215.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/9-10/utjecaj-ratnih-dogadanja-na-tjelesnu-tezinu-i-visinu-djece-pri-upisu-u-1-razred-osnovne-skole/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2005/LV-127-211.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/pregled-ucenika-za-obrtnicka-zanimanja/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-324.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/konzervativno-lijecenje-benigne-hiperplazije-prostate/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-316.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/alzheimerova-bolest-suvremeni-dijagnosticki-pristup-temeljen-na-dokazima/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-312.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/neurofibromatoza-tip-1-von-recklinghausenova-bolest-ili-periferna-neurofibromatoza-od-fenotipa-do-gena/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-303.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/laparoskopska-kolorektalna-kirurgija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/laparoskopska-kolorektalna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/laparoskopska-kolorektalna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/laparoskopska-kolorektalna-kirurgija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/laparoskopska-kolorektalna-kirurgija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/laparoskopska-kolorektalna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/laparoskopska-kolorektalna-kirurgija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/laparoskopska-kolorektalna-kirurgija/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-298.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/anestezija-i-perioperacijski-postupak-u-resekcijskoj-kirurgiji-karcinoma-jednjaka/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-293.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/hipofosfatazija-prikaz-dviju-bolesnica-sa-spontanim-poboljsanjem-kostane-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-288.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/vrijedovi-jednjaka-prouzroceni-doksiciklinom-prikaz-dvaju-bolesnika-i-pregled-literature/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-285.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/transluminalna-balonska-valvuloplastika-u-novorodencadi-i-dojencadi-s-kriticnom-aortnom-stenozom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-280.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2005/11-12/randomizirano-dvostruko-slijepo-placebom-kontrolirano-ispitivanje-antilipemicke-ucinkovitosti-i-neskodljivosti-dijetetske-namirnice-polikozanola-u-bolesnika-s-umjerenom-hiperlipidemijom/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2005/LV-127-273.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/reakcija-transplantata-protiv-primatelja-uzrokovana-transfuzijom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-39.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/opca-psihosomatikau-djecjoj-i-adolescentnoj-dobi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-32.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/suvremeno-kirursko-lijecenje-tumora-selarne-regije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-26.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/specificnosti-anestezije-u-laparoskopskoj-kirurgiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-22.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/rekonstrukcija-nosnog-vrska-kombiniranom-tehnikom-hrskavicnih-diskova-i-onlay-umetka/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-18.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/utjecaj-pojedinih-simptoma-posttraumatskoga-stresnog-poremecaja-i-intenziteta-klinicke-slike-na-radnu-sposobnost-oboljelih/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-11.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/navika-pusenja-djelatnika-u-zdravstvu-koprivnicko-krizevacke-zupanije-usporedna-studija-1998-i-2002/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-6.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/1-2/125-godina-pracenja-dojenacke-smrtnosti-u-hrvatskoj-1874-1999-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2004/LV-126-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/etika-i-transplantacija-organa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/etika-i-transplantacija-organa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/etika-i-transplantacija-organa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/etika-i-transplantacija-organa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/etika-i-transplantacija-organa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/etika-i-transplantacija-organa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/etika-i-transplantacija-organa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/etika-i-transplantacija-organa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-86.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/dusikov-oksid-vazna-signalna-molekula-u-normalnoj-i-patoloskoj-trudnoci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-80.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/osteoporoza-u-muskaraca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/osteoporoza-u-muskaraca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/osteoporoza-u-muskaraca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/osteoporoza-u-muskaraca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/osteoporoza-u-muskaraca/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/osteoporoza-u-muskaraca/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/osteoporoza-u-muskaraca/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/osteoporoza-u-muskaraca/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-76.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/prirodeno-savinuce-penisa-korda-bez-hipospadije-kirursko-lijecenje-savinuca-penisa-iili-formiranje-nove-mokracne-cijevi-slobodnim-transplantatom-sluznice-usta/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-71.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/zastupljenost-neinvazivnih-tis-i-minimalnih-invazivnih-karcinoma-t1ab-medu-karcinomima-dojke-u-splitskoj-regiji/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-60.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/cimbenici-rizika-i-karotidna-ateroskleroza-u-bolesnika-s-tranzitornom-ishemijskom-atakom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-57.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/paraneoplasticki-sindrom-povezan-s-antifosfolipidnim-protutijelima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-155.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/novije-spoznaje-o-fizioloskim-svojstvima-i-ucincima-bubreznog-dopamina/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-147.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/nove-mogucnosti-lijecenja-inzulinom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-141.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/usporedba-otvorene-i-laparoskopske-kolecistektomije-u-lijecenju-akutnog-kolecistitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-137.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/poboljsava-li-ucinkovitija-hemodijaliza-odgovor-na-cijepljenje-protiv-virusa-hepatitisa-b/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-133.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/letalni-granulom-sredine-lica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/letalni-granulom-sredine-lica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/letalni-granulom-sredine-lica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/letalni-granulom-sredine-lica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/letalni-granulom-sredine-lica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/letalni-granulom-sredine-lica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/letalni-granulom-sredine-lica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/letalni-granulom-sredine-lica/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-129.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/ocne-manifestacije-lajmske-borelioze-u-sjeverozapadnoj-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-124.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/dijagnosticki-rezultati-dupleks-ultrasonografije-arterije-karotis-u-privatnim-ordinacijama-grada-zagreba/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-120.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/5-6/rasirenost-rizicnih-ponasanja-ucenika-srednjih-skola/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2004/LV-126-115.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/psihijatrijska-epidemiologija-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-215.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/farmakoterapija-alzheimerove-bolesti-pristup-temeljen-na-dokazima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-211.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/spoznajni-poremecaji-u-multiploj-sklerozi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-204.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/laparoskopski-kirurki-zahvati-u-trudnoci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-201.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/nealkoholni-steatohepatitis-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/nealkoholni-steatohepatitis-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/nealkoholni-steatohepatitis-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/nealkoholni-steatohepatitis-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/nealkoholni-steatohepatitis-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/nealkoholni-steatohepatitis-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/nealkoholni-steatohepatitis-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/nealkoholni-steatohepatitis-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-197.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/ostecenje-glavnog-bronha-uzrokovano-aspiracijom-tablete-zeljeznog-sulfata/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-194.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/dopler-povrsinskih-limfnih-cvorova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/dopler-povrsinskih-limfnih-cvorova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/dopler-povrsinskih-limfnih-cvorova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/dopler-povrsinskih-limfnih-cvorova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/dopler-povrsinskih-limfnih-cvorova/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/dopler-povrsinskih-limfnih-cvorova/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/dopler-povrsinskih-limfnih-cvorova/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/dopler-povrsinskih-limfnih-cvorova/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-185.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/epidemioloska-slika-psihijatrijskih-hospitalizacija-opce-bolnice-bjelovar/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-182.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/7-8/smjernice-antimikrobnog-lijecenja-i-profilakse-infekcija-mokracnog-sustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2004/LV-126-169.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/jednostavne-bubrezne-ciste/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/jednostavne-bubrezne-ciste/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/jednostavne-bubrezne-ciste/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/jednostavne-bubrezne-ciste/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/jednostavne-bubrezne-ciste/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/jednostavne-bubrezne-ciste/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/jednostavne-bubrezne-ciste/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/jednostavne-bubrezne-ciste/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-260.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/lijecenje-i-prevencija-virusnog-hepatitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-254.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/minimalno-invazivna-paratiroidektomija-vodena-sondom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-250.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/primjena-visokofrekventno-titrajuceg-rezaca-u-laparoskopskoj-kirurgiji/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-246.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/laparoskopski-pristup-postoperativnoj-ventralnoj-herniji-carbajova-operacija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-243.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/ciklokriokoagulacija-u-lijecenju-neovaskularnoga-glaukoma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-240.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/zbrinjavanje-bolesnika-s-hipertenzivnom-krizom-u-centru-za-hitnu-medicinsku-pomoc-doma-zdravlja-opatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-234.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/9-10/dijagnosticka-vrijednost-biopsije-miokarda-u-dijagramu-dijagnostickog-toka-kardiomiopatija-u-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2004/LV-126-227.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/pasivno-pusenje-i-djeca-procjena-izlozenosti-i-zdravstvene-posljedice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-325.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/%ce%b2-laktamaze-u-laboratoriju-i-njihova-uloga-u-rezistenciji-i-dio-evolucija-bakterijske-rezistencije-uzrokovane-%ce%b2-laktamazama/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-314.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/balintova-grupa-pomoc-u-radu-lijecnika-obiteljske-medicine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-311.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/rituksimab-u-lijecenju-indolentnih-nehodgkinovih-limfoma/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-307.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/laparoskopsko-zbrinjavanje-kolecistoduodenalne-fistule-prikaz-slucaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-304.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/dijagnosticka-obrada-rocnog-vojnika-kod-kojeg-je-slucajno-utvrden-pozitivan-nalaz-virusa-hepatitisa-c-prikaz-slucaja/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-301.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/transkutana-elektrostimulacija-srca-u-izvanbolnickim-uvjetima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-298.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/pojavnost-cd30-na-limfocitima-u-upalnom-infiltratu-akutne-faze-atopijskog-dermatitisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-291.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/11-12/usporedba-vrijednosti-citoloske-i-histoloske-analize-bioptickog-uzorka-zelucane-sluznice-u-dijagnozi-malignih-bolesti/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2004/LV-126-287.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/de-re-publica-otorhinolaryngologica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/de-re-publica-otorhinolaryngologica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/de-re-publica-otorhinolaryngologica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/de-re-publica-otorhinolaryngologica/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/de-re-publica-otorhinolaryngologica/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/de-re-publica-otorhinolaryngologica/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/de-re-publica-otorhinolaryngologica/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/de-re-publica-otorhinolaryngologica/" />
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-90.pdf</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2004/3-4/uestalost-senzibilizacije-na-maslinu-u-bolesnika-s-peludnom-alergijom-na-podruju-zadra-i-dubrovnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2004/LV-126-65.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/procjena-programa-specijalizacije-iz-psihijatrije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-36.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/analiza-tranzicije-zdravstvenog-sustava-sto-misle-korisnici-zdravstvene-zastite/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-32.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/istrazivanja-toksicnih-ucinaka-benzena-i-toluena/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-28.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/bolesti-profesionalnih-glazbenika-instrumentalista/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-23.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/virus-variole-kao-biolosko-oruzje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/virus-variole-kao-biolosko-oruzje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/virus-variole-kao-biolosko-oruzje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/virus-variole-kao-biolosko-oruzje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/virus-variole-kao-biolosko-oruzje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/virus-variole-kao-biolosko-oruzje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/virus-variole-kao-biolosko-oruzje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/virus-variole-kao-biolosko-oruzje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-16.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/eventracija-osita/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/eventracija-osita/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/eventracija-osita/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/eventracija-osita/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/eventracija-osita/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/eventracija-osita/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/eventracija-osita/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/eventracija-osita/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-13.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/odvikavanje-od-pusenja-transdermalnim-nikotinskim-sustavom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-8.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/pobolijevanje-rocnih-vojnika-na-temeljnoj-vojnoj-obuci/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-6.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/1-2/recirkulacija-ureje-i-ucinkovitost-dijalize-pri-uporabi-dvoluminalnih-dijaliznih-katetera-razlicite-lokalizacije-smije-li-se-venski-krak-katetera-rabiti-kao-arterijski-i-obrnuto/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/1-2-2003/LV-125-1.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/suvremeni-pristup-bolnickom-zbrinjavanju-djece/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-87.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/alergijski-poremecaji-disnog-sustava-i-koze-kao-javnozdravstveni-problem/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-81.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/renalna-dislipidemija-u-bolesnika-na-kronicnoj-hemodijalizi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-77.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/evaluacija-genetickih-uzroka-mentalne-retardacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-71.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/okultni-papilarni-karcinom-stitne-zlijezde-s-neobicnim-neuroloskim-simptomima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-68.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/mediteranski-nacin-prehrane-i-ucestalost-zlocudnih-tumora-probavnog-sustava-na-hrvatskim-otocima/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-60.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/3-4/probir-downova-sindroma-trostrukim-testom-u-drugom-tromjesecju-trudnoce/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/3-4-2003/LV-125-55.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/cijepljenje-protiv-hepatitisa-b-na-kronicnoj-hemodijalizi/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-156.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/ucinci-organskih-aerosola-na-disni-sustav-profesionalno-izlozenih-osoba/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-151.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/bronhoalveolarna-lavaza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/bronhoalveolarna-lavaza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/bronhoalveolarna-lavaza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/bronhoalveolarna-lavaza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/bronhoalveolarna-lavaza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/bronhoalveolarna-lavaza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/bronhoalveolarna-lavaza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/bronhoalveolarna-lavaza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-145.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/fractura-radii-loco-typico-nasa-iskustva/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-139.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/infekcija-uzrokovana-sa-streptococcus-suis-zoonoza-na-koju-treba-misliti-prikaz-dvaju-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-134.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/bronchiolitis-obliterans-s-organiziranom-pneumonijom-u-bolesnika-lijecenog-amiodaronom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-131.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/izolirani-hemangioblastom-vratne-kraljeznicne-mozdine-prikaz-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-129.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/prevalencija-zucnih-kamenaca-u-hemodijaliziranih-bolesnika/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-124.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/5-6/unos-dijetalnoga-kalcija-i-prevalencija-deformacija-kraljezaka-u-uzorku-starije-populacije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/5-6-2003/LV-125-117.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-prvi-dio-organizacija-skrbi-za-bolesnike-s-mozdanim-udarom-lijecenje-mozdanog-udara-i-neurorehabilitacija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-200.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/endoskopski-ultrazvuk-i-dijagnosticki-algoritam-u-bolestima-gastrointestinalnog-sustava/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-192.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/ktv-kao-mjera-kolicine-hemodijalize/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-188.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/pojava-b-kronicne-limfocitne-leukemije-u-hodgkinovoj-bolesti-prikaz-bolesnice/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-184.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/citodijagnostika-ozracenih-stanica-dojke-vrijednost-i-moguce-pogreske/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-180.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/lijecenje-kronicne-mijeloicne-leukemije-u-uznapredovaloj-fazi-bolesti-imatinibom/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-176.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/zastupljenost-tjelesnih-minor-anomalija-u-djece-ostecena-sluha/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-171.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/7-8/istrazivanje-nesreca-na-koprivnickom-podrucju/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/7-8-2003/LV-125-165.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/prva-on-line-trajna-teleedukacija-iz-gastroenterologije-u-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-271.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/nearteriticka-ishemicka-opticka-neuropatija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-265.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/uloga-angiogeneze-u-rastu-i-progresiji-tumora-terapija-inhibitorima-angiogeneze-od-obecavajucih-rezultata-pokusnih-zivotinjskih-modela-do-realnosti-klinicke-primjene/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-260.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/je-li-transfuzija-jedne-doze-koncentriranih-eritrocita-losa-klinicka-praksa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-255.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/sindrom-iznenadne-dojenacke-smrti-sids-u-republici-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-251.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/utjecu-li-materijal-i-tehnika-sivanja-na-cijeljenje-uterotomije-pri-carskome-rezu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-245.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/vaznost-odredivanja-razlicitih-histoloskih-sastavnica-tumora-zametnih-stanica-testisa/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-242.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/epidemiologija-prirodenih-bolesti-srca-u-hrvatskoj-multicentricna-nacionalna-studija-1995-2000/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-232.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/9-10/sadasnje-stanje-elektrostimulacije-srca-u-republici-hrvatskoj/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/9-10-2003/LV-125-227.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/kreiranje-strategije-zdravlja-na-lokalnoj-razini-procesom-gradske-slike-zdravlja-i-gradskog-plana-za-zdravlje/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-334.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/sto-godina-klinicke-elektrokardiografije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/sto-godina-klinicke-elektrokardiografije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/sto-godina-klinicke-elektrokardiografije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/sto-godina-klinicke-elektrokardiografije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/sto-godina-klinicke-elektrokardiografije/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/sto-godina-klinicke-elektrokardiografije/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/sto-godina-klinicke-elektrokardiografije/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/sto-godina-klinicke-elektrokardiografije/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-329.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/preporuke-za-zbrinjavanje-bolesnika-s-mozdanim-udarom-drugi-dio-primarna-i-sekundarna-prevencija-mozdanog-udara/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-322.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/terapijski-pristup-akutnom-pankreatitisu/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-317.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/glutaricka-acidurija-tipa-1-primjer-vaznosti-ranog-prepoznavanja-tzv-cerebralnih-organskih-acidurija/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-312.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/rast-makrosomne-novorodencadi-tijekom-prve-godine/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-305.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/utjecaj-ratnih-i-poslijeratnih-dogadanja-na-rizicna-ponasanja-ucenika-srednjih-skola/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-301.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/postupnik-za-dijagnozu-vezikuloznih-i-buloznih-dermatoza/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-296.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/perkutana-endoskopska-gastrostomija-petogodisnje-iskustvo-naseg-centra-1997-2002/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-292.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/clanci/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/en/articles/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/</loc>
    <xhtml:link rel="alternate" hreflang="hr" href="https://lv.abol.hr/clanci/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="en" href="https://lv.abol.hr/en/articles/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/" />
    <xhtml:link rel="alternate" hreflang="x-default" href="https://lv.abol.hr/clanci/2003/11-12/lijecnici-specijalisti-u-hrvatskoj-opci-pregled-mogucnost-planiranja-i-izobrazbe-u-buducnosti/" />
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/media/journals/lijecnicki-vjesnik/pdf/11-12-2003/LV-125-281.pdf</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/4/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/5/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/7/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/8/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/9/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/10/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/11/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/12/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/13/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/14/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/15/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/16/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/17/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/18/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/19/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/20/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/22/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/23/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/24/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/25/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/26/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/27/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/28/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/29/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/30/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/32/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/33/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/34/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/35/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/36/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/37/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/38/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/39/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/40/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/41/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/42/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/43/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/44/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/45/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/46/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/47/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/48/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/49/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/50/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/51/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/52/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/53/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/54/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/55/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/56/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/57/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/58/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/59/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/60/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/61/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/62/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/63/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/64/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/65/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/66/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/67/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/68/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/69/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/70/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/71/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/72/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/73/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/74/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/75/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/76/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/77/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/78/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/79/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/80/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/81/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/82/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/83/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/84/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/85/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/86/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/87/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/88/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/89/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/90/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/91/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/92/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/93/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/95/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/97/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/99/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/100/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/101/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/102/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/103/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/104/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/105/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/106/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/107/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/108/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/109/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/110/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/111/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/112/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/113/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/114/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/115/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/116/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/117/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/118/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/119/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/120/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/121/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/122/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/123/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/124/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/125/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/126/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/127/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/128/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/129/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/130/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/131/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/132/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/133/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/134/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/135/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/136/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/137/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/138/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/139/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/140/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/142/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/143/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/144/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/145/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/147/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/148/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/149/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/150/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/151/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/153/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/154/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/155/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/156/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/157/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/158/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/159/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/160/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/161/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/162/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/163/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/164/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/165/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/167/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/168/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/169/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/170/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/171/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/172/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/173/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/174/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/175/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/177/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/178/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/179/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/180/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/181/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/182/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/183/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/184/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/185/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/186/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/187/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/188/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/189/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/190/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/191/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/192/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/193/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/194/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/195/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/196/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/197/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/198/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/199/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/200/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/201/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/202/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/204/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/205/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/206/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/207/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/208/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/209/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/210/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/211/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/212/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/213/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/214/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/215/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/216/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/217/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/218/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/219/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/220/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/221/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/222/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/223/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/224/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/225/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/226/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/227/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/228/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/229/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/230/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/231/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/232/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/233/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/234/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/236/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/237/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/238/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/239/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/240/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/241/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/242/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/243/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/244/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/245/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/246/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/247/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/248/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/249/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/250/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/251/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/252/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/253/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/254/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/255/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/256/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/257/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/258/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/259/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/260/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/261/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/262/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/263/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/264/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/265/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/266/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/267/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/268/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/269/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/270/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/271/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/272/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/273/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/274/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/275/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/277/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/278/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/279/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/281/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/282/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/283/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/284/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/285/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/286/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/287/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/288/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/289/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/290/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/291/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/292/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/293/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/294/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/295/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/296/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/297/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/298/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/299/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/300/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/301/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/302/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/303/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/304/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/305/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/306/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/307/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/308/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/309/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/310/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/311/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/312/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/313/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/314/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/315/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/316/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/317/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/318/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/319/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/320/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/321/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/323/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/324/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/325/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/327/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/328/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/329/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/331/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/332/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/333/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/334/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/335/</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/336/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/337/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/338/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/339/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/340/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/341/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/342/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/343/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/344/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/345/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/346/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/347/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/348/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/349/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/350/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/351/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/352/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/353/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/355/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/356/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/357/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/358/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/359/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/360/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/361/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/362/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/363/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/364/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/365/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/366/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/367/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/368/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/369/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/370/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/371/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/372/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/373/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/374/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/375/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/376/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/377/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/378/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/379/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/380/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/381/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/382/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/383/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/384/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/385/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/386/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/387/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/388/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/389/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/390/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/391/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/392/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/393/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/394/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/395/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/396/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/397/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/398/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/399/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/400/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/401/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/402/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/403/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/404/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/405/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/406/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/407/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/409/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/410/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/411/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/412/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/413/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/414/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/415/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/416/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/417/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/418/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/419/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/420/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/421/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/422/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/423/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/424/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/425/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/426/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/427/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/428/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/429/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/430/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/431/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/432/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/433/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/434/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/435/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/436/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/438/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/439/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/440/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/441/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/442/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/443/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/444/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/445/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/446/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/447/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/448/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/449/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/450/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/451/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/452/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/453/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/454/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/455/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/456/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/457/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/458/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/459/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/460/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/461/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/462/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/463/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/464/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/465/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/466/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/467/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/468/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/469/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/470/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/471/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/472/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/473/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/474/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/475/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/476/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/477/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/479/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/480/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/481/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/482/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/483/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/484/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/485/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/486/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/487/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/488/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/489/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/490/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/491/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/492/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/493/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/494/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/495/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/496/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/497/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/498/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/499/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/500/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/501/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/502/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/503/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/504/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/505/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/507/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/508/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/509/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/511/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/512/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/513/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/514/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/515/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/516/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/517/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/518/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/519/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/520/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/521/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/522/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/523/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/524/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/525/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/527/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/528/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/529/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/531/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/532/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/533/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/534/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/535/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/536/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/537/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/538/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/539/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/540/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/541/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/542/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/543/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/544/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/545/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/546/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/547/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/548/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/550/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/551/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/552/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/553/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/554/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/555/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/556/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/557/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/558/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/559/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/560/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/561/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/562/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/563/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/564/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/565/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/566/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/567/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/569/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/570/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/571/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/572/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/573/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/574/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/575/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/576/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/577/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/578/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/579/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/580/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/581/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/582/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/583/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/584/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/585/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/586/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/587/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/588/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/589/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/590/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/591/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/592/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/593/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/594/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/595/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/596/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/597/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/598/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/599/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/600/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/601/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/602/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/603/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/604/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/605/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/606/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/607/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/608/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/609/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/610/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/611/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/612/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/613/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/614/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/615/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/616/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/617/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/618/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/619/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/620/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/621/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/622/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/623/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/624/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/625/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/626/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/627/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/628/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/629/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/630/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/631/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/632/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/633/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/634/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/635/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/636/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/637/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/638/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/639/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/640/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/641/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/642/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/643/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/644/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/645/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/646/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/647/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/648/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/649/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/650/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/651/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/652/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/653/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/654/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/655/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/656/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/657/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/658/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/659/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/661/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/662/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/663/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/665/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/666/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/667/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/668/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/669/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/670/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/671/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/672/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/673/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/674/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/675/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/676/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/677/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/678/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/679/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/680/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/681/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/682/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/683/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/684/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/685/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/686/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/687/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/688/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/689/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/690/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/691/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/692/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/693/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/694/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/695/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/696/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/697/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/698/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/700/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/701/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/702/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/703/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/704/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/705/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/706/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/707/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/708/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/709/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/711/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/712/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/713/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/714/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/715/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/717/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/718/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/719/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/720/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/722/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/723/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/724/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/725/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/726/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/727/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/728/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/729/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/732/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/733/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/734/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/735/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/736/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/737/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/738/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/739/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/741/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/742/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/743/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/744/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/745/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/746/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/747/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/748/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/749/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/750/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/751/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/752/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/753/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/754/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/755/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/756/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/757/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/758/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/759/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/760/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/761/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/762/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/763/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/764/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/765/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/766/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/767/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/768/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/769/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/770/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/771/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/772/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/773/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/774/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/775/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/776/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/777/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/778/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/779/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/780/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/781/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/782/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/783/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/784/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/785/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/786/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/787/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/789/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/790/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/791/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/792/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/793/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/794/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/795/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/796/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/797/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/798/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/799/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/800/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/801/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/802/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/803/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/804/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/805/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/806/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/807/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/808/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/809/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/810/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/811/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/812/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/813/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/814/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/815/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/816/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/817/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/818/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/819/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/820/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/821/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/822/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/823/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/824/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/825/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/826/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/827/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/828/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/830/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/831/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/832/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/833/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/834/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/835/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/837/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/838/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/839/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/840/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/841/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/842/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/843/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/844/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/845/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/846/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/847/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/848/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/849/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/850/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/851/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/852/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/853/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/854/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/855/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/856/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/857/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/858/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/859/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/860/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/861/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/862/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/863/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/864/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/865/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/866/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/867/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/868/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/869/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/870/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/871/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/872/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/873/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/874/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/875/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/876/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/877/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/878/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/879/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/880/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/881/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/882/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/883/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/884/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/885/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/886/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/887/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/888/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/889/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/890/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/891/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/892/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/893/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/894/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/895/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/896/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/897/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/898/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/899/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/900/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/901/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/902/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/903/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/904/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/905/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/906/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/907/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/908/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/909/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/910/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/911/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/912/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/913/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/914/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/915/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/916/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/917/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/918/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/919/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/920/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/921/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/922/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/923/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/924/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/925/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/926/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/927/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/928/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/929/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/930/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/931/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/932/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/933/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/934/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/935/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/936/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/937/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/938/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/939/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/940/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/941/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/942/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/943/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/944/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/945/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/946/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/947/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/948/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/949/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/950/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/951/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/952/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/953/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/955/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/956/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/957/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/958/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/959/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/960/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/961/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/962/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/963/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/964/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/965/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/966/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/967/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/968/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/969/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/970/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/971/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/972/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/973/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/974/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/975/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/976/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/977/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/978/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/979/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/980/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/981/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/982/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/983/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/984/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/985/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/986/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/987/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/988/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/989/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/990/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/991/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/992/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/993/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/994/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/995/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/997/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/998/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/999/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1000/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1001/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1002/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1003/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1004/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1005/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1006/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1007/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1008/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1009/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1010/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1011/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1012/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1013/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1014/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1015/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1016/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1017/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1018/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1019/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1020/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1021/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1022/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1023/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1024/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1025/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1026/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1027/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1028/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1029/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1030/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1031/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1032/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1033/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1034/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1035/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1036/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1037/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1038/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1039/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1040/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1041/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1042/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1043/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1044/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1045/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1046/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1047/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1048/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1049/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1050/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1051/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1052/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1053/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1055/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1056/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1057/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1058/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1059/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1060/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1061/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1062/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1063/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1064/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1065/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1067/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1068/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1069/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1070/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1071/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1072/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1073/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1074/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1075/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1076/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1077/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1078/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1079/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1080/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1081/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1082/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1083/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1084/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1085/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1086/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1087/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1088/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1089/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1090/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1091/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1092/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1093/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1094/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1095/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1096/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1097/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1098/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1099/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1100/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1101/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1102/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1103/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1104/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1105/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1106/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1107/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1108/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1109/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1110/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1111/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1112/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1113/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1114/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1115/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1116/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1117/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1118/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1119/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1120/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1121/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1122/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1123/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1124/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1125/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1126/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1127/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1128/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1129/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1130/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1131/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1132/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1133/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1134/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1135/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1136/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1137/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1138/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1139/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1140/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1141/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1142/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1143/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1144/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1145/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1146/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1147/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1148/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1149/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1150/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1151/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1152/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1153/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1154/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1155/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1156/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1157/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1158/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1159/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1160/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1161/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1162/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1163/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1164/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1165/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1166/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1167/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1168/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1169/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1170/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1171/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1172/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1173/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1174/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1175/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1176/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1177/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1179/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1180/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1181/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1182/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1183/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1184/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1185/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1186/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1187/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1188/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1189/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1190/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1191/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1192/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1193/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1194/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1195/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1198/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1199/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1200/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1201/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1202/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1203/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1204/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1205/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1206/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1207/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1208/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1209/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1210/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1211/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1212/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1213/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1214/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1215/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1216/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1217/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1218/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1219/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1220/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1221/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1222/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1223/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1224/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1225/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1226/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1227/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1228/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1229/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1230/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1231/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1232/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1233/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1234/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1235/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1236/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1237/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1238/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1239/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1240/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1241/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1242/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1243/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1244/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1245/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1246/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1247/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1248/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1249/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1250/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1251/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1252/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1253/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1254/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1255/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1256/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1257/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1258/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1259/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1260/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1261/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1262/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1263/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1264/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1265/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1266/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1267/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1268/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1269/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1270/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1271/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1272/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1273/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1276/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1277/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1278/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1279/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1280/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1281/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1282/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1283/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1284/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1285/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1286/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1287/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1288/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1289/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1290/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1291/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1292/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1293/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1294/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1297/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1298/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1299/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1300/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1301/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1302/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1303/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1304/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1305/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1306/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1308/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1309/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1310/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1311/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1312/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1313/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1314/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1315/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1316/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1317/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1318/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1319/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1320/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1321/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1322/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1323/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1324/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1325/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1326/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1327/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1328/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1329/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1330/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1331/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1332/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1333/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1334/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1335/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1336/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1337/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1338/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1339/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1340/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1341/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1342/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1343/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1344/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1345/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1346/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1347/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1348/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1349/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1350/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1351/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1352/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1353/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1355/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1356/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1357/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1358/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1359/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1360/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1361/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1362/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1363/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1364/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1365/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1366/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1367/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1368/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1369/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1370/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1371/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1372/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1373/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1374/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1375/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1376/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1377/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1378/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1379/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1380/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1381/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1382/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1383/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1384/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1385/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1386/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1387/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1388/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1389/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1390/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1391/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1392/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1393/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1394/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1395/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1396/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1397/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1398/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1399/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1400/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1401/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1402/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1403/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1404/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1405/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1406/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1407/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1408/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1409/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1410/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1411/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1412/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1413/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1414/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1415/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1416/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1417/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1418/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1419/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1420/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1421/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1422/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1423/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1424/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1425/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1426/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1427/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1428/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1429/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1430/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1431/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1432/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1433/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1435/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1437/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1438/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1439/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1440/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1441/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1442/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1443/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1444/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1445/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1446/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1447/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1448/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1449/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1450/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1451/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1452/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1453/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1454/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1455/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1456/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1457/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1458/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1459/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1460/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1461/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1462/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1463/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1464/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1465/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1466/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1467/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1468/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1469/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1470/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1471/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1472/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1473/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1474/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1475/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1476/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1477/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1478/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1479/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1480/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1481/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1482/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1483/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1484/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1485/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1486/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1487/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1488/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1489/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1490/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1491/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1492/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1493/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1494/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1495/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1496/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1497/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1499/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1500/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1501/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1502/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1503/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1504/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1505/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1506/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1507/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1508/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1509/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1510/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1511/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1512/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1513/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1514/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1515/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1516/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1517/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1518/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1519/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1520/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1522/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1523/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1524/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1525/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1526/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1527/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1528/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1529/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1530/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1531/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1532/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1533/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1534/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1535/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1536/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1537/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1538/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1539/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1540/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1541/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1542/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1543/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1544/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1545/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1546/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1547/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1548/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1549/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1550/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1551/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1552/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1553/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1554/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1555/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1556/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1557/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1558/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1559/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1560/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1561/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1562/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1563/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1564/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1565/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1566/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1567/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1568/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1569/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1570/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1571/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1572/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1573/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1574/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1575/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1577/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1578/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1579/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1580/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1581/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1582/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1583/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1584/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1585/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1586/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1587/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1588/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1589/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1590/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1591/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1592/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1593/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1594/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1595/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1596/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1597/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1598/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1599/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1601/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1602/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1604/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1605/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1606/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1607/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1608/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1609/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1610/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1611/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1612/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1613/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1614/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1615/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1616/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1617/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1618/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1619/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1620/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1621/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1622/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1623/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1624/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1625/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1626/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1627/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1628/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1629/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1630/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1631/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1632/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1633/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1634/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1635/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1636/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1638/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1639/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1640/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1641/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1642/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1643/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1644/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1645/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1646/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1647/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1648/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1649/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1650/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1651/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1652/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1653/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1654/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1655/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1656/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1657/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1658/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1660/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1661/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1662/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1663/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1664/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1665/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1666/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1667/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1668/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1669/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1670/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1671/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1672/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1673/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1674/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1676/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1677/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1678/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1679/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1680/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1681/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1682/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1683/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1684/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1685/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1686/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1687/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1688/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1689/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1690/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1691/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1692/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1693/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1694/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1695/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1696/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1697/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1698/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1699/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1700/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1701/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1702/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1703/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1704/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1705/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1706/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1707/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1708/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1709/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1710/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1711/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1712/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1713/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1714/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1715/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1716/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1717/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1718/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1719/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1720/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1721/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1722/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1723/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1724/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1725/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1726/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1727/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1728/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1729/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1730/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1731/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1732/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1733/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1734/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1735/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1736/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1737/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1738/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1740/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1741/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1742/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1743/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1744/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1745/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1747/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1748/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1749/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1750/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1751/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1752/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1753/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1754/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1755/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1756/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1757/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1758/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1759/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1760/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1761/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1762/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1763/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1764/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1765/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1766/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1767/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1768/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1769/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1770/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1771/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1772/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1773/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1774/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1775/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1776/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1777/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1778/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1779/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1780/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1781/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1782/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1783/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1784/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1785/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1786/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1787/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1789/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1790/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1791/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1792/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1793/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1794/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1795/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1796/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1797/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1798/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1799/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1800/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1802/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1803/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1804/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1806/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1807/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1808/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1809/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1810/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1811/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1812/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1813/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1814/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1815/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1816/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1817/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1818/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1819/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1820/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1821/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1822/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1823/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1824/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1825/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1826/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1827/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1828/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1829/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1830/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1831/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1832/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1833/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1834/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1835/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1836/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1837/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1838/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1839/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1840/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1841/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1842/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1843/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1844/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1845/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1846/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1847/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1848/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1849/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1850/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1851/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1852/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1853/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1854/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1855/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1856/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1857/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1858/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1859/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1860/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1861/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1862/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1863/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1864/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1865/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1866/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1867/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1868/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1869/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1870/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1871/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1872/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1873/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1874/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1875/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1876/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1877/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1878/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1879/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1880/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1881/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1882/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1883/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1884/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1885/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1886/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1887/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1888/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1889/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1890/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1891/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1892/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1893/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1894/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1895/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1896/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1897/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1898/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1899/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1900/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1901/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1902/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1903/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1904/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1905/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1906/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1907/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1908/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1909/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1910/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1911/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1912/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1913/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1914/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1915/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1916/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1917/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1918/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1919/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1920/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1921/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1922/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1923/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1924/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1925/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1926/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1928/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1929/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1930/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1931/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1932/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1933/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1935/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1936/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1937/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1938/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1939/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1940/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1941/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1942/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1943/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1944/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1945/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1946/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1947/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1948/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1949/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1950/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1951/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1952/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1953/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1954/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1955/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1956/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1957/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1958/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1960/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1961/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1962/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1963/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1964/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1965/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1966/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1967/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1968/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1969/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1970/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1971/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1972/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1973/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1974/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1975/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1976/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1977/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1978/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1979/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1980/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1981/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1982/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1983/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1984/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1985/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1986/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1987/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1988/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1990/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1991/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1992/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1993/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1994/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1995/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1996/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1997/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/1998/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2000/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2001/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2002/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2003/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2004/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2005/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2006/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2007/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2008/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2009/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2010/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2011/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2012/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2013/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2014/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2015/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2016/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2017/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2018/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2019/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2020/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2021/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2022/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2023/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2024/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2025/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2026/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2027/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2028/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2029/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2030/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2031/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2033/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2034/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2035/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2036/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2037/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2038/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2039/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2040/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2041/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2042/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2043/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2044/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2045/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2046/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2047/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2048/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2050/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2051/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2052/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2053/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2054/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2055/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2056/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2057/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2058/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2059/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2060/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2061/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2062/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2063/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2064/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2065/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2066/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2067/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2068/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2069/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2070/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2071/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2072/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2073/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2074/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2075/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2076/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2077/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2079/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2081/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2082/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2083/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2084/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2085/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2086/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2087/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2088/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2089/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2090/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2091/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2092/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2093/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2094/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2095/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2096/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2097/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2098/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2099/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2100/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2101/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2102/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2103/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2104/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2105/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2106/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2107/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2108/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2109/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2110/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2111/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2112/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2113/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2114/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2115/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2116/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2117/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2118/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2119/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2120/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2121/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2122/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2123/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2124/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2126/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2127/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2128/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2129/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2130/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2131/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2132/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2133/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2134/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2135/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2136/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2138/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2139/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2140/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2141/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2142/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2143/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2144/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2145/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2146/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2147/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2148/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2149/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2150/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2151/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2152/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2153/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2154/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2156/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2157/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2158/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2159/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2160/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2161/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2162/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2163/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2164/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2165/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2166/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2167/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2169/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2170/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2172/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2173/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2174/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2175/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2176/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2177/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2179/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2181/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2182/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2183/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2184/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2185/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2186/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2187/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2188/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2189/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2190/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2191/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2192/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2193/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2194/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2197/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2198/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2199/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2200/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2201/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2202/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2203/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2204/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2205/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2206/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2207/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2208/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2209/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2210/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2211/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2212/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2213/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2214/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2215/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2218/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2219/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2221/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2224/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2226/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2227/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2228/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2229/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2230/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2231/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2232/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2233/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2234/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2235/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2236/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2237/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2238/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2239/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2240/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2241/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2242/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2243/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2244/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2245/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2246/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2247/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2248/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2249/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2250/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2251/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2252/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2253/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2254/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2255/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2256/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2257/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2258/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2259/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2261/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2262/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2263/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2264/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2265/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2266/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2267/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2268/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2269/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2270/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2271/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2272/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2273/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2274/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2275/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2276/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2277/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2278/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2279/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2280/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2281/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2283/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2284/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2285/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2286/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2287/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2288/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2289/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2290/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2291/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2292/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2293/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2294/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2295/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2296/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2297/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2298/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2299/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2300/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2301/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2302/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2303/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2304/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2305/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2306/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2307/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2308/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2309/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2310/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2311/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2312/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2313/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2314/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2315/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2316/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2317/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2318/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2319/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2320/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2321/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2322/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2323/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2324/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2325/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2326/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2327/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2328/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2329/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2330/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2331/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2332/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2333/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2334/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2335/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2336/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2337/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2338/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2339/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2340/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2341/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2342/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2343/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2344/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2345/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2346/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2347/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2348/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2349/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2350/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2353/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2354/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2355/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2356/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2358/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2359/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2360/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2362/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2363/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2364/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2365/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2366/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2367/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2368/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2371/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2372/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2373/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2375/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2376/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2386/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2387/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2388/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2389/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2390/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2391/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2394/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2396/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2398/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2399/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2400/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2401/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2403/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2406/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2407/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2409/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2410/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2411/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2412/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2413/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2414/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2415/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2416/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2418/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2420/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2421/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2422/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2424/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2425/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2426/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2427/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2428/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2429/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2430/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2432/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2433/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2434/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2435/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2437/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2438/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2439/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2440/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2441/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2442/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2443/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2444/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2445/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2446/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2447/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2448/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2449/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2451/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2452/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2453/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2454/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2455/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2456/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2457/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2458/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2459/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2460/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2461/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2463/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2464/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2465/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2466/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2467/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2468/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2469/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2470/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2471/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2472/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2473/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2474/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2475/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2476/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2477/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2478/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2480/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2481/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2483/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2484/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2485/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2486/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2487/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2488/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2489/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2490/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2491/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2493/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2494/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2495/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2497/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2498/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2500/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2501/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2502/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2503/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2504/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2505/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2507/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2508/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2511/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2512/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2513/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2514/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2515/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2519/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2520/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2521/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2522/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2524/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2525/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2526/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2527/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2528/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2529/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2531/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2532/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2533/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2534/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2535/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2536/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2537/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2538/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2539/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2540/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2541/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2542/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2544/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2545/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2546/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2547/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2548/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2549/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2550/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2551/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2552/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2553/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2554/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2555/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2556/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2557/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2558/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2559/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2560/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2561/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2562/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2563/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2564/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2565/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2566/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2567/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2568/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2569/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2570/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2571/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2572/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2573/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2575/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2576/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2577/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2578/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2579/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2580/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2581/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2582/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2583/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2584/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2585/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2586/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2587/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2588/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2589/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2590/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2591/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2592/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2593/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2594/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2596/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2597/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2598/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2599/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2600/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2602/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2603/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2604/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2606/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2607/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2609/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2610/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2612/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2613/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2614/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2615/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2616/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2617/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2618/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2619/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2621/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2622/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2624/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2626/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2627/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2628/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2629/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2630/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2631/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2633/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2634/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2635/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2636/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2637/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2638/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2639/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2640/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2641/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2642/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2643/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2644/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2645/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2647/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2649/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2651/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2654/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2656/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2660/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2661/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2662/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2663/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2664/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2665/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2666/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2668/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2669/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2670/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2671/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2672/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2673/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2674/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2675/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2677/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2678/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2679/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2680/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2681/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2682/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2683/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2684/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2685/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2686/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2687/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2688/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2689/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2691/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2692/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2693/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2695/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2696/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2697/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2698/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2699/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2700/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2701/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2703/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2704/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2705/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2706/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2708/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2709/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2710/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2711/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2712/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2713/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2714/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2715/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2716/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2717/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2718/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2719/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2720/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2721/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2722/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2723/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2724/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2725/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2726/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2727/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2728/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2729/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2730/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2731/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2732/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2733/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2734/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2735/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2736/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2737/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2738/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2739/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2740/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2741/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2742/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2743/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2744/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2745/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2746/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2747/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2748/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2749/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2750/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2751/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2752/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2753/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2754/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2755/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2756/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2757/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2758/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2759/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2761/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2762/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2763/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2764/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2765/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2766/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2767/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2768/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2770/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2771/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2772/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2773/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2774/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2775/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2776/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2777/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2778/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2780/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2782/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2784/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2785/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2786/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2787/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2788/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2789/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2790/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2791/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2792/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2795/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2796/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2798/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2800/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2801/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2802/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2805/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2806/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2807/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2808/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2809/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2811/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2812/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2813/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2814/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2815/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2816/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2817/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2818/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2820/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2821/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2822/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2823/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2825/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2826/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2827/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2828/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2829/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2830/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2831/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2832/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2834/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2835/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2836/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2837/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2838/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2839/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2840/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2841/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2842/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2843/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2844/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2845/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2846/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2847/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2848/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2849/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2850/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2851/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2853/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2854/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2855/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2856/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2857/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2858/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2859/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2860/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2861/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2862/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2863/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2864/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2865/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2868/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2869/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2870/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2871/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2872/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2873/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2874/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2875/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2876/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2877/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2878/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2879/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2880/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2881/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2882/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2884/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2885/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2886/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2887/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2888/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2889/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2890/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2891/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2893/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2894/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2896/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2897/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2898/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2899/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2900/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2901/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2902/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2903/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2904/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2905/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2906/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2907/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2908/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2909/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2910/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2911/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2912/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2913/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2914/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2916/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2917/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2918/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2920/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2921/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2922/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2923/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2924/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2925/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2927/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2928/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2930/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2931/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2932/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2933/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2934/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2935/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2936/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2937/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2938/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2940/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2941/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2942/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2944/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2945/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2946/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2947/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2949/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2952/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2955/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2956/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2957/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2958/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2959/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2960/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2961/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2962/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2963/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2964/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2965/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2966/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2967/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2968/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2969/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2970/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2972/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2973/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2974/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2976/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2977/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2978/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2980/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2983/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2985/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2986/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2987/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2988/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2990/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2991/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2992/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2993/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2994/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2996/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2997/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2998/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/2999/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3004/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3005/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3006/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3007/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3008/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3009/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3010/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3011/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3014/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3015/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3016/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3017/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3018/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3019/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3021/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3022/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3024/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3026/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3027/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3028/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3029/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3030/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3032/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3033/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3034/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3035/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3037/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3038/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3039/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3041/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3045/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3046/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3047/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3048/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3049/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3050/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3051/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3052/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3053/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3054/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3055/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3056/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3058/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3059/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3060/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3061/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3062/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3063/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3064/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3065/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3066/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3067/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3068/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3069/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3070/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3071/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3072/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3073/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3074/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3075/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3076/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3077/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3078/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3079/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3081/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3082/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3083/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3084/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3085/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3086/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3087/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3088/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3089/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3090/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3092/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3093/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3094/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3095/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3096/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3097/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3098/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3099/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3100/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3101/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3102/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3104/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3105/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3106/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3107/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3108/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3109/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3110/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3111/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3112/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3114/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3115/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3116/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3117/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3118/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3119/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3120/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3121/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3122/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3124/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3126/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3127/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3128/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3129/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3130/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3131/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3132/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3133/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3134/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3136/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3137/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3138/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3139/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3140/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3141/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3142/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3143/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3144/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3148/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3149/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3150/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3151/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3152/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3153/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3155/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3156/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3157/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3158/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3159/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3161/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3162/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3163/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3164/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3165/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3166/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3167/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3168/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3169/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3170/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3171/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3172/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3173/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3174/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3175/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3176/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3177/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3178/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3179/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3180/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3181/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3182/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3183/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3184/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3185/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3186/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3187/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3188/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3189/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3190/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3191/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3192/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3193/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3194/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3195/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3196/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3197/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3199/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3200/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3201/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3202/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3203/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3204/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3205/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3206/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3207/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3209/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3212/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3214/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3215/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3216/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3217/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3218/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3219/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3221/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3222/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3223/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3224/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3225/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3227/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3228/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3229/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3231/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3232/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3233/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3235/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3237/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3239/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3240/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3241/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3242/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3243/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3245/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3246/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3247/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3248/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3249/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3250/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3253/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3254/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3256/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3257/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3258/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3259/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3260/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3261/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3262/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3263/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3264/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3265/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3266/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3267/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3268/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3269/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3270/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3272/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3273/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3274/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3275/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3276/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3277/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3278/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3279/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3280/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3281/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3282/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3283/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3284/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3285/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3286/</loc>
    <lastmod>2026-05-12</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3287/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3288/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3289/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3290/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3292/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3294/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3296/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3297/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3298/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3299/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3300/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3301/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3302/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3303/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3304/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3305/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3307/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3308/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3309/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3310/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3311/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3312/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3314/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3316/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3317/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3319/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3320/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3321/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3323/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3324/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3325/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3327/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3328/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3329/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3330/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3331/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3332/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3333/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3335/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3337/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3338/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3350/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3351/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3352/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3353/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3354/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3355/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3356/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3358/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3359/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3360/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3361/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3362/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3363/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3364/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3365/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3366/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3367/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3368/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3369/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3370/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3371/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3372/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3373/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3374/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3375/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3376/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3377/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3378/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3379/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3380/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3381/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3382/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3383/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3384/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3385/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3386/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3387/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3388/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3389/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3390/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3391/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3392/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3393/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3394/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3395/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3396/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3397/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3398/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3399/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3400/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3401/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3402/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3403/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3404/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3405/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3406/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3407/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3408/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3409/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3410/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3411/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3412/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3413/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3414/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3415/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3416/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3417/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3418/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3419/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3420/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3421/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3422/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3423/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3424/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3425/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3426/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3427/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3428/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3429/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3430/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3431/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3432/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3433/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3434/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3435/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3436/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3437/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3438/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3439/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3440/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3441/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3442/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3443/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3444/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3445/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3446/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3447/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3448/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3449/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3450/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3451/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3452/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3453/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3454/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3455/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3456/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3457/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3458/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3459/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3460/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3461/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3462/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3463/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3464/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3465/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3466/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3467/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3468/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3469/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3470/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3471/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3472/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3473/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3474/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3475/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3476/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3477/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3478/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3479/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3480/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3481/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3482/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3483/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3484/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3485/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3486/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3487/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3488/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3489/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3490/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3491/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3492/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3493/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3494/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3495/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3496/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3497/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3498/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3499/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3500/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3501/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3502/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3503/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3504/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3505/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3506/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3507/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3508/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3509/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3510/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3511/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3512/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3513/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3514/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3515/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3516/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3517/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3518/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3519/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3520/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3521/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3522/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3523/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3524/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3525/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3526/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3527/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3528/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3529/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3530/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3531/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3532/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3533/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3534/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3535/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3536/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3537/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3538/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3539/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3540/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3541/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3542/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3543/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3544/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3545/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3546/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3547/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3548/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3549/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3550/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3551/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3552/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3553/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3554/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3555/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3556/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3557/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3558/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3559/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3560/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3561/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3562/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3563/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3564/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3565/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3566/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3567/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3568/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3569/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3570/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3571/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3572/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3573/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3574/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3575/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3576/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3577/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3578/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3579/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3580/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3581/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3582/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3583/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3584/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3585/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3586/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3587/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3588/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3589/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3590/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3591/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3592/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3593/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3594/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3595/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3596/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3597/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3598/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3599/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3600/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3601/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3602/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3603/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3604/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3605/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3606/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3607/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3608/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3609/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3610/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3611/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3612/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3613/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3614/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3615/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3616/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3617/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3618/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3619/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3620/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3621/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3622/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3623/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3624/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3625/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3626/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3627/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3628/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3629/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3630/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3631/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3632/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3633/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3634/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3635/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3636/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3637/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3638/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3639/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3640/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3641/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3642/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3643/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3644/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3645/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3646/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3647/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3648/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3649/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3650/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3651/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3652/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3653/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3654/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3655/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3656/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3657/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3658/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3659/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3660/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3661/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3662/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3663/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3664/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3665/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3666/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3667/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3668/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3669/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3670/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3671/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3672/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3673/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3674/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3675/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3676/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3677/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3678/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3679/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3680/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3681/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3682/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3683/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3684/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3685/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3686/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3687/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3688/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3689/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3690/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3691/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3692/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3693/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3694/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3695/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3696/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3697/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3698/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3699/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3700/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3701/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3702/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3703/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3704/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3705/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3706/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3707/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3708/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3709/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3710/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3711/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3712/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3713/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3714/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3715/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3716/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3717/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3718/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3719/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3720/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3721/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3722/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3723/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3724/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3725/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3726/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3727/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3728/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3729/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3730/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3731/</loc>
    <lastmod>2026-05-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3734/</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3735/</loc>
    <lastmod>2026-05-13</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3736/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3737/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3738/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3739/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3740/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3741/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3742/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3743/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3744/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3745/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3746/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3747/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3748/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3749/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3750/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3751/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3752/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3753/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3754/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3755/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3756/</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3758/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3759/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3760/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3761/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3762/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3763/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3764/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3765/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3766/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3767/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3768/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3769/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3770/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3771/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3772/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3773/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3774/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3775/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3776/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3777/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3778/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3779/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3780/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3781/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3782/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3783/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3784/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3785/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3786/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3787/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3788/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3789/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3790/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3791/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3792/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3793/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3794/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3795/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3796/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3797/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3798/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3799/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3800/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3801/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3802/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3803/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3804/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3805/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3806/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3807/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3808/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3809/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3810/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3811/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3812/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3813/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3814/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3815/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3816/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3817/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3818/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3819/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3820/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3821/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3822/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3823/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3824/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3825/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3826/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3827/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3828/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3829/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3830/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3831/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3832/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3833/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3834/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3835/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3836/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3837/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3838/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3839/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3840/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3841/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3842/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3843/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3844/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3845/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3846/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3847/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3848/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3849/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3850/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3851/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3852/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3853/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3854/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3855/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3856/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3857/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3858/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3859/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3860/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3861/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3862/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3863/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3864/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3865/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3866/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3867/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3868/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3869/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3870/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3871/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3872/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3873/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3874/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3875/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3876/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3877/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3878/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3879/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3880/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3881/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3882/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3883/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3884/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3885/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3886/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3887/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3888/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
  <url>
    <loc>https://lv.abol.hr/autori/3889/</loc>
    <lastmod>2026-07-21</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.4</priority>
  </url>
</urlset>
